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S u m m a ry
A num ber of functionally  related chem icals have been 
identified which overcome the replication defect of in 1814, an HSV-1 
mutant with a 12bp insertion mutation that inactivates the virion
transinducing factor, Vmw65. Hexamethylene bisacetamide (HMBA) and 
d im ethy lsu lphox ide  (DMSO) are poten t inducers o f term inal 
differentiation in cultured erythroleukaemic cells, and have also been 
shown to increase the speed and efficiency of reactivation of latent 
HSV-1 and HSV-2 after explantation of ganglia.
The work presented in this thesis demonstrates that the 
presence of 3-5mM HMBA in the cell culture medium, the optimum 
concentration for induction murine erythroleukaem ic cell (MELC) 
differentiation, increases the titre of znl814 on human foetal lung (HFL) 
cells 500-fold, enabling the mutant to initiate infection almost as
efficiently as wild type HSV-1. The titre of 1814R, the rescued 
"revertant" virus, was virtually unaffected by the presence of 5mM
HMBA. Related compounds DMSO and hypoxanthine, which induce MELC 
differentiation, also significantly increased the titre of 1814. A
number of known metabolites of HMBA did not increase the titre of
in 1814, either alone or in combination with various concentration of
HMBA.
The effect of HMBA is not cell type specific, as it was reproduced
in a number of cell lines including HFL, BHK and HeLa. Pre-treatment of
cells with HMBA prior to infection had no effect on the subsequent titre
of in 1814, demonstrating that HMBA does not act by inducing stable
cellular changes. HMBA exposure was shown to be required only 
transiently , im m ediately after adsorption, indicating that HMBA 
functions at the beginning of the virus life cycle.
RNA dot blot analysis revealed that the presence of HMBA
resulted in an increase in immediate early (IE) RNA accumulation after
infection of cells in the presence of cycloheximide, such that the RNA 
levels in znl814-infected cells approached values observed in wild type 
HSV-1-infected cells in the absence of HMBA. The observation that 
HMBA increases IE-RNA levels in the presence of cycloheximide, 
suggests that its target is a pre-existing cellular or viral component(s).
Southern blot analysis of nuclear DNA isolated from HFL cells 
infected with in 1814 in the presence or absence of HMBA, demonstrated
that the transport of viral DNA to the cell nucleus was not affected by 
HMBA.
A range o f plasm ids with the chloroam phenicol acetyl 
transferase (CAT) gene under the control of various viral promoters 
were introduced in HFL cells by lipofection. In this transient expression 
system, no detectable promoter or sequence specificity was identified in 
the mode of action of HMBA since increased CAT activity was observed 
from IE, early and late HSV-1 promoters and from the human 
cytomegalovirus (HCMV) and SV40 enhancers, in the presence of 5mM 
HMBA.
The question of specificity was subsequently addressed using a 
range of mutant viruses which allowed direct investigation into the 
effect of HMBA on different promoters in the viral genome. These 
results demonstrated that HMBA does not substantially compensate for 
the absence of VmwllO or adenovirus (Ad) E la, nor does it act as or 
induce an active cellular homologue of Vmwl75. Further analyses 
revealed that the HCMV enhancer and SV40 promoter/enhancer are 
responsive to activation by HMBA when integrated into the HSV 
genom e.
Gel retardation analysis revealed that HMBA does not promote
IEC formation with the TAATGARAT motif nor does it act as a "linker 
molecule", allowing mutant Vmw65, extracted from m l 814 virions, to 
interact with Oct-1 and TAATGARAT. Therefore HMBA does not act as or 
induce a cellular homologue of Vmw65. In addition, HMBA-treatment of 
nuclear extracts did not promote complex formation at other protein
binding motifs involved in regulation of transcription.
The HMBA effect on the titre of m l814 was not attributable to its 
demethylating properties as treatment with 5-azacytidine, an inhibitor 
of DNA methylation, did not increase the titre of in 1814. Addition of 8pM 
5-azacytidine actually decreased the titre of m l814 , especially when
present both prior to and after the addition of the virus, whereas little
effect was seen on the titre of 1814R.
HMBA-mediated modulation of protein kinase C (PKC) activity 
did not appear to be responsible for the effect on the titre of m l 814, as 
an inh ib ito r o f HM BA -induced MELC d ifferen tia tion , 12-0  -
tetradecanoylphorbol-13-acetate (TPA), did not antagonize the HMBA 
effect on m l8 1 4  titre. In addition, exposure to leupeptin, which is 
known to inhibit the conversion of membrane bound inactive PKC to
the soluble activated form, also failed to antagonize the effect of HMBA 
on the titre of m l 814.
The addition of 5mM HMBA to the cell culture medium increased 
the e ffic ien cy  o f  calc ium  ph o sp h ate -m ed ia ted  tran sfec tio n  
approximately threefold, for both wild type HSV-1 and m l814 viral DNA.
In an in vitro transcription initiation system, extracts prepared 
from HMBA-treated HeLa cells did not show increased transcription 
from the following promoters recognised by RNA polymerase II:- HSV-1 
IE-1 promoter; IE-4 promoter, in the presence or absence of the 
upstream sequences; HCMV IE promoter and the Ad major late promoter. 
Similarly, no increase in transcription of the the RNA polymerase III 
transcribed Ad VA genes using the HMBA-treated extract was observed 
compared to the activity of the untreated extract. The polar planar 
HMBA molecule does not function simply as a consequence of its overall 
negative charge as the inclusion of various concentrations of HMBA in 
the transcription reaction had an inhibitory effect.
A series of thymidine kinase (TK) transformed cell lines were 
constructed, with the HSV-1 TK gene under the control of different 
classes of HSV promoters. HMBA treatment did not have any dramatic 
effect on the level of expression from the HSV-1 TK, IE-3 or IE-4 
promoters in the cellular genome. Therefore, the results obtained 
indicate that HMBA can have a different effect on the same promoter 
sequence depending on the structural environment of that promoter.
The resu lts  suggest tha t HMBA- and DM SO-m ediated 
enhancement of reactivation from latency is due to a direct increase in 
IE RNA production, rather than demethylation. Determination of the 
molecular basis for the activity of HMBA on z/il814 infection may reveal 
the primary events by which the compound affects the poorly 
understood process of reactivation . In addition, these studies 
demonstrate a primary effect of HMBA on gene regulation which may 
be a paradigm for initial events during MELC differentiation.
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1. INTRODUCTION
1.1. The Herpesviruses  
1 .1 .1  T h e  Herpesviridae
Membership of the family Herpesviridae is defined by the structural 
architecture of the virion and by a number of specific biological properties. 
The unifying characteristics are listed below, and have^ been described in all 
herpesviruses examined to date (For detailed review see Roizman, 1990).
(1) Herpesviruses specify enzymes and other factors involved in nucleoside 
and nucleotide metabolism.
(2) Viral DNA synthesis and capsid assembly takes place in the nucleus.
(3) Virus replication leads to the destruction of the infected cell.
(4) Herpesviruses are capable of remaining in a latent state in the host cell 
for the lifetime of the host.
The virions of different members of the herpesvir idae  family cannot 
be distinguished by electron microscopic examination. However, they are 
readily identifiable by certain biological properties, virion immunological 
specificity and by genome size, arrangement and base composition. The 
fam ily h e r p e s v i r i d a e  is composed of three subfam ilies, namely 
a lp h a h e r p e s v i r in a e ,  b e ta h er p e sv i r in a e  and g a m m a h e r p e s v i r i n a e  (Section 
1.1.3).
1 .1 .2  S tructural com ponents of Herpes Simplex Virus 
(HSV) virions
A typical HSV virion consists of a core, a capsid, a tegument and an 
envelope. The fibrillar core contains a linear double stranded DNA molecule 
(Wildy et al ,  1960; Furlong et al ,  1972.) within an icosahedral capsid, 
approximately 100-1 lOnm in diameter. The capsid contains 12 pentameric and 
150 hexameric capsomeres which show 5:3:1 axial symmetry (Wildy et al,  
1960; McCombs et al., 1971). Schrag et al.( 1989) produced the first three- 
dimensional structure of both full and empty HSV-1 capsids, using low dose 
cryo-electron microscopy in conjunction with computer image analysis. This 
study deduced that the nucleocapsid was arranged into three distinct 
structural layers that they designated (i) the outer shell comprising six- 
coordinated capsomeres which appear hexagonal, (ii) an interm ediate
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proteinaceous layer with an underlying lattice displaying T=4 icosahedral 
symmetry, and (iii) an inner shell containing the viral DNA.
In addition to protein and DNA, the HSV-1 nucleocapsid contains
spermine which is thought to neutralize some of the negative charge on the 
DNA and hence facilitate dense packaging of DNA into virions (Roizman and 
Furlong, 1974).
The capsid is surrounded by an amorphous, asymmetrical material
designated the tegument (Roizman & Furlong, 1974). This structure is 
genetically determined by the virus (McCombs et al., 1971), but the amount of
the tegument material can differ, even in the same infected cell (Furlong e t
al., 1972). The final outermost component is the viral membrane or envelope,
which is probably derived from the host cell's nuclear membrane. This triple 
layered structure includes viral glycoprotein spikes projecting from the 
surface (Morgan et al., 1959; Epstein, 1962; Hamparian et al., 1963; Morgan et
al., 1968; Asher et al., 1969; Spears & Roizman, 1972; Stannard et al., 1987.).
1 .1 .3  Taxonomy of Herpesviruses
N
The classification of the herpesvir idae  family into three subfamilies, 
namely alpha-,  beta-,  and g a m m aherpesv i r inae ,  was decided by the Herpes 
Study Group appointed by the International Committee on Taxonomy of 
Viruses. These groupings are based on the criteria of host range, length of 
reproductive cycle, cytopathology and characteristics of latent infection 
(Roizman et al., 1981).
The neurotrop ic viruses HSV-1, HSV-2 and VZV are all members of 
alphaherpesvirinae. They are typified by a variable host range in vitro
and a relatively short reproductive cycle which results in the 
rapid spread of infection in cell culture with efficient destruction of 
susceptible cells. Alphaherpesviruses  have the capacity to establish latent 
infections that are frequently, but not exclusively, in sensory ganglia.
Betaherpesvirinae,  such as HCMV, show a narrow host range in vivo, 
and in vitro these viruses replicate most efficiently in fibroblast cells of the 
appropriate host. This subfamily is also characterised by a relatively long 
reproductive cycle, with only a slow spread of infection from cell to cell in 
tissue culture. Frequently, such infected cell are enlarged and form 
cytomegalia. Latent infections have been described in salivary glands, 
lymphoreticular cells, kidneys and other tissues.
During infection in vivo, members of the g a m m a h e r p e s v i r i n a e  , 
such as EBV, are restricted to replication in the same family or order as the
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host. In vitro, these viruses infect lymphoblastoid cells and, with exceptions, 
appear to be specific for either B or T lymphocytes. Lymphotrophic infection 
is frequently associated with the lack of production of infectious progeny
virus. As expected, the lymphoid tissue has been identified as the site of latent 
in fe c tio n .
It is now increasingly evident that the c lassification  of 
herpesviruses on the basis of their biological properties may not accurately 
reflect their phylogenetic relationships. For example sequence analysis of 
HHV-6 (Salahuddin et al, 1986) suggests that this virus is more closely related 
to betaherpesvirinae, (Lawrence et al,  1990) while its host range resembles 
that of gam m aherpesv ir inae .
1.1.4 Epidemiology of Herpesviruses
In most cases, primary infection with HSV-1 occurs early in life, and 
any associated disease is frequently indistinguishable from other childhood 
illnesses. After the initial infection, HSV-1 is retained in a latent form in theN
neurons of the sensory ganglia (Baringer and Swoveland, 1973; Fraser et al,
1981). Clinical symptoms are not apparent during long term latent infection.
Various factors, such as stress, fatigue and exposure to sunlight, are involved 
in triggering the reactivation of latent virus and the subsequent recurrence
of lesions.
A cold sore lesion on the mouth or lips is due to HSV-1 infection 
(herpes labialis), whereas HSV-1 infection of the corneal epithelia results in 
herpes keratoconjunctivitus, which in severe cases may lead to blindness. 
HSV-1 is also associated with skin infections (herpes herpeticum) and with a
broad spectrum of neonatal infections. The most devastating HSV-1 infection
is herpes simplex encephalitis (W hitley, 1985). Immune compromised 
patients and renal and cardiac recipients are at particular risk for increased 
severity of HSV infection (Logan et al ,  1971, Muller et al, 1972, Pass et al,  
1978).
HSV-2 infection is associated with genital lesions (herpes genitalis)
and is usually sexually transmitted, although infection may occur at birth 
(Whitley, 1985). A small number of cases of genital herpes are associated with 
HSV-1 infection, which are clinically less severe and less prone to 
recurrences than HSV-2 infection.
Varicella zoster virus (VZV) is the causative agent of the childhood
disease varicella (chicken pox). Infection is spread via the respiratory route 
and through direct contact, resulting in an irritable skin rash. Shingles
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Human herpes virus type 7 (HHV-7) was isolated by Frenkel et al. 
(1990) in an HIV-1 study, from a culture of CD4+ T cells obtained from 
a healthy individual. The use of monoclonal antibodies and western 
blot analysis has demonstrated that HHV-6 and HHV-7 are 
antigenically distinct (Wyatt et al.t 1991). Subsequently, HHV-7 has 
been frequently isolated from the saliva of healthy individuals 
(Wyatt & Frenkel, 1992).
(herpes zoster) is associated with a painful rash of dermatomal distribution 
which results from the reactivation of latent VZV from the sensory ganglia 
(Hope-Simpson, 1965; Vafai et al,  1988). Both the incidence and the degree of 
severity of shingles increases with age and in the immunocompromised 
(Schimpff et al,  1977; Kennedy, 1987).
Infection with the Epstein Barr Virus (EBV) is often asymptomatic 
with benign disease in children. However, if  the time of initial infection is 
delayed until adolescence, then EBV infection may manifest itself as 
infectious mononucleosis (glandular fever). EBV is | associated with the
development of Burkitt's Lymphoma and is linked to a high incidence of
nasopharyngeal carcinoma (Epstein and Achong, 1986).
Human cytom egalovirus (HCMV) in fec tions are norm ally  
asymptomatic with an increased antibody titre the only evidence of
infection. HCMV establishes latency in a number of cell types implicated in
the transmission of the virus such as blood, kidney and in host defence cells,
for example macrophages (Huang et al ,  1978). HCMV is the major cause of
viral congenital abnormalities in newborns (Hamilton, 1982). HCMV 
infection may result in the development of a syndrome resembling EBV 
infectious mononucleosis.
Human herpesvirus 6 (HHV-6) was originally isolated from patients 
with AIDS and lymphoproliferative disorders (Salahuddin et al,  1986). It has 
since been isolated from the saliva of normal adults (Harnett et al,  1990; Levy 
et al,  1990) and it is clear that 80-90% of the population develop antibodies to 
HHV-6 early in life (Saxinger et al,  1988; Okunu et al, 1989). HHV-6 has been 
isolated from children suffering from roseola infantum (exanthum subitum) 
and there is evidence that this is the causative agent of the disease 
(Yamanishi et al ,  1988). It is not yet clear whether HHV-6 is responsible for 
any other human diseases and its role in human biology remains largely
ftundefined .
1.1.5 Genome structures of human Herpesviruses
All human herpesviruses have large double stranded linear DNA
genomes, the structural features of which are illustrated in Figure 1.1.The 
complete nucleotide sequence of HSV-1 has been determined (McGeoch et al,  
1985, 1986, 1988; Perry & McGeoch, 1988) and comprises approximately 152kbp 
with a molecular weight of approximately 100 x 10^ kDal (Becker et al,  1968; 
Kieff et al,  1971). HSV-1 has a high G+C base composition of 68.3%. However,
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Figure 1.1 Gross structures of HSV genomes
The genome structures of the six known human herpesvirus are 
presented diagramatically as linear molecules. The unique sequences 
and repeat elements are represented as bold lines and open boxes
respectively. Arrows indicate the relative sequence orientation.
The abbreviations employed in the diagram are listed below
Ul unique long
Us unique short
I/TRl  internal/term inal long repeat 
I/TRs internal/term inal short repeat 
Dl direct repeat left
Dr  direct repeat right
MIR major internal repeat
o ri origin of DNA replication
This figure was reproduced from McGeoch (1989).
Figure 1.1
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this value is not constant throughout the genome, with a G+C content of 79.5% 
in the Rs elements.
Electron microscopic studies have shown that the HSV-1 genome 
consists o f two covalently linked segments, the long region (L) and short 
region (S). The L segment comprises an unique sequence (Ul ) bounded by a 
pair of oppositely orientated repeat elements (Rl )- The sequence elements 
present in the left terminus (TRl ) designated a,b, are complementary to the 
internal inverted repeat (TRl ), namely b ',a \ The same nomenclature is 
applied to the S region, which therefore consists of I R s , Us and TRs 
(Sheldrick & Berthelot, 1974; Figure 1.2).
Based on open reading frame (ORF) predictions, the HSV-1 genome is
estimated to encode 7 4 unique genes, two of which are repeated. 58 genes
reside in the Ul  region, 12 in Us- one in each of TRt and TRr and one in each
Ackerman et al.. 1986: Chou & Roizman. 1990; 
of TRs and IRs (McGeoch et al,  1988; ngure l.Jjj Barker & R0izmanj 1992)
The inverted repeats, R l  and R s , are approximately 9lu0bp and 
6600bp in size, respectively, (McGeoch et al., 1988). R l  and Rs share the 400bp 
a sequence (Davison & Wilkie, 1981) which is the minimum terminal 
repetitive sequence required for optimal circularization (Wadsworth et al., 
1976). One or more copies of the 'a' sequence are located internally at the 
joint between the long and short segments in the opposite orientation to the 
terminal a sequences (Sheldrick & Berthelot, 1974; Wadsworth et al., 1976; 
Wagner & Summers, 1978). An overhanging residue, with a free 3' hydroxyl 
group, is found at the ends of the terminal a sequences (Mocarski & Roizman,
1982).
Preparations of HSV-1 DNA consist of equimolar quantities of four 
sequence orientation isomers, with U l  and Us lying independently in one of 
two possible orientations with respect to the joint between the L and S 
segments (Delius & Clements, 1976; Wilkie, 1976). One particular isomer has 
been designated as the prototype orientation to enable standardization of 
genetic maps (Roizman, 1979; McGeoch, 1989). Evidence is available to support 
the notion that all four isomers result in both the production of infectious 
progeny (Davison & Wilkie, 1983) and the development of latent infection 
(Efstathiou et al., 1986).
To date, approaching 33kbp of HSV-2 DNA sequence has been 
determined, with all of the Us region known (McGeoch et al ,  1987). HSV-2 is 
closely related to HSV-1, their genome sequences being closely co-linear 
(Davison & Wilkie, 1983) and the coding sequences of corresponding genes 
showing 70-80% nucleotide homology (McGeoch et al, 1987).
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Figure 1.2 The positions of the a, b, and c sequences
within the HSV genome
The positions of the a, b, and c sequences are indicated. The a’, b' and c'
sequences are identical to, but in the opposite orientation from, the a, b
and c sequences. The number of a sequences at the junction between 
the L and S components of the HSV genome is variable, but often equal 
to one.
Figure 1.2
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Figure 1.3 Organisation of HSV-1 genes
The locations of the predicted HSV-1 ORFs are shown as arrows, and the 
corresponding proposed polyadenylation sites are denoted with vertical 
bars. The upper and lower scales represent map units and kilobase pairs 
respectively. DNA origins of replications are indicated by an X (Stow, 
1982; Spaete & Frenkel, 1982; Stow & McMonagle, 1983; Weller et al., 
1985).
This figure was reproduced from McGeoch et al. (1988).
(Ackerman et al., 1986; Chou & Roizman, 1990; Barker & Roizman, 1992)
Figure 1.3
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The entire sequence of the 125kbp genome of VZV is known (Davison 
& Scott, 1986). The VZV genome has a molecular weight of 80 x 10^ kDal, with a 
G+C content of 46%, both of which are lower than the equivalent values for 
HSV-1. The gross structure resembles that of HSV-1, with the exception of the 
size of the repeats flanking Ul  which is only 88bp in VZV compared to 9200bp 
in HSV-1. VZV also exists in four isomeric forms, however two of these, 
representing one orientation of Ul  » are 20 times more abundant than the 
other forms (Davison, 1984).
The first herpesvirus to be entirely sequenced was the B95-8 strain of 
EBV (Baer et al., 1984) with a genome size of approximately 172kbp and a G+C 
content of 59.9%. Further investigation revealed that this strain of EBV 
contains a 13.6kbp deletion, therefore 186kbp is more likely to represent the 
true size (Raab-Traub, 1980). The organisation of the repeated elements in
EBV varies greatly from that of HSV-1 (Fig. 1.1). A direct repeat of a 540bp 
sequence comprises the termini. Internally, the genome carries a set of 
3072bp directly repeated elements, the major internal repeat (MIR), which 
separates the Us and Ur . D r  and D r  are almost identical lOOObp repeat
elements flanking the Ur  segm ent.
The HCMV genome, the largest of the human herpesvirus, is almost 
230kbp with a molecular weight of 147 x 10^ kDal (Geelen et al., 1978) and a 
G+C content of 56%. The DNA sequence of the strain A D I69 has been 
determined (Chee et al ,  1990) and with respect to the layout of repeat and 
unique sequences its overall structure is similar to that of HSV-1 (Kilpatrick 
& Huang, 1977; Westrate et al., 1980). Like HSV-1, the HCMV genome has 
equimolar amounts of four orientation isomers (Kilpatrick et al,  1976) and an
equivalent of the HSV-1 a sequence is also present (Spaete & Mocarski, 1985).
The HHV-6 genome is approximately 160kbp in with a base 
composition of 41% G+C. It consists of a single unique sequence bounded by a 
set of large direct repeats and shows some sequence homology with a region 
of the HCMV genome (Efstathiou et al., 1988).
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1.2 Herpes Simplex Virus Lytic Cycle
1.2.1 Initial steps in HSV infection
HSV replication commences with the adsorption of the virion to the 
cell, followed by penetration through the host membrane. WuDunn & Spear
(1989) demonstrated that the initial interaction between both HSV-1 and HSV- 
2 and the cell membrane is the binding to cell surface heparan sulphate 
moieties. Agents which block this interaction, or enzymatic digestion of 
heparan sulphate, also effectively prevent viral adsorption and penetration. 
There is a requirement for multiple virion-cell surface interactions to occur 
subsequent to adsorption, to allow fusion of the virion to the cell to 
commence. Recently Tufaro et al  (Abstract, 17th International Herpesvirus 
Workshop, 1992) demonstrated that a cell line defective in synthesizing the 
carbohydrate chains of heparan sulphate proteoglycans is actually 
permissive for HSV infection, thus indicating that other cell surface 
molecules may substitute for this function.
HSV penetration can occur by both the fusion of the viral envelope 
with the cell membrane ( Epstein et a l,  1964; Morgan et al, 1968; Smith &
DeHarven, 1974) and by endocytosis (Hummeler et a l ,  1969; Smith & 
DeHarven, 1974; Dales & Silverberg, 1969). However, the predominant 
pathway for productive entry of HSV-1 is by fusion at the cell membrane 
(Rosenthal et al, 1989). The study by Rosenthal et a l  (1989) also demonstrated 
that the penetration of HSV-1 KOS was 100 fold less likely to occur at mildly 
acidic conditions (pH6.3) than at physiological pH (pH7.4). The relevence of 
this observation is that electron microscopy studies previously demonstrated 
that fusion predominates at pH7.4, and endocytosis at pH6.3. In addition mildly 
acidic conditions have also been shown to inhibit HSV-induced cell to cell 
fusion and syncytium formation (Lancz & Bradstreat, 1976).
The envelope glycoproteins gB, gD and gH play essential roles in
viral penetration (Cai et al, 1987, 1988; Desai et al,  1988; Ligas et al,  1988;
Little et a l ,  1981). Neutralizing monoclonal antibodies raised against gB, gD 
and gH individually block viral penetration, but have a negligible effect on 
virion adsorption (Fuller et al, 1987; Highlander et al,  1987, 1988). Recently, 
Hutchinson et a l  (1992a, 1992b) identified glycoproteins gK and gL, both of 
which appear to be essential for HSV replication. gC significantly enhances 
the binding and infectivity for HEp-2 and Vero cells (Herold et a l,  1991). The 
other known glycoproteins (gE, gG, gl) are apparently dispensable for virus
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replication in cultured cells (Drapel et al, 1984; Longnecker & Roizman, 1987; 
Neidhert et a l,  1987).
1.2.2 Alteration of host macromolecular synthesis .
The sequential expression of HSV genes during lytic infection 
usually occurs against a declining background of host macromolecular 
synthesis (Roizman et al, 1965; Fenwick, 1984). This inhibition of cellular 
DNA, RNA and protein synthesis, or "host shut-off, is a complex multistage 
p rocess.
The early or primary phase of host shut-off is mediated by a virion 
component (Nishioka & Silverstein, 1977) responsible for the dissaggregation 
of cellular polyribosomes (Sy diskis & Roizman, 1966, 1967) and the
subsequent degradation of host mRNAs (Schek & Bachenheimer, 1985). The 
effects of early host shut-off are seen in the presence of actinomycin 
(Fenwick & Walker, 1978) and with UV-irradiated HSV-1 (Nishioka & 
Silverstein, 1977), thus indicating that a virion component is responsible for 
the phenomenon. The early shut-off is followed by delayed or late shut-off 
which is conditional upon the synthesis of viral RNA and proteins. Late shut- 
off is responsible for the enhanced reduction of host protein synthesis and 
for a decrease in cellular DNA synthesis (Fenwick, 1984).
A range of mutants deficient in host shutoff
(vhs mutants) have been isolated .and characterised (Read & Frenkel, 1983;JCwo*9 efal,
Kwong & Frenkel, 198/) and have proved important for studying shut-off. 
vhs  1 is defective in early shutoff and consequently fails to degrade pre­
existing mRNAs in the absence of viral gene expression. In contrast v h s  
mutants are not defective in late shutoff. The presence of the vhs 1 mutation 
dramatically increases the functional half-lives of viral mRNAs representing 
all kinetic classes (Oroskar & Read, 1989). The vhs  gene product appears to 
destabilise mRNAs with little or no apparent sequence specificity but the 
mechanism of this vhs induced mRNA turnover is not yet known. It has been 
proposed that the vhs  gene may either encode a RNase or activate a pre­
existing cellular nuclease. Alternatively, the vhs  function may act by 
modifying the translational machinery thus rendering the associated mRNA 
more susceptible to nuclease attack (Oroskar & Read, 1989). The vhs  1 
mutation has been mapped to a fragment spanning map coordinates 0.604 to 
0.606, which contains the UL41 open reading frame, and this gene product is 
responsible for the early suppression of protein synthesis (Morse et a l,  1978; 
Kwong et a l,  1988; McGeoch et al, 1988). UL41 is not an essential structural
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component of the virion because viruses containing insertions or deletions 
in UL41 are viable (Fenwick & Everett, 1990). Several lines of evidence 
recently demonstrated that the virion transactivator Vmw65 binds to the vhs  
gene, product (Weinheimer et a l, Abstract, 17th International Herpesvirus 
Workshop, 1992). Subsequent mutational analysis revealed that vhs residues 
178-344 were sufficient for complex formation, and that the acidic 
transcriptional activation domain of Vmw65 was not required. The authors 
proposed that newly synthesized Vmw65 serves to sequester or dampen the 
activity of the vhs protein produced during the late phase of the lytic cycle 
(W einheim er et al., Abstract, 17th International Herpesvirus Workshop, 
1992).
Godowski & Knipe (1985) proposed that the production of a viral 
protein, possibly ICP8, early in infection is responsible for the protection of 
viral mRNAs from the effects of the virion-associated UL41 gene product. 
This study demonstrated that infection with the ICP8 ts mutant ts 13, at the 
non-permissive temperature, led to a substantially lower level of ICP4 
(Vmwl75) mRNA accumulation than detected during infection with wild type 
HSV-1 (KOS). It is therefore possible that ICP8 may function as a mRNA 
stabilizing factor counteracting the effect of UL41 as ICP8 has a strong 
affinity for both single stranded and polyA+ RNA (Ruyechan & Weir, 1984) 
and has previously been shown to downregulate the expression of other viral 
genes (Godowski & Knipe, 1985).
Not all cellular genes are downregulated during viral infection.
Histone gene expression is not repressed by HSV infection (Mayman & 
Nishioka, 1985), while the abundance of cellular heat shock proteins actually 
increases during HSV infection (La Thangue et al, 1984; Patel et al, 1985; 
Kemp et al, 1986). A recent study of three 70,000 molecular weight heat shock 
genes has shown that only h sp 70 is induced by HSV-1 infection (Phillips e t  
a l ,  1991). This specific transcriptional activation of hsplO  in HeLa cells is 
transient and followed by a rapid repression (Phillips et al, 1991). Notarianni
and Preston (1982) demonstrated that the overproduction of immediate early
polypeptides during tsK infection at the non-permissive temperature led to 
increased synthesis of host heat shock proteins, and further studies showed 
that it is the overproduction of the mutant Vmwl75 polypeptide that induces 
the stress response (Russell et al, 1987b). The abolition of Vmw63 function 
during HSV-1 infection prevents the accumulation of a 40kd cellular protein. 
Vmw63 acts in conjunction with another as yet unspecified factor present in
the infected cell (Esteridge et a l ,  1989). Infection of HFL cells with a 
temperature sensitive mutant, ts 1204, deficient in penetration at the non-
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permissive temperature, induces the synthesis of a 56kd cellular protein. p56 
induction is not detected during a wild type HSV-1 infection, where it is
probably inhibited by the expression of art early viral protein (Preston,
1990).
1.2.3 Transcriptional features of HSV-1 genes
HSV-1 genes are transcribed by cellular RNA polymerase II, in the 
nucleus of the host cell (Alwine et al., 1974; Ben-Zeev & Becker, 1977; Costanzo 
et al., 1977). The resultant viral mRNAs share common structural features 
with cellular RNAs. They have a 5' cap structure, are polyadenylated at the 3' 
end, and are internally methylated (Bachenheimer & Roizman, 1972; 
Silverstein et al., 1973; Bartoski & Roizman, 1976). The occurrence of 3' co­
terminal families, where a particular gene has its own promoter and unique 
5' terminal sequences, but shares 3' terminal sequences with other
transcripts, is common. This arrangement is seen in the Us where 11 of the 
13 mRNAs (encoding 12 proteins) are arranged into four nested families 
(Rixon & McGeoch, 1984, 1985; McGeoch et al, 1986.). Overlapping reading 
frames and 5' ends on opposite strands are also observed, albeit relatively 
rarely (Rixon & McGeoch, 1984; Wilkie et al, 1980). Spliced transcripts are 
also a minority feature of HSV-1 transcription. Out of the 7? proposed distinct 
genes (Fig. 1.2), only the IE-1 (Perry et al., 1986), IE-4/5 (Watson et al., 1981; 
Rixon & Clements, 1982), UL15 (Costa et al., 1985; McGeoch et al., 1988) and the 
latency associated transcripts (LATs) (Wagner et al, 1988; Wescher et al,
1988) are known to generate mature mRNA by splicing.
HSV-1 gene expression occurs in a coordinated temporal manner, 
with HSV transcription divided into three distinct phases, namely IE (a), E (p) 
and L (y) (Swanstrom & Wagner, 1974; Jones & Roizman, 1979; Clements et al, 
1977). The IE genes are the first class to be transcribed immediately upon 
entry into the host cell and in the absence of de novo protein synthesis 
(Kozak & Roizman, 1974; Clements et al., 1977; Jones & Roizman, 1979). IE 
polypeptides play regulatory roles in HSV gene expression, and the
properties of the five IE proteins are described in section 1.2.5. Subsequent 
expression of early genes which encode proteins involved in DNA replication 
and nucleotide metabolism is dependent upon functional IE gene products. 
Vmw63 appears to be involved in the switch from early to late gene
expression (Sacks et a l,  1985; McCarthy et al., 1989; Rice & Knipe, 1990). Late
gene expression is split into two different stages, early late (y i) and "true"
late (Y2) with the distinction that transcription of Y2 genes occurs only after
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viral DNA replication has taken place (Jones & Roizman, 1979; Holland et al, 
1980; Hall et a l,  1982; Godowski & Knipe, 1985; Johnson et a l,  1986). In 
contrast, yi proteins are produced at detectable levels when DNA synthesis is 
inhibited. Late genes generally encode structural proteins and proteins 
involved in the production of progeny virions.
The expression of HSV-1 genes is primarily controlled at the level of 
transcription initiation. However, McLauchlan et a l  (1989) demonstrated that 
an HSV-induced factor regulates polyadenylation site usage. The presence of 
this heat labile factor selectively increases cleavage at a late polyadenylation 
site in vitro. However, sequence comparison of polyadenylation sites 
representing all temporal classes of HSV genes does not reveal any consensus 
sequence associated specifically with late polyadenylation sites (McLauchlan 
et al, 1989).
Temporal regulation of the three classes of HSV genes is governed by 
the 5' flanking sequences associated with the different promoters classes. 
Sequence analysis of upstream promoter regions demonstrated that they 
contained c i s -acting elements recognised by both viral and cellular 
transacting factors.
1.2.4 Immediate-early gene expression
The nature of the regulatory sequences associated with immediate 
early (IE) gene expression was originally investigated by Post et a l  (1981). 
Their paper describes the conversion of TK' viruses to a TK+ phenotype in 
which structural sequences of the HSV thymidine kinase gene were linked to 
either its own promoter or to the 5' flanking sequences constituting the IE-3 
promoter. Cells infected with the IE-3-TK recombinant virus under immediate 
early conditions showed induced TK activity upon the release of the 
cycloheximide block. In contrast, the wild type virus did not express 
thymidine kinase in the absence of protein synthesis. The IE-3 5* terminal 
sequences are sufficient to confer IE- regulatory characteristics upon the 
normally early TK gene, and the positioning of these sequences at the 3' end 
of the promoter abolished the expression of TK (Post et a l,  1981). A TK+ 
transformed cell line was also constructed with the TK gene under the 
control of the IE-3 promoter. Superinfection with a TK' virus resulted in the 
stimulation of TK activity from the IE-3 promoter, even in the presence of 
cycloheximide. A similar induction was observed at both permissive and non- 
permissive temperatures by the superinfection of a ts virus (ts502-A305) that 
lacks a functional Vmwl75. Post et a l  (1981) suggested that enhancement
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from the IE-3-TK chimera was due to a virion component, provided by the 
superinfecting TK" virus, which did not depend on IE gene products. Similar 
results were later obtained using TK+ cell lines derived from IE-l-TK and IE- 
3-TK chimeras (Mackem & Roizman, 1982a, 1982b).
U V -irradiated TK" virus was shown to be as effective as untreated 
virus at inducing TK activity from IE-3-TK chimeras (Batterson & Roizman,
1983). A temperature sensitive mutant, fsB7, defective in uncoating, 
stimulated IE gene expression at the non-permissive temperature, at which 
viral DNA is not released from the capsid, indicating that the factor 
responsible for induction of IE genes is a component located outwith the 
nucleocapsid (Batterson & Roizman, 1983). This virion component was later 
identified by Campbell et al  (1984) in a series of co-transfection experiments 
in which cloned restriction fragments of HSV and an IE-TK reporter plasmid 
were introduced into cells and the resultant TK activity was determined. The 
B a m Hlf fragment (0.64 to 0.69 map units) was found to encode an activity 
which stimulates only IE-TK activity. This transactivation activity was 
subsequently localised to a 2.3kbp subclone of the Bam  Hlf fragment. Hall e t  
al. (1982) showed that a major 1.9kb mRNA species was the only entire 
transcript originating from the region encompassed by this subclone. 
H ybrid-arrested  translation, in conjunction with im m unoprecipitation 
analyses, were employed to verify that this transactivating virion component 
was indeed Vmw65 (Campbell et al, 1984).
The product of the UL48 gene, Vmw65 (also known as VP16), is the 
major tegument protein, and it is estimated that there are approximately 1000 
molecules per virion (Heine et al, 1974; Roizman & Furlong, 1974). Vmw65 is 
essential for the assembly of progeny virions, since the HSV-2 mutant ts 2203,
whose mutation maps to Vmw65 coding sequences, fails to assemble virus
particles at the non-permissive temperature (Ace et al, 1988).
The sequence elements located in the 5' upstream region responsible 
for m ediating the responsiveness to transactivation by Vmw65 were
determined by sequence and deletion analyses. A consensus AT-rich cis- 
acting sequence, TAATGARATTC (R = purine) was identified, the presence of 
which was integral to Vmw65 responsiveness. (Mackem & Roizman, 1982a,b,c; 
Cordingley et a l,  1983; Kristie & Roizman, 1984; Lang et al, 1984; Preston & 
Tannahil, 1984; Gaffney et al, 1985; Bzik & Preston, 1986). The TAATGARAT 
consensus sequence was shown to be present in the far upstream regions of 
all the HSV-1 IE genes (Murchie & McGeoch, 1982; Mackem & Roizman, 
1982a,b; Whitton et al, 1983; Whitton & Clements, 1984) and its activity is also 
modulated by flanking sequences. In IE4/5 and IE-3, these regions contain
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the heptanucleotide CCCGCCC or its complement GGGCGGG (Preston & 
Tannahill, 1984) which represent binding sites for the transcription factor 
Spl (Jones & Tjian, 1985). Studies by Kristie & Roizman (1984) highlight the 
importance of similar flanking sequences, the GA-rich motifs identified in 
the upstream regulatory regions of the IE-2, IE-3 and IE-4/5 promoters. These 
GA-rich elements do not have any independent activity, but can convert an 
otherwise non-functional related element, TAACGAGGAAG, to a state of virion 
responsiveness (Bzik & Preston, 1986).
The IE-3 far upstream region, between nucleotide positions -174 to 
-332, contains an enhancer-like element (Post et al., 1981; Mackem & 
Roizman, 1982a; Cordingley et al, 1983; Lang et al, 1984; Preston & Tannahill,
1984) which is not functionally dependent on Vmw65, and can stimulate 
expression in both orientations and from a considerable distance (>1000bp) 
(Lang et a l,  1984; Preston & Tannahill, 1984). However, in contrast to other 
characterised enhancers, this element does not appear to function when 
positioned downstream of the target gene. Both the GC-rich and GA-motifs are 
integral components of this enhancer (Preston & Tannahill, 1984).
After the discovery that Vmw65 acts through the TAATGARAT 
element, emphasis moved towards revealing its mode of action. Vmw65 itself 
does not possess any intrinsic DNA binding activity, neither specifically for 
the TAATGARAT element nor non-specifically for double stranded DNA 
(Marsden et al, 1987; Preston et al, 1988). This apparent paradox was resolved 
when Vmw65 was shown to form a specific complex with the TAATGARAT 
motif, only in the presence of cellular proteins under conditions that support 
the binding of these cellular factors to DNA (McKnight et al, 1987; O'Hare & 
Goding, 1988; Preston et al, 1988). Studies prior to this work had revealed that 
nuclear extracts from uninfected tissue culture cells contained two major 
proteins that specifically bound to the TAATGARAT site (Kristie & Roizman,
1987). DNase I footprinting analysis and gel retardation assays using 
uninfected HeLa nuclear extract, confirmed the formation of a specific 
complex between cellular proteins and the TAATGARAT motif (O'Hare & 
Goding, 1988; Preston et a l,  1988). This novel complex, denoted the IEC 
(immediate early complex), was detected using either infected nuclear extract 
or uninfected extract supplemented with virion extract (Preston et a l,  1988).
Monoclonal antibodies, LP1 (McLean et a l,  1982) and MA1044 
(Campbell et a l,  1984), and a third raised against a peptide representing the 
C-terminus of Vmw65 (Dalrymple et al, 1985; Pellet et al, 1985) specifically 
decreased the electrophoretic mobility of the IEC (Preston et a l,  1988). The 
addition of affinity purified Vmw65 or in vitro synthesized [-^ S ]-m eth io n in e
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labelled Vmw65 to a HeLa cell nuclear extract correlated with IEC formation 
(McKnight et a l,  1987; Preston et a l,  1988) thus confirming that Vmw65 is 
indeed a component of the IEC.
Several point mutations in the TAATGARAT element, such as TAA to 
TCC, abolish IEC formation and oligonucleotides containing this mutant 
sequence also fail to compete with TAATGARAT for IEC formation (O'Hare & 
Goding, 1988; Preston et al, 1988). When a range of mutant oligonucleotides 
were individually introduced upstream  of a previously non-responsive 
promoter, a direct correlation between failure to direct IEC formation and the 
inability to confer Vmw65 responsiveness was established (Preston et a l,  
1988; O'Hare & Goding, 1988).
Sequence analysis revealed that the TAATGARAT motif is highly 
homologous to the NFIII binding site in the adenovirus origin of DNA 
replication (Pruijn et al, 1986), to the octamer consensus element ATGCAAAT 
(Rosales et al, 1987) located in the immunoglobulin light chain enhancer 
and promoter (Ephrussi et a l,  1985; Falkner et al, 1984) and the human 
histone H2B promoter (Sive & Roeder, 1986). O'Hare and Goding (1988) 
initially suggested that the protein Oct-1 (NFIII, OTF-1), present in a wide 
range of cell types, was one of the cellular components of IEC. Gerster & 
Roeder (1988) subsequently confirmed that Oct-1 purified from HeLa cells was 
required for the formation of the tertiary complex IEC (Gerster & Roeder,
1988). Involvement of one or more additional cellular factors was implied as 
the incubation of in vitro synthesized Vmw65 and purified Oct-1 with 
TAATGARAT did not result in IEC formation. However, subsequent addition of 
an Oct-1 depleted HeLa cell nuclear extract dramatically restored binding to 
TAATGARAT (Gerster & Roeder, 1988).
Several transcription factors, such as Oct-1, Pit-1 and wnc86, involved 
in tissue-specific and developmental regulation (Bodner et a l ,  1988; 
Ingraham et a l ,  1988; Finney et a l ,  1988) share a characteristic POU domain 
comprised of two conserved motifs, the POU-specific domain and the POU 
homeodomain. Regions of the highly conserved POU domain are homologous 
to the proposed DNA-binding domain of D rosoph ila  developmentally 
regulated transcription factors (Ko et a l ,  1988; Muller et a l ,  1988; Scheider et  
a l ,  1988).
A combination of deletion and insertional mutagenesis revealed that 
Vmw65 is composed of two distinct and functionally separable domains 
(Sadowski et a l,  1988). The C-terminal 78 amino acids specify the trans­
activation activity whereas the N-terminal region contains the requirements 
for IEC formation. The C-terminal domain is markedly enriched for
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negatively charged amino acid residues. Out of the 78 C-terminal amino acids, 
21 have acidic side chains that are either aspartic or glutamic acid residues 
and none are basic (Dalrymple et a l,  1985). This 'acidic tail' is highly 
reminiscent of the acidic transcriptional activation domains previously 
identified in the yeast regulatory proteins GCN4 and GAL4 which are involved 
in the regulation of amino acid biosynthesis and galactose metabolism 
respectively (Hope & Struhl, 1986; Gill & Ptashne, 1987). The Vmw65 acidic 
domain functions in vivo when coupled to the DNA binding domain of either 
GAL4 (Sadowski et al, 1988) or to the human oestrogen receptor (Tora et al,
1989). The hybrid GAL4-Vmw65 protein also functions as a transcriptional 
activator in vitro with both yeast (Berger et al, 1990) and HeLa cell extracts 
(Carey et al, 1990). Using an in vitro assay, Berger et al  (1990) demonstrated 
that the chimeric protein selectively inhibited activated but not basal 
transcription. This inhibitory effect is thought to be due to the sequestering 
of factors essential for transcriptional activation (P tashne, 1988). 
Biochemical evidence has since been provided for a transcriptional 
intermediary factor (TIF) in HeLa whole cell extracts which is required to 
mediate the stimulatory activity of the acidic activator GAL4-Vmw65 (White et  
al,, 1991). This factor is distinct from previously identified transcription
factors as it is not essential for basal transcription. White et al. (1991) propose 
an association between TIF(s) and TFIID, and suggest that the TIF(s) may be 
the direct target of the acidic domain of GAL4-Vmw65.
TriV,zenberg et al (1988b) constructed a series of C-terminal deletions 
in Vmw65 and demonstrated that the C-terminal 78 amino acids were crucial 
for transcriptional stimulation. A C-terminal truncated protein, encoding 
only part of the acidic region, is partially active in transactivation assays.
Triezenberg et a l  (1988a) originally suggested that the overall number of 
negatively charged residues is important and not necessarily the integrity of
the acidic region itself. However, detailed mutagenic analysis of the acidic
activation domain has since revealed that although the net charge 
contributed, it was not sufficient for transcriptional activation by Vmw65
(Cress & Triezenberg, 1991). The phenylalanine residue at position 442 is
extremely sensitive to mutation, and is thought to be involved in a
hydrophobic interaction (Cress & Triezenberg, 1991).
Using a transient expression system in conjunction with N-terminal 
deletion mutants, Greaves & O'Hare (1990) demonstrated that the N-terminal 
403 amino acids are essential for IEC formation. A truncated form of Vmw65, 
specifying only the N-terminal portion and therefore lacking the acidic tail,
dominantly interfered with the wild type activator in transient transfection
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M cKnight et al. (1986, 1987) identified two factors, namely the
products of UL46 and UL47, that enhance the efficiency of Vmw65
dependent activation of IE gene expression. Subsequent work using 
viral deletion mutants demonstrated that neither UL46 nor UL47
encoded gene products, either separately or in combination, were
required for viral growth in tissue culture (Zhang et al., 1991). A 
UL47 deletion mutant resulted in an 80% reduction in ability to
induce the expression of an IE-regulated thymidine kinase gene
resident in 143TK' cells. A UL46 deletion mutant had no effect on the 
level of Vmw65 synthesized in the infected cell (Zhang et al., 1991). 
Zhang and McKnight (1993) showed that the UL46 and UL47 viral 
deletion mutants lacked VP11 and VP12 or VP13 and VP14
respectively. It was proposed that these proteins act at the same level
since single mutants were associated with a 2h delay in TK 
expression while double mutants were associated with a 4h delay in 
TK expression. The authors predicted that the ability of UL46 and 
UL47 to enhance transcription resulted from the stochiometric
association of VP11/VP12 and VP13/VP14 with Vmw65 in the 
infecting virion (Zhang and McKnight 1993).
assays (Triezenberg et a l ,  1988b). Triezenberg et a l  (1988a) proposed that 
this N-terminal segment competes with the native protein for the specific 
interaction sites on the cellular DNA binding proteins. A similar hypothesis 
was postulated to explain the specific reduction in permissiveness to. HSV-1 
replication of a transformed cell line expressing a truncated Vmw65 protein 
lacking the acidic activation domain by HSV-1 at low MOI (Freidman et al,
1988)
Ace et a l  (1988) constructed a series of 12bp linker insertion mutants 
throughout the Vmw65 open reading frame. Each mutant plasmid was assayed 
for its ability to stimulate IE promoters in short term transfection assays; to 
form IEC in an in vitro binding assay; and for the ability to rescue the HSV-2 
assembly mutant ts 2203. These results demonstrate a direct correlation 
between ability to form the tertiary complex IEC, and stimulation of IE- gene 
transcription (Ace et al, 1988). To determine which domains of Vmw65 are 
involved in the correct assembly of progeny virions, the mutated plasmids 
were assayed for their ability to rescue ts 2203, which fails to assemble 
virions at the non-permissive temperature. One plasmid, in 14, rescued ts  
2203, therefore the insertion had not disrupted a domain crucial for the 
structural integrity of Vmw65. However, in 14 failed to form the IEC, 
demonstrating that Vmw65's functional domains are separable and raising 
the possibility that viable viruses containing the in 14 insertion could be 
constructed (Ace et al, 1988). This was subsequently achieved by Ace et a l
(1989) who constructed the mutant in i 814.
The mutant in 1814 contains a 4 amino acid insertion at codon 379
which disrupts the region of Vmw65 required for IEC formation, but does not 
interfere with virion assembly (Ace et al, 1988, 1989; Greaves & O'Hare, 1990). 
This mutation causes a decrease in the levels of IE-RNA accumulation and 
viral protein synthesis under immediate early conditions. Comparison of BHK 
cells infected with /n l8 1 4  or HSV-1 in the presence of cycloheximide 
demonstrated a 4-5 fold reduction in the level of accumulation of IE-1 and IE- 
2 RNA and a 2 fold decrease in IE-4 RNA, whereas the level of IE-3 RNA was 
unchanged. D ensitom etric analysis o f ^ S]-m ethionine labelled  IE
polypeptides revealed that the levels of VmwllO and Vmw63 polypeptides 
were also reduced 4-5 fold, and the level of Vmwl75 was unaffected. Both of 
these values are in good agreement with the IE RNA synthesis rates. However, 
it was not possible to measure the Vmw68 levels accurately because this 
polypeptide ran as a diffuse band (Ace et a l ,  1989). rn 1814 has a high
particle:pfu ratio (1000:1) which means that at low MOI plaque formation is
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W einheimer et al. (1992) recently described the construction of a 
mutant virus containing a deletion in the Vmw65 open reading 
frame, such that no functional Vmw65 is produced. This mutant 
replicated as efficiently as wild type HSV-1 during infection of a 
Vmw65 expressing transformed cell line, resulting in the production 
of mutant viruses containing cell-derived Vmw64 recruited during 
virion assembly. Although this cell derived Vmw65 was functional 
for IE gene tra n s induction, plaque assays and single step replication 
assays revealed that the mutant failed to replicate during subsequent 
infection of cells that do not express Vmw65. This work demonstrates 
that the absence of Vmw65 at late times during infection precluded 
the production of infectious progeny virus and correlates with 
defective HSV-1 particle assembly (Weinheimer et al., 1992).
severely disabled. This high particle:pfu ratio is even more pronounced in 
HFL cells (Ace et al., 1989; Harris & Preston, 1992).
It appears that the metabolic state of the host cell influences the
efficiency of plaque formation, as the apparent titre of a given stock of 
in 1814 on different batches of BHK cells can vary by as much as 10 fold (Ace 
et al, 1989). Preston (unpublished observations) noted that titration of in 1814 
on freshly seeded HFL cells also increases the efficiency of plaque formation.
Recently, Daksis & Preston (1992) demonstrated that in the absence of 
functional Vmw65, HSV-1 immediate early gene expression varies during the 
cell cycle. They found that /«1814 formed plaques less efficiently on HeLa 
cells synchronised at the G2 phase of the cell cycle than at G l/S, 
demonstrating an increased requirement for Vmw65 when cultures reached
the G2 phase.
The reduced ability of in 1814 to initiate plaque formation at low MOI 
was partially overcome by either the provision of VmwllO in trans or by
prior infection with UV-irradiated tsK supplying functional Vmw65 (Ace e t
al., 1989). The importance of functional Vmw65 in the progression into
productive lytic infection was strengthened by Werstuck et a l  (1990), who 
showed that transfection of HSV-1 viral DNA into a cell line expressing
Vmw65 resulted in enhanced infectivity.
The work by Ace et a l  (1989) demonstrated that transinduction of IE
gene expression by Vmw65 is extremely important at both low MOI in tissue 
culture systems and in vivo, as rn 1814 is essentially avirulent in mice. This in 
v ivo  situation also emphasizes the importance of host cell factors in the 
decision between the replication of in 1814 or the establishment of a latent
infection, in 1814 has been used as a tool to investigate the role of Vmw65 in 
latent infections, in vitro (Harris & Preston, 1992) and in vivo (Steiner et al, 
1990).*
The presence of hexamethylene bisacetamide (HMBA) in the culture
medium has recently been shown to overcome the replication defect of
inl814 (McFarlane et al, 1992; this thesis). HMBA and DMSO are known to 
induce differentiation of cultured erythroleukemic cells and to enhance the 
reactivation of latent HSV after explantation of the ganglia. HMBA increased 
the level of IE RNA accumulation in the presence of cycloheximide.
McFarlane et al  (1992) propose that HMBA- and DMSO-mediated enhancement 
of reactivation from latency is due to an increase in IE RNA production.
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1.2.5 P rop erties  and fun ction s of im m edia te  early
p o l y p e p t i d e s
HSV-1 encodes 5 immediate early genes specifying the polypeptides 
VmwllO (ICPO), Vmw63 (ICP27), Vmwl75 (ICP4), Vmw68 (ICP22) and Vmwl2 
(ICP47) (Watson et al, 1979; Anderson et al, 1980).
1.2.5.1 V m w l75
The IE-3 gene, encoding Vmwl75, is located in both copies of the 
short repeat regions and is therefore diploid (Rixon et a l,  1982). From SDS 
polyacrylamide gel electrophoresis the polypeptide product has an estimated 
molecular weight of 175,000 and consists of 1298 amino acid residues 
(McGeoch et a l,  1986). Vmwl75 is a critical immediate early gene product as it 
is essential for the subsequent expression of both early and late genes and 
for the repression or autoregulation of immediate early gene expression 
(Preston, 1979a; Watson & Clements, 1980).
Vmwl75 is a nuclear DNA binding protein which is post- 
translationally modified by phosphorylation at both serine and threonine 
residues and can be poly(ADP-ribosyl)ated in isolated nuclei (Powell &
Purifoy, 1976; Pereira et al, 1977; Cabral et al, 1980; Hay & Hay, 1980; Preston 
& Notarianni, 1983; Faber & Wilcox, 1986). It is possible that the state of
phosphorylation of Vmwl75 affects its regulatory activities as pulse-chase 
experiments indicate that phosphate groups can cycle on and off the protein 
during infection (Wilcox et a l,  1980). It is now known that different 
electrophoretic forms of Vmwl75 differ in their abilities to bind to specific
HSV regulatory sequences (Michael et al,  1988). Vmwl75 can be isolated in 
multimeric forms, but normally exists as a homodimer (Metzler & Wilcox,
1985).
Vmwl75 can specifically recognize and bind to bipartite sites related 
to the sequence ATCGTnnnnnCGG (Faber & Wilcox, 1986; Muller, 1987; Kattor- 
Codey & Wilcox, 1989; Pizer et a l,  1991; Everett & Orr, 1991), but this sequence 
alone is not sufficient for binding (Roberts et al, 1988; Pizer et a l ,  1991). 
Indeed, other binding sites have been defined which do not contain the
consensus Vmwl75 binding site (Beard et al,  1986; Kristie & Roizman, 1986; 
Michael et a l,  1988; Michael & Roizman, 1989; Tedder et a l ,  1989). The 
situation is further complicated because consensus Vmwl75 binding sites are 
not commonly found in the promoter regions of many early and late genes
despite the observation that Vmwl75 is essential for their activation. The 
early TK promoter contains weaker, non-consensus, sites (Imbalzano et al,
1990) and it has recently been suggested that transactivation of the TK 
promoter by Vmwl75 does not depend on binding to these sites (Imbalzano et  
al., 1990; Shepard & DeLuca, 1991). The late gD promoter contains two Vmwl75 
binding sites 5' of the promoter region, and a third site downstream of the 
transcriptional start site. In transfection assays, these sites have been shown 
to contribute to activation (Tedder et al., 1989) and multimerization of any one 
of these sites is correlated with increased activation by Vmwl75 (Tedder et al.,
1988). However, Everett (1983, 1984b) demonstrated that the two upstream 
sites are not essential for transactivation by Vmwl75 under conditions 
providing all the immediate early polypeptides. Recently a mutant virus was 
constructed harbouring mutations in all three Vmwl75 binding sites in the 
gD promoter (Smiley et al, 1992). This study reveals that these sites are not 
essential for transcription of gD RNA during virus infection, and led to the 
proposition that the Vmwl75 binding sites are sufficiently numerous or 
redundant in the viral genome, such that if any particular site is removed, 
then its role is taken on by another site (Smiley et al, 1992).
Comparison of the predicted amino acid sequence of Vmwl75 with 
related proteins expressed by VZV (McGeoch et al, 1986), PRV (Vlcek et al,
1989) and EHV-1 (Grundy et a l,  1989) revealed that Vmwl75 is highly 
conserved and is composed of 5 domains. Regions 2 and 4 show a high degree
of conservation while regions 1, 3 and 5 are less related.
Evidence has accumulated supporting the hypothesis that binding of 
Vmwl75 to the viral genome is an important stage in the activation of 
transcription. The mutant tsK has a single amino acid substitution at residue 
475 in the DNA binding domain (Davison et al, 1984) and at the NPT, and this 
abberant Vmwl75 polypeptide neither binds DNA nor activates gene 
expression (Preston, 1979b; Paterson & Everett, 1988).
Insertion and deletion mutants in plasmid-encoded Vmwl75 have 
been studied in DNA binding assays. These experiments demonstrate that the 
principal part of the polypeptide important for DNA binding is in region 2 
(DeLuca & Schaffer, 1988; Paterson & Everett, 1988; Shepard et al, 1989). 
When these plasmids were co-transfected with a reporter gene construct in 
transient transfection assays, Paterson & Everett (1988) deduced that both 
regions 2 and 4 were involved in the regulation of gene expression by 
Vmwl75. The portion of the protein essential for transactivation also has the
ability to bind DNA and is highly conserved amongst the other members of
the a lp h a h e r p e s v ir in a e  subfamily (McGeoch et a l, 1986; Cheung, 1989;
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Grundy et a l,  1989; Vlcek et al, 1989). The mutation in tsK lies in this highly
conserved region (Davison et al, 1984).
The product of the VZV gene 62, a 140,000 polypeptide, has been
shown to complement the growth of HSV-1 viruses with temperature 
sensitive lesions and deletions in Vmwl75 (Felser et al, 1987, 1988). Based on 
this functional homology, Disney & Everett (1990) constructed a recombinant 
virus in which both copies of the Vmwl75 coding sequence were replaced by 
the VZV open reading frame of gene 62 (Davison & Wilkie 1983; McGeoch et
al., 1986). The progeny virus, HSV-140, was viable in tissue culture but failed
to form plaques. At a high MOI, the expression of certain late genes was
reduced, but the majority of the viral polypeptides were synthesized in 
apparently normal amounts. Analysis of protein synthesis revealed that the 
VZV 140,000 protein was present in large amounts late in infection, 
indicating that this polypeptide does not autoregulate the HSV IE-3 promoter 
(Disney & Everett, 1990). In contrast, Vmwl75 represses its own expression
through binding to the specific Vmwl75 DNA binding sequence at the cap
site of the IE-3 promoter (Muller et al., 1987; Roberts et a l ,  1988). This 
phenomenon of autoregulation can be reproduced in transient assays (O'Hare 
& Hayward, 1985b, 1987). In vitro analyses have demonstrated that mutants of 
Vmwl75 that fail to bind to the IE-3 cap site also fail to repress expression 
from the IE-3 promoter (DeLuca & Schaffer, 1988; Paterson & Everett, 1988). It 
has recently been demonstrated that the activation domain of Vmwl75 
interacts with the host transcriptional apparatus through direct protein- 
protein contacts with TFIID and TFIIB (Smith & DeLuca, Abstract, 17th 
International Herpesvirus Workshop, 1992).
Everett et al. (1992) showed that the process of Vmwl75 binding to
DNA physically bends it to a 60° angle at or very close to its binding site.
Binding of both purified Vmwl75 DNA binding domain and partially purified
preparations of the intact protein induced DNA bending (Everett et a l ,  1992).
The VZV homologue 140,000 protein does not bend DNA but does disrupt the
helix (Tyler & Everett, personal communication). This observation may, at
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least partially explain why the VZV homologue does not/( tunctionally 
substitute for Vmwl75 in HSV (Disney & Everett, 1990).
1.2.5.2 VmwllO
The IE-1 gene is located entirely within the long repeat elements 
( R l )  of the HSV genome, and is therefore diploid (Preston et a l,  1978). The 
primary transcript is spliced to remove 2 introns which, unusually for HSV,
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are in polypeptide coding regions (Perry et al., 1986). The latency associated 
transcripts (LATs) (Section 1.3.2.5) partially overlap and show sequence 
complementarity with the 3' ends of the IE-1 mRNA (Stevens et al., 1987;
Wagner et al, 1988; Wechsler et al, 1988).
The IE-1 gene encodes a 775 amino acid polypeptide product with a
predicted molecular weight of 78,452. However, SDS polyacrylamide gel 
electrophoresis indicated that VmwllO has an apparent molecular weight of 
110,000, as a consequence of | m o d if ic a tio n s , VmwllO is a nuclear
phosphoprotein (M arsden et al., 1976) which binds to DNA in crude cell
extracts in vitro and is associated with chromatin in vivo (Pereira et a l,  1977; 
Hay & Hay, 1980). Analysis of the polypeptide sequence reveals a cysteine 
rich potential zinc finger binding domain between amino acids 130 and 160. 
/\ zinc finger structural m otif was originally identified in the transcription factor 
TFIIIA (Miller et al., 1986) and subsequently in a number of DNA binding
proteins which participate in the regulation of transcription (Berg, 1986;
Evans & Hollenberg, 1988). Everett et al., (1991) used metal affinity
chromatography to demonstrate that VmwllO in nuclear extracts is retained 
on zinc columns and that this interaction does not depend on the zinc finger.
Removal of the zinc finger abolishes the normal nuclear localization of
VmwllO resulting in a cytoplasmic association. Given that zinc fingers are 
also involved in the protein:protein interactions required for transactivation 
of HIV (Frankel et al., 1988), it has been postulated that the function of the 
zinc finger in VmwllO is to promote an association with another protein,
perhaps through the C-terminal region (Everett et al., 1991). The ability of
VmwllO to bind zinc has recently been confirmed by Vaughan et al. (1992).
Vm wllO  is a potent and promiscuous transactivator o f gene
expression in transient transfection assays (Everett, 1984a; O’Hare & Hayward, 
1985a; Gelman & Silverstein, 1985; Quinlan & Knipe, 1985). It displays a lack of 
target spec ific ity , being capable of activating transcrip tion  from
herpesvirus promoters representing all temporal classes, and from a large 
number of heterologous promoters such as the HIV LTR (Mosca et al, 1987) 
and the SV40 early promoter (O'Hare et a l ,  1986; Everett, 1988). VmwllO can 
also act in synergy with Vmwl75 to activate transcription (Everett 1984a,
1986) and, in some transfection systems, this synergistic activation can 
represent a 20 fold increase in activity compared to the levels obtained with
either alone (Everett, 1984a).
The functional domains of Vm wllO  were investigated  by 
constructing a series of small in-frame insertion or deletion mutants and
testing these variants for their ability to transactivate a gD-promoter linked
2 1
to a CAT reporter gene in a transient transfection assay, both in the presence 
and absence of Vmwl75 (Everett, 1987a, 1988). 5 separate regions were 
identified which were required for maximum synergistic activity with 
Vmwl75. The C-terminal rich domain appears to be crucial for
function in synergy with Vmwl75, but not a requirement for the intrinsic 
activity of VmwllO alone. Immunofluorescent staining revealed that the C- 
terminal amino acids 474 to 509 contained features essential, but not 
sufficient, for nuclear localization (Perry et al, 1986; Everett, 1986; Kalderon 
et al, 1984).
To determine whether the functional regions defined by transient 
transfection assays using plasmid borne Vm wllO had corrresponding 
consequences in the viral genome, mutant virus with defined lesions in the
IE-1 gene were constructed (Stow & Stow, 1986; Everett, 1989). d/1403, dl X0.7 
and dl X3.1 are viable mutant viruses containing large internal deletions in
both copies of the IE-1 gene (Stow & Stow, 1986; Sacks & Schaffer, 1987). 
Despite retaining their ability to replicate in a range of cell lines, these
mutant viruses show a 10-100 fold reduction in virus yield compared to the
wild type virus (Stow & Stow, 1986; Sacks & Schaffer, 1987). d/1403 contains a
2126bp deletion removing the majority of the VmwllO coding sequences and 
approximately 750bp from the 3' end of LAT (Stow & Stow, 1986). d/1403, like
/«1814 (Ace et al, 1989), has a high particle:pfu ratio on BHK cells, which
means at a low MOI the abolition of VmwllO function results in a deficiency 
in the initiation of plaque formation. Analysis of polypeptide profiles 
demonstrated that the function of VmwllO is dispensable at a high MOI (Stow 
& Stow, 1986). The phenotypes of the viral mutants FXE (lacking the zinc 
finger region) and D22 (containing a 26 amino acid deletion in region 1) 
were very similar to that of d/1403 (Everett, 1989). These results correlated 
with those obtained in the transfection assays, where the FXE and D22 
deletions had an adverse effect on the activity of VmwllO alone and in the 
presence of Vmwl75 (Everett, 1987b, 1988).
1.2.5.3 Vmw63
UL54 encodes Vmw63, a phosphorylated protein which is found in the 
nucleus of infected cells (Honess & Roizman, 1974; Wilcox et a l ,  1980;
Ackerman et al, 1984; Knipe et al, 1987).
A pivotal role for Vmw63 in viral gene expression was originally 
im plicated by work carried out using viruses containing temperature 
sensitive lesions or deletions in the IE-2 gene (Sacks et a l,  1985; McCarthy e t
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al., 1989, Smith et al., 1991). Northern blot analysis demonstrated that a ts
Vmw63 mutant showed a decreased level of expression of many yi genes and
failed to induce the expression of Y2 genes at the NPT. These defects in late 
gene expression cannot be attributed to abnormal viral DNA replication 
(Sacks et al., 1985; Sandri-Goldin et al., 1981). In contrast, some immediate
early and early gene products were overproduced relative to wild type HSV-1
infected cells, suggesting an essential role for Vmw63 in the modulation of 
early and late gene expression. (McCarthy et al., 1989; Sacks et al., 1985).
Pulse-labelling experiments also detected overexpression of Vm wl75, 
VmwllO and Vmw63 in mutant infected cells, suggesting that Vmw63 is 
involved in the negative regulation of IE gene expression during infection 
(Rice & Knipe, 1988).
Additional evidence supporting an essential role for Vmw63 in viral 
gene expression was obtained from transfection experiments. Everett (1984a)
showed that plasmid encoded Vmw63 enhanced the expression from a yj gene 
promoter, that of Vmwl55, when Vmwl75 and VmwllO were also present in 
transient transfection assays. In contrast, in the absence of Vmwl75 and 
VmwllO, Vmw63 alone has very little effect on expression from either HSV 
or heterologous promoters (DeLuca & Schaffer, 1985; Everett, 1986; Gelman & 
Silverstein, 1987; Sekulovich et al., 1988). Using a range of target promoters 
representing all temporal classes, Sekulovich et al. (1988) showed that, in the 
presence of Vmwl75 and VmwllO, Vmw63 can function as a transrepressor or 
transactivator depending on the target promoter. In addition, through the
use of transfection assays, Vmw63 was shown to increase CAT activity from a 
Y1 promoter, Vmwl55, whereas an early promoter, that of TK, was repressed
(Sekulovich et al., 1988). These results are consistent with the proposed in  
vivo  role of Vmw63 in the switch off of early functions and the activation of 
late functions (Sacks et al., 1985).
The activation domain has been mapped to the C-terminal half of the 
polypeptide, encompassing a region of approximately 250 amino acids 
(Hardwick et al., 1989; Rice et al., 1990; McMahon & Schaffer, 1990) while the 
repressor activity was mapped to the C-terminal 78 amino acids containing a 
potential zinc finger domain similar to that reported in the glutocorticoid 
receptor DNA-binding domain (Berg, 1986, 1988; Green et al., 1988). Vmw63 is 
retained on a metal chelating column in the presence of zinc (Vaughan et al., 
1992) and appears to posses single stranded DNA binding activity (Hay & Hay, 
1980; Vaughan et al., 1992). In addition, it is possible that Vmw63 also 
interacts directly with Vmwl75 and VmwllO as it has little effect on its own 
in transfection assays, (Rice & Knipe, 1988) and Vmwl75 is modified to a
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slower migratory form in the presence of  Vmw63 (Su & Knipe, 1989). 
Vmwl75 itself does not possess a zinc finger and is therefore not retained on 
a zinc column. However, in the presence of Vmw63 there is some retention of 
Vmwl75.
Recent analyses of several in-frame deletion mutants has identified 
important functional regions in the N-terminal half of Vmw63 (Lam et al., 
Abstract, 17th International Herpesvirus Workshop, 1992). A recombinant 
virus containing a deletion in the highly acidic region between amino acids 
16 to 63 shows a reduced rate of viral DNA synthesis. Another mutant, lacking 
amino acids 138 to 152, encodes a mutant Vmw63 polypeptide that localizes to 
the nucleus, but is excluded from the nucleolus. This domain, composed solely 
of arginine and glycine residues, is similar to a region found in several 
cellular proteins implicated in nuclear RNA processing. Sequences located 
between N-terminal 109 and 138 residues appear to contain a nuclear 
localization signal (Lam et a l,  Abstract, 17th International Herpesvirus 
Workshop, 1992).
Recent results suggest that Vmw63 acts, at least in part, at the post- 
transcriptional level to regulate the expression of IE and L gene products 
(Smith et a l,  1992, Sandri-Goldin & Mendoza, 1992). This work revealed an 
apparent lack of correlation between the rate of synthesis of new IE and E 
mRNAs, and their accumulation. In the absence of functional Vmw63, there 
was an accumulation of IE polypeptides despite a significant decrease in the 
level of synthesis of new transcripts. In contrast, under the same conditions, 
late polypeptides failed to accumulate despite the synthesis of new transcripts 
being unimpaired. Sandri-Goldin and Mendoza (1992) demonstrated in 
transfection assays, that the activation function of Vmw63 in conjunction 
with VmwllO and Vmwl75 is not dependent of the promoter, but instead 
correlates with different mRNA processing signals. Further evidence that 
Vmw63 functions via a post-translational mechanism was obtained by 
Chapman et al. (1992) who showed that Vmw63 alone can increase expression 
from a retroviral vector containing Moloney Murine Leukemia virus 
(MoMuLV) sequences. This activation was dependent on the 3’ LTR, and was 
not affected by the promoter (Chapman et al., 1992). Therefore, it is likely 
that Vmw63 exerts this effect through a role in processing or stabilization of 
transcripts (Rice & Knipe, 1990; Smith et al, 1992; Chapman et al., 1992).
Phelan et al. (Abstract, 17th International Herpesvirus Workshop, 
1992) reported that the expression of functional Vmw63 is required for LPF 
(late polyadenylation factor) activity, which selectively increases the usage 
of a virus late poly(A) site in preference to an IE site (McLauchlan et al.,
24
1989). In addition, Sandri-Goldin and Mendoza (1992) demonstrated that 
Vmw63 reduces the level of spliced target mRNAs in transfection 
experiments, suggesting that Vmw63 may interfere with host cell splicing. 
Immunofluorescence studies illustrated that Vmw63 is distributed in a 
punctate manner and appears to partially co-localize with the U2snRNP 
(Martin et al., 1987; Phelan et al, Abstract, 17th International Herpesvirus
workshop, 1992) and that the distribution of SnRNPs in Vmw63 null mutant- 
infected cells was indistinguishable from the mock (Hardy et al., Abstract, 
17th International Herpesvirus Workshop, 1992). These findings suggest a 
role for Vmw63 in the disruption of the normal splicing apparatus and is
consistent with a role in the polyadenylation and/or splicing processes.
1.2.5.4 Vmw68
The US1 gene encodes the IE polypeptide Vmw68 (McGeoch et al.,
1985). The primary transcript contains a single intron in the 5' non-coding 
region. This 5' regulatory domain also encompasses one of the two ORIs 
elements, involved in DNA synthesis (Preston & Tannahil, 1984).
On polyacrylamide gels, Vmw68 has an estimated molecular weight of
70,000 (Honess & Roizman, 1974; Post & Roizman, 1981). Vmw68 is
phosphorylated and accumulates in the nucleus of infected cells (Wilcox e t
al., 1980). Vmw68 is not an essential polypeptide as a mutant virus 
harbouring a 500bp deletion in the IE-4 gene grows efficiently on HEp-2 and 
Vero cell lines (Post & Roizman, 1981). However on a rodent cell line and 
resting confluent HEL cells, this mutant displayed a growth dependence on 
MOI and a decreased plating efficiency. In HEL cells, the production of a late 
chimeric Y2 -TK protein was significantly reduced (Sears et al., 1985a). This 
work implied the existence of a host cell factor capable of complementing the
i
function of Vmw68 (Sears et al, 1985a).
1.2.5.5 V m w l2
The role of Vmwl2 in the viral life cycle is presently undefined. 
Unlike the four other immediate early polypeptides, Vm wl2 is not
phosphorylated and is located in the cytoplasm of the host cell (Marsden e t 
al., 1982). This polypeptide is not essential for virus replication in tissue 
culture, as deletions within the IE-5 gene have little effect on the growth of 
HSV (Longnecker & Roizman, 1986; Umene, 1986; Brown & Harland, 1987).
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1.2.6 Early gene expression
Early gene expression is dependent upon the synthesis of immediate 
early polypeptide Vmwl75 (Honess & Roizman, 1974; Clements et
al., 1977). Initial evaluation of the early TK promoter was achieved by 
microinjecting a series of 5' and 3' deletion mutants into Xenopus laevis 
oocytes and measuring the resulting mRNA accumulation (McKnight et al, 
1981). In this heterologous uninduced system, four c i s - acting sequence 
elements were identified (McKnight & Kingsbury, 1982) and subsequently 
shown to be recognition sites for cellular transcription factors (Jones et al, 
1985). The promoter/regulatory sequences of the TK gene comprise a
proximal TATA homology, a CCAAT box and two GC-rich Spl binding sites 
(McKnight et al., 1981; McKnight & Kingsbury, 1982; Jones et ah, 1985). The 
distance between these c is-elem ents is im portant for their function 
(McKnight, 1982; Eisenberg et al, 1985). These same promoter domains were 
identified in a transient expression assay in mouse L-cells, indicating that
early gene regulation is mediated by general cellular transcription factors. 
In vitro transcription experiments subsequently showed that the components 
required were present in both mock and HSV-infected cells, indicating that 
the activation of early gene expression is not solely due to binding of a viral 
regulatory protein (Jones et al, 1985). Analysis of a series of linker scanning 
mutations in the TK promoter in the viral genome led to the conclusion that
TK promoter recognition is quantitatively similar in basal and regulated 
environments (Coen et al, 1986).
The regulated expression of the gD promoter was investigated in 
short-term transfection experiments (Everett, 1983). D eletion analysis 
revealed that all the signals required for fully regulated transcription lie 
within 83bp of the mRNA cap site, a region which contains the TATA box and 
GA rich elements (Everett, 1983).
Recently Imbalzano et a l  (1990) introduced TK promoter mutations
into a Vmwl75 deficient viral background, and showed that Spl and CCAAT
binding protein sites are not required for early gene induction. The relative
contributions of these binding sites varies depending upon the presence or 
absence of Vmwl75. It was found that Vmwl75 can functionally substitute for 
the cellular transcription factor Spl in the absence of Spl binding sites. This
hypothesis is feasible if the mechanisms of Vmwl75 and Spl function involve 
interactions with common proteins, such as TFIID or the Spl co-activator or
adaptor molecule (Peterson et al, 1990; Pugh & Tjian, 1990; Imbalzano et al,
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1990). This may account for the difference in response to Vmwl75 by early 
genes, which frequently contain Spl sites, and late genes, which lack such 
e lem ents.
1.2.7 Late gene expression
The transcription of late genes is dependent upon functional IE 
products. Work with tem perature-sensitive mutants dem onstrated that 
Vmwl75 and Vmw63 are essential for full expression from late promoters 
(DeLuca et al., 1984; DeLuca & Schaffer, 1985; Sacks et al., 1985; Michael et al, 
1988). The UL49 late promoter can be activated in the absence of DNA 
replication, by co-transfection with IE-gene products (Hall et al., 1982). 
However, the abundant expression of true late (7 2 ) genes requires viral DNA 
replication as an ORIs negative plasmid lacking a functional origin of 
replication shows markedly reduced, but detectable, levels of expression from 
the US11 promoter (Johnson et al, 1986a; Johnson & Everett, 1986a; Godowski 
& Knipe, 1985, 1986). DNA replication appears to induce a cis-acting
modification that renders the template DNA permissive for late gene 
expression (Mavromara-Nazos & Roizman, 1989).
Johnson & Everett (1986a, 1986b) used a transient assay with a 
plasmid encoded US 11 gene linked to an ORIs to identify the sequence 
requirements for the expression of late genes. Only 31bp of sequence 5' to the 
cap site were required for abundant late gene expression (Johnson & Everett, 
1986b). The TATA box is the only consensus sequence element required 5’ of 
the mRNA cap site. However, the US 11 promoter sequences used in these 
investigations also included sequences 3' of the initiation site (+37) (Everett & 
Johnson, 1986b). The relevence of these additional sequences was revealed 
when Kibler et al. (1991) demonstrated that sequences outwith the US 11 
cap/leader region confer true late regulation on a minimal promoter. An 
oligonucleotide spanning the US 11 TATA box was not sufficient to drive 
detectable levels of expression, unless the US 11 cap/leader region (-11 to +39) 
was placed downstream, and imposed a strict requirement for DNA replication 
(Kibler et al., 1991). Mutation of the TATA consensus sequence in the gH 
promoter largely eliminates reporter gene activity (Steffy & Weir, 1991). 
However, intact TATA elements are not always sufficient for late promoter 
activity since linker scanning mutants near the transcriptional start sites of 
the gH and gC promoters markedly reduced promoter activity, implying that 
functional initiator elements may be active in HSV late genes (Steffy & Weir,
1991).
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It has been suggested that only a subset of TATA elements can 
function as late promoters since the introduction of the early TK TATA 
sequences into the gC locus does not direct late gene expression (Homa et al., 
1988). There appears to be a correlation between promoter complexity and 
temporal regulation, because removal of the upstream elements of the early 
gD promoter and linkage to an ORIs changes the regulation to that of a true 
late gene (Johnson & Everett, 1986b). Sequences 3' to the cap site have also 
been implicated as control elements (Michael et al, 1988; Mavromara-Nazos & 
Roizman, 1989; Homa et al, 1990). Substitution of the UL49 leader for an early 
TK leader altered the temporal regulation of the hybrid TK gene, strongly 
suggesting that the leader sequences impart some of the kinetic class 
specificity to the late gene family (Mavromara-Nazos & Roizman, 1989). In 
addition, sequences located in the US 11 cap/leader region were shown to 
impose a strict requirement for viral DNA replication on a minimal TATA box 
promoter (Kibler et a l,  1991). However, the gC cap/leader region does not 
contain any such regulatory sequences (Homa et al, 1988) implying that not 
all true late genes are controlled in the same fashion as US 11. In transient 
transfection assays, gC and US 11 show different requirem ents for 
transcriptional activation. gC can be expressed from an unreplicated 
template (Shapira et a l,  1987) whereas US 11 requires replication in c is  
(Johnson & Everett, 1986a).
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1.3 Herpes Simplex Virus Latency
1.3.1 Definition of Latency
After infection with HSV at a peripheral site, and the invasion of the 
sensory nerve endings, the virus ascends by retrograde axonal transport 
(Ochs, 1974; Kristenssen, 1978) in nerve axons to the nuclei of associated 
sensory ganglia. At this pivotal stage, either viral replication resulting in
neuronal destruction occurs or a latent infection is established. Periodically
the latent viral genome may be reactivated, either spontaneously or in 
response to an external stimulus. It is then transported anterograde in axons, 
passing from the axon to epithelial cells at or near the primary site of 
infection where a productive infection occurs.
Using a combination of in vitro tissue culture models and animal 
models, latency may be functionally dissected into a least four sequential 
stages: (i) In the first instance there may be viral replication in the
peripheral tissue. In the absence of viral replication in the ganglia a latent 
state may then be (ii) established and (iii) maintained. Finally, the latent
infection may be (iv) reactivated leading to a productive infection at or near 
the primary site of inoculation
This section (1.3) discusses the various aspects of latency with 
particular emphasis on the factors involved in the control of reactivation
from the latent state.
1.3.2 Establishment and maintenance of latency
1.3.2.1 Site of latent infection
An overwhelming body of evidence has implicated neuronal tissues 
as the site of latent HSV. Originally a correlation between trigeminal nerve 
surgery and the development of cutaneous lesions in humans was noted by 
Cushing (1905). HSV neurotropism was later also demonstrated in animals
studies (Doerr, 1920; Goodpasture & Teague, 1923; Friedenwald, 1923;
M arinesco et al., 1973). Following the development of experimental
reactivation by explantation (Plummer et al., 1970) and co-cultivation with 
permissive cells (Stevens & Cook, 1971; Stevens et al., 1972; Knotts et al., 1973; 
Plummer, 1973; Wohlenberg et al., 1979; Harbour et al., 1981), infectious virus 
was isolated from sensory ganglia of human cadavars (Bastian et a l.,\912',
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Baringer & Swoveland, 1973; Warren et a l,  1977, 1978; Lonsdale et al., 1979) 
and from experimental animals such as the mouse (Stevens & Cook, 1971),
rabbit (Stevens et al., 1972; Nesburn et al., 1972) and guinea pig (Scriba,
1976). It has since been demonstrated that, depending on the site of primary 
infection, latency can be established in any peripheral nervous tissue,
including the autonomic ganglia (Price et al., 1975a; Martin et al., 1977; 
Warren et al., 1978) and adrenal medulla (Cook & Stevens, 1976). In situ 
hybridization (Cook et al., 1974) and im m unofluorescence analyses 
(McLennan & Darby, 1980; Kennedy et al., 1983) have confirmed that latent 
virus reactivates from the neurons of ganglia.
Latent DNA has also been isolated from the CNS of rabbits (Plummer 
et al., 1970), mice (Cook & Stevens, 1976; Knotts et al., 1973; Cabrera et a l,  1980) 
and guinea pigs (Tenser & Hsung, 1977) but not from humans, although DNA 
homologous to HSV DNA has been detected in human brains (Sequiera et al.,
1979; Fraser et al., 1981). The incidence of latency in the CNS is much lower 
than in the sensory ganglia (Cabrera et al., 1980). However, the inability to 
detect reactivated virus may either reflect the inefficient reactivation of
latent virus by explantation or indicate the presence of defective genomes.
The possibility of latent infections within in non-neuronal tissues
cannot be excluded as infectious virus has been recovered by cultivation of
corneal discs from mice, rabbits, and man (Shimeld et al., 1982; Abghari &
Stulting, 1988) previously infected via this tissue. In addition, both HSV-1 and
HSV-2 has been recovered from the sites of primary infection in guinea pigs
(Scriba, 1976, 1977; Walz et al., 1977; Donnenberg et al., 1980). Futhermore, the
prolonged persistence of both HSV-1 and HSV-2 has been demonstrated in
skin and subcutaneous tissue cultures derived from the denervated feet of
mice following inoculation of the mouse footpad (Al-Saa(Ji pt al.. 1983: Snhak-
(Clements & Jamieson, 1989) 
Sharpe et al., 1984; Clements & Subak-Sharpe, 1988; Al-Saadi et al., 1988).
Prolonged treatment of latently infected mice with acyclovir did not preclude
the recovery of HSV from either footpad or ocular tissues following explant
and culture, suggesting that the virus isolated was a consequence of a latent
infection and not due to a low grade chronic infection (Clements & Subak-
Sharpe, 1988; Al-Saadi et al., 1988; Claoue et al., 1990).
1.3.2.2 Structure of the latent genome
Following corneal inoculation of HSV, examination of DNA isolated 
from latently infected murine ganglia and CNS revealed that the latent DNA 
was in a different physical state from that observed both during acute
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infection and in virions. Rock & Fraser (1983) demonstrated a lack of 
terminal fragments of HSV DNA in latently infected tissues,
Southern
hybridization revealed that virion jo in t fragments were present at an 
approximately 2:1 molar ratio with respect to the unique sequences of HSV 
demonstrating that the genome termini are covalently linked (Rock & Fraser,
1985). They proposed that the latent HSV DNA exists in an "endless" state and 
is not monomeric and linear, extensively rearranged or integrated into the
cellular genome via the terminal fragments. The endless configuration of 
latent HSV DNA was later confirmed in murine and human trigeminal
ganglia by Efstathiou et al. (1986). Buoyant density gradient centrifugation 
physically separated viral and cellular DNA indicating that the latent genome 
probably existed as a circular episome (Mellerick & Fraser, 1987). In vivo, the 
latent genome is associated with nucleosomes in a chromatin structure
(Deshmane & Fraser, 1989).
Because DNA methylation is associated with transcriptional inactivity 
(Ehlrich & Yang., 1981; Yisraeli & Szyf, 1984) it has been suggested as the 
mechanism whereby the latent HSV genome is retained in an inactive form 
(Youssoufian et al., 1982; Stephanopoulos et al., 1988). In accordance with this 
proposition, examination of a latent genome established in vitro revealed it to 
be hypermethylated (Youssoufian et al., 1982). In addition, reactivation from 
la ten tly  infected  ganglia in vitro is enhanced by treatm ent with 
hypomethylating agents such as HMBA and DMSO (Whitby et al., 1987; 
Stephanopoulos et al., 1988; Bernstein & Knaps, 1988; see section 1.4.4). 
However, demethylation is unlikely to be the underlying control mechanism 
during latency as DNA isolated from latently infected mouse CNS is not 
extensively methylated (Dressier et al., 1987).
Taking into consideration the number of neurons containing LAT+
(latency associated transcripts, section 1.4.4) in conjunction with the amount 
of viral DNA present per ganglion, Stevens (1989) estimated that there are 
approximately 20 copies of viral DNA per latently infected neuron.
1.3.2.3 Role of viral factors in establishment of latency
Despite numerous studies using a range of temperature sensitive, 
insertion and deletion mutants, no specific viral gene product(s) has been 
detected which is required for the establishment of latency. Initially, a 
number of ts HSV-1 and HSV-2 mutants were tested for their ability to 
establish and maintain a latent infection in the nervous system of the mouse,
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which has a core temperature of 38.5°C. Mutants were judged to have 
established latency with the detection of mutant virus after explantation and 
co-cultivation of the appropriate tissue at temperature permissive for mutant 
virus growth (Lofgren et al., 1977; McLennan & Darby, 1980; Watson et al., 
1980; Al-Saadi et al., 1983).
Russell et al. (1987a) showed that mutants tsK and /n l411, lacking a 
functional Vmwl75, established latency in an in vitro system (Russell & 
Preston, 1986). As Vmwl75 is an essential polypeptide for productive 
infection, these results indicate that growth and spread of the input virus is 
not essential for the establishment of latency.
Studies with the VmwllO deletion mutant, dl 1403 (Stow & Stow, 1986) 
have revealed that VmwllO is also dispensable for the establishment of 
latency in vitro (Russell et al., 1987a) and in vivo both in the mouse eye 
model (Leib et al., 1989a) and footpad model (Clements & Stow, 1989). 
Furthermore, other VmwllO deletion mutants, namely d lX 3.1 and d lX 0.7, are 
also capable of establishing a latent infection in murine ganglia (Leib et al., 
1989a). LAT expression is not required for the establishment of a latent 
infection (Steiner et al., 1990; Leib et al., 1989b).
The controversy shrouding the role of the viral thymidine kinase in 
the establishment of latency has recently been lifted (Tenser et al., 1989; 
Leist et al., 1989; Coen et al., 1989). It was originally believed that TK deficient 
mutants showed a reduction in their capacity to establish latency (Price & 
Khan, 1981; Tenser et al., 1979, 1981). However, Sears et al. (1985b) 
subsequently reported a lack of correlation between the level of viral TK 
activity expressed by various mutants and the ability to establish latent 
infections. This situation was further complicated by the identification of the 
UL24 gene partially overlapping the TK coding sequences (McGeoch et al., 
1988; Jacobson et al., 1989). Mutations within the UL24 coding region have a 
deleterious effect on viral growth in tissue culture (Jacobson et al., 1989) and 
it is therefore feasible that the observed phenotypes of the TK ' a r e  
attributable to lesion in TK, UL24 or both. A defined mutant virus, which 
lacks 816bp affecting only the TK ORF, was described by Efstathiou et al., 
(1989). In the mouse ear model, this mutant replicated with reduced 
efficiency compared to the wild type virus. Although viral specific DNA was 
not detected in the neuronal tissues of latently infected mice, superinfection 
of explanted ganglia by wild type virus led to the recovery of the TK' mutant 
(Efstathiou et al., 1989).
Prior to the identification of the LATs (Stevens et al., 1987), it was 
impossible to differentiate between establishment and reactivation as the
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ability of a particular mutant to reactivate was used as a marker for its ability 
to establish latency. Coen et al. (1989) used LAT expression in neuronal nuclei 
as a marker for latent infection and demonstrated that and ACV-resistant 
HSV-1 mutant specifically deleted in the TK gene established latency. The TK' 
mutant was recovered following superinfection of the mouse trigeminal 
ganglia with a replication incompetent mutant (Coen et al., 1989). In addition, 
Kosz-Vnenchak et al. (1990) showed, with the detection of nuclear LAT RNA 
expression, that defined TK' mutants establish latency in the neurons of 
mouse trigeminal ganglia after corneal inoculation. Therefore, TK deficient 
viruses can establish latency efficiently, but are unable to reactivate 
(Efstathiou et al., 1989; Coen et al., 1989; Kosz-Vnenchak et a l ,  1990).
Vmw65 is dispensable for the establishment of latency as in 1814 (Ace 
et al., 1989) is latency-competent both in vivo (Steiner et al., 1990) and in  
vitro  (Harris & Preston, 1991). Steiner et al. (1990) demonstrated that i n i 814 
establishes latency following corneal inoculation, despite the absence of 
detectable in 1814 replication at the periphery and trigeminal ganglia. This 
work also revealed that in 1814 establishes latency im m ediately upon 
reaching the sensory ganglia, between 12-48h p.i. (Steiner et al., 1990). Ecob- 
Prince et al. (Abstract, 17th International Herpesvirus Workshop, 1992) 
recently demonstrated similar levels of LAT+ neurons following footpad 
inoculation of mice with 10^ particles of either i«1814 or 1814R. They 
concluded that in 1814 establishes latent infections on a particle, rather than 
pfu, basis in murine dorsal root ganglia. Kristie & Roizman (1987) proposed 
that the block leading to latency is at the level of immediate early gene 
expression and therefore the absence of Vmw65 would predispose HSV to
latency. Certainly the results of Steiner et al. (1990) and Harris & Preston 
(1991) support the view that the lack of Vmw65 transactivation of the
immediate early genes may be the normal route to the establishment of 
latency. Infection of mice with a recombinant virus expressing Vmw65 
under the inducible control of a metallothioneine promoter did not preclude 
the establishment of latency (Sears et al., 1991). In addition, the neuronal 
expression of Vmw65 by a transgenic mouse also failed to prevent the 
establishment of latency (Sears et al., 1991). Therefore, the absence of Vmw65 
alone does not account for the establishment of latency, although it may play
an auxiliary or pivotal role in the lytic-latent decision.
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1.3.2.4 Role of host cell factors in the establishment and 
maintenance of latency
Given that virtually any HSV deletion mutant can establish latency in 
mice (Weber et al., 1987; Sears et al., 1985b; Leib et al., 1989b; Katz et al., 1990) 
and that viral DNA replication (Steiner et al., 1990; Harris & Preston, 1991) 
and gene expression (Sederati et al., 1989) are not prerequisites for latency, it 
is possible that cellular factors play an important role in the repression of 
viral gene expression.
The action of the host immune system may be a determining factor as 
to the outcome of an HSV infection. Administration of antiviral drugs 
(Wohlenberg et al., 1976; Klein et al., 1977, 1978a, 1978b, 1979) or prior 
immunization of animals (Price et al., 1975b; McKendall, 1977; Klein et al., 
1978a; Price & Schmitz, 1979; Tullo et a l ,  1982, 1983) decreases the incidence 
of latency. During the acute phase of infection, both antiviral IgG (Stevens & 
Cook, 1974) and interferon (Sokawa et al., 1980) play a role in the clearance of 
infectious virus from the ganglia.
During establishment of latency in vitro at 42°C, the cellular heat 
shock response may alter the normal pattern of viral gene expression 
(Russell & Preston, 1986). Such supraoptimal temperatures may induce cell 
cycle changes which mimic the quiescent nature of neuronal cells or 
inactivate an essential viral or cellular polypeptide (Russell & Preston, 1986; 
Harris & Preston, 1991).
Kemp et al. (1990) demonstrated that the cellular transcription factor 
Oct-2, originally identified in mouse neuroblastoma cells, was responsible for 
the repression of IE gene expression and consequent failure of the lytic cycle 
in hybrid dorsal root ganglion/neuroblastoma cells. This repressor lacks the 
activation domain found in the B-lymphocyte form of Oct-2, due to an 
a lte rn a tiv e  sp lic ing  event. T rea tm en t of h yb rid  dorsa l root 
ganglion/neuroblastom a cells in vitro with NGF increases the level of this 
neuronal-specific repressor, suggesting that agents which modulate latency 
may do so by affecting repressor levels (Lillycrop et al., 1992).
The maintenance of the latent state of HSV is dependent upon the 
presence of nerve growth factor (NGF). Deprivation of NGF leads to the 
destabilization of latency in primary sympathetic and sensory neurons in 
culture (Wilcox & Johnson, 1988; Wilcox et al., 1990). In addition in vivo, the 
severing of sensory neurons prevents the transport of NGF to the neural cell
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body resulting in reactivation (Carton & Kilbourne, 1952; Walz et al., 1974; 
Thoenen & Barde, 1980).
1.3.2.5 Latency associated transcripts (LATs)
Transcription of the HSV genome during the latent phase is
restricted to the latency associated transcripts (LATs), which were originally 
identified in murine sensory ganglia by in situ hybridization (Stevens et al., 
1987; Deatly et al., 1987). Related transcripts have also been detected in
latently infected sensory neurons of rabbits (Rock et al., 1988; Wagner et al., 
1988) and humans (Croen et al., 1988; Gordon et al., 1988; Steiner et al., 1988; 
Stevens et al., 1988; Wechsler et al., 1988).
LATs initiate 3' to the IE-1 gene and are partially complementary to
the VmwllO transcripts. There are at least two LAT species, the predominant 
transcript being approximately 1.8-2.2kb in length, and the less abundant 
LAT approximately 1.2-1.5kb. The size of the LATs depends upon the strain of 
the virus and the species of the host animal (Wagner et al., 1988). The 
predominant 2.2kb LAT species has been detected during lytic infection of 
tissue culture cells and acute infection of peripheral tissue, albeit with a 
different subcellular distribution and at an extrem ely low level in 
comparison with that found during the latent state (Wagner et al., 1988; 
Spivack & Fraser, 1987).
Sequence analysis of the LATs revealed that the predominant LAT 
species contains two putative ORFs, ORF1 and ORF2, which have a potential 
coding capacity of 36kD and 12kD respectively. ORF2 is retained by the 
smaller less abundant transcript after a putative splicing event (Wechsler e t  
al., 1988). Despite the presence of an ORF, it is unlikely that the LATs encode a 
functional protein product due to their nuclear localisation and lack of 
detectable 3' polyadenylation (Spivack & Fraser, 1987; Wagner et al., 1988). In 
addition, using serum raised against synthetic polypeptides representing 
predicted LAT protein sequences Wagner et al. (1988) failed to detect any 
protein products. Lynas et al. (1989) sequenced the PCR product obtained by 
amplification of LAT sequences from total cell RNA extracted from latently 
infected murine trigeminal and cervical ganglia. The virus strain used was 
shown to contain a number of base changes and deletions with respect to the 
published sequences for HSV-1 strains KOS(M) and 17+ , which introduced 
termination signals into the putative ORF2.
The LAT promoter maps to approximately 700bp u pstream  of the 
nominal start site of the major LAT and contains a TATA box, potential CCAAT
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box and several Spl binding sites (Wagner et al., 1988; Wechsler et al., 1989). 
Other potential regulatory elements in this control region include a Vmwl75 
binding site (Batchelor & O'Hare, 1990), a cAMP responsive element (Leib e t  
al., 1991) and a palindromic sequence responsible for the binding of the host 
factor LPBF (Zwagastra et al., 1991), indicating that the control of LAT 
expression is probably subject to both host and viral factors.
Sequences between -798 to -658 (Batchelor & O'Hare, 1990) and -819 to 
-662 (Zwaagstra et al., 1990, 1991) upstream of the proposed site of LAT 
initiation, confer promoter activity when fused to the CAT coding region, in 
both neuronal and non-neuronal cells, suggesting that the LATs are indeed 
transcribed from this promoter. The subsequent deletion of this promoter 
region generates a mutant virus which fails to express LATs (Javier et al., 
1988; Leib et al., 1989; Steiner et al., 1989) supporting this hypothesis. The 
observation of Dobson et al. (1989) that the insertion of a p-globin coding 
sequence downstream of the putative LAT promoter results in p -g lo b in  
transcripts, but not LATs, in latently infected ganglia provides further 
evidence that LATs are indeed transcribed from this promoter. The LAT 
promoter is thought to confer the neuronal specificity of LAT expression 
(Batchelor & O'Hare, 1990; Zwaagstra et al., 1990, 1991)
Several groups have reported the existence of an 8.3kb or 8.5kb 
polyadenylated transcript (Dobson et al., 1989; Zwaagstra et al., 1990; Mitchell 
et al., 1990), whose transcriptional start site was mapped to 24bp downstream 
of the putative LAT TATA box (Dobson et a l,  1989), in both latent and lytically 
infected cells. The observations that HSV-1 and HSV-2 LAT sequences showed 
both insignificant conservation and atypical codon usage (McGeoch et al.,
1991) and that the 5' terminus of LAT mapped to a splice donor site with a 
splice acceptor consensus located 1.95kbp downstream, lead to the proposition 
that the LATs were infect stable introns. Evidence supporting this hypothesis 
was provided by Farrell et al. (1990) who demonstrated that the LAT gene was 
processed as an intron. Northern blot analysis revealed that the putative LAT 
intron, cloned into the p-galactosidase gene, was spliced from the primary 
transcript generating an intact, correctly sized p-galactosidase transcript and 
the 2.0kb LAT.
However, not all the data are consistent with the hypothesis that the 
LAT is an intron. If a large. 8-9kb primary transcript does exist, then splicing 
to remove the 2.0kb LAT intron would generate a 6-7kb LAT RNA, which has 
not been detected. In addition, if the 2.0kb LAT is indeed an intron, then it is 
an extremely unusual one as it too contains introns. Spivack et al. (1991) 
determined the structure of the 2.0kb and 1.5kb LATs by sequence analysis of
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^ D o e rig  et al., (1991), in an in vitro latency model, detected an 80kDal 
protein from a region covering part of open reading frame 1 (ORF) 
of the 2.0kb LAT and downstream sequences. However, this is not 
consistent with the ORF analyses (Weschler et al., 1989; McGeoch et  
O.I., 1991; Spivak et al., 1991).
d
cDNA libraries and RNA PCR products. They showed that the 3' ends of the 
2.0kb LAT in vivo is upstream of a consensus splice acceptor site. 
Furthermore, the nucleotide sequences at the 5' and 3' ends of the LAT intron 
are similar to that seen in eukaryotic protein encoding genes, with the 
exception of a GC instead of the consensus GT at the 5* end of the LAT intron. 
Spivack et al. (1991) proposed that the GC splice donor site confers tissue 
specificity on LAT splicing. Removal of the LAT intron brings a 276 
nucleotide leader sequence close to ORF1 and ORF2 and relieves translation 
inhibition of the LAT ORFs by that intron. The data of Spivack et al. (1991) is 
consistent with the existence of a short leader sequence or multiple LAT 
transcription start sites.
It appears unlikely that LATs function via an antisense modulation of 
VmwllO expression, as the disruption of LATs affects neither lytic growth in 
tissue culture nor acute infection in vivo. As previously discussed, LATs are 
unlikely to act through a protein product (Puga & Notkins, 1987; Wagner e t  
al., 1988; Dobson et al., 1989), although it is feasible that if LATs are in fact 
stable introns, then part of the 8.3kb or 8.5kb transcript may be protein 
coding. As LAT deficient viruses are capable of establishing, maintaining and 
reactivating from latency, it appears that LATs are not essential at any stage 
of the lytic cycle (Javier et al., 1988; Sedarati et al., 1989). The possible role of 
LATs in reactivation is discussed in section 1.3.3.3.
1.3.3 Reactivation from latency
Wildy et al., (1982) defined reactivation as the "reawakening of virus 
from the latent state, either spontaneously or as a result of external stimuli, 
so that infectious virus may be isolated."
1.3.3.1 In vivo models for studying reactivation
A large number of induction procedures have been developed which 
reactivate latent HSV in vivo. However, most of these treatments bear very 
little resemblance to the normal physiological stimuli. For example, trauma to 
the ganglia or neurectomy prevents, or substantially reduces, the transport 
of NGF to the neural cell body, and leads to the reactivation of latent virus 
(Walz et al., 1974; Price & Schmitz, 1978; Beyer et al., 1990). Reactivation can 
also be induced by physical or chemical traumas such as UV irradiation 
(Blyth et al., 1976), stress, stripping of cellophane tape from the skin 
(Harbour et al., 1983) and administration of DMSO to the site of peripheral
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infection (Harbour et al., 1983). In addition, manipulation of the host immune
system by the administration of immunosuppressive drugs (Openshaw et al., 
1979; Hurd & Robinson, 1977), superinfection by bacteria (Stevens et al., 1975) 
and anaphylactic shock (Good & Campbell, 1948) all induce the reactivation of 
latent HSV.
The rabbit ocular model is a favoured system for studying 
reactivation from latency in vivo , because of the frequent occurrence of 
spontaneous reactivation (Berman & Hill, 1985; Nesburn et al., 1967) and the 
availability of a number of methods which reproducibly induce viral 
reactivation or shedding. These methods include the iontophoresis of 
epinephrine or 6-hydroxydopamine into the corneas (Hill et al., 1985; 
Shimomura et al., 1983), systemic or topical treatment with steroids (Spurney 
& Rosenthal, 1972), and the intrastromal injection of water (Gordon et al. , 
1990). In contrast, spontaneous reactivation is not seen in mice, and although
guinea pigs with an apparent latent HSV-2 infection display frequent 
spontaneous recurrences, it is possible that these lesions represent a 
persistent infection (Scriba et al., 1976; Stanberry et al., 1982, 1985). Guinea- 
pigs are also known not to react to induction procedures used in other 
systems (Roizman & Sears, 1987).
However, in vivo only a very small percentage of neurons in the
sensory ganglia harbour latent infections, thus making investigations both
difficult and expensive. The heterogeneity of the neural tissues and
complexity of the host environment complicates the interpretation of these 
results (Ho, 1992).
1.3.3.2 In vitro systems for studying reactivation
The reactivation of latent HSV was originally assayed by the 
euHu/C.
explantation and in vitro^oi latently infected ganglia (Stevens & Cook, 1971). 
The sensitivity of co-cultivation is greatly enhanced by prior disaggregation
of ganglia with trypsin/EDTA treatment (Nesburn et al., 1980). However,
while these explant techniques provide an assay for the presence of latent
virus, they may not accurately reflect events in the host environment.
A number of tissue culture systems have been developed in which a
uniform population of cells may be latently infected and subsequently 
reactivated by a number of treatm ents, many of which bear little  
resemblance to the normal physiological stimuli. Reactivation in tissue 
culture systems may be facilitated by temperature downshift from 40°C to
3 7 ° C  (Wighdahl et al., 1981) or the withdrawal of inhibitors of DNA
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replication (Cook & Brown, 1987). Wilcox and Johnson, (1987, 1988) have 
developed an in vitro latency system using primary rat sympathetic neurons
which may be comparable to the in vivo situation as they showed that the
addition of anti-NGF antibodies induced reactivation.
An in vitro latency system for HSV-2 has been described by Russell
and Preston (1986) which does not employ inhibitors of viral DNA
replication. Latency is established at a low m.o.i. in HFL cells at the
supraoptimal temperature of 42°C, and a stable latent state is maintained at
3 7°C , a temperature permissive for virus growth. Latent HSV-2 may be
routinely reactivated by superinfection with tsK at the NPT (38.5°C) or with
HCMV. Preston and Russell (1991) have subsequently demonstrated that the
new-
latent HSV-2 genome is predominantly ^ linear in the in vitro system, which is 
consistent with the in vivo situation (Section 1.3.2.2)
1.3.3.3 Role of viral factors in reactivation
The identification of viral factors involved in reactivation began
with the demonstration that latent HSV in tissue culture cells could be
reactivated by superinfection with ts mutants of HSV or HCMV (Colberg-Poley 
et al., 1979; Wigdahl et al., 1983; Lewis et al., 1984). Given that both fsK and 
in 1411, which lack functional Vmwl75, reactivated latent HSV-2 in a tissue
culture system it was concluded that Vmwl75 is not required for reactivation 
in vitro (Russell et al., 1987a). Superinfection with tsK was as efficient as 
using a mutant deficient in late viral functions, ts I, suggesting that one or
more of the IE polypeptides, excluding Vmwl75, was responsible for
reactivation (Russell & Preston, 1986). The virion components were ruled out 
as UV-irradiated tsK failed to reactivate latent HSV-2 (Russell & Preston, 
1986). The VmwllO deletion mutant, d/1403 (Stow & Stow, 1986) failed to 
reactivate latent HSV-2, suggesting a role for VmwllO in reactivation 
(Russell et al., 1987a). This was confirmed by both Harris et al. (1989) and Zhu 
et al. (1990) who demonstrated that an Ad5 recombinant virus expressing
VmwllO was capable of reactivating latent HSV-2 in vitro. In this system, the 
D14 mutant harbouring a 41 amino acid deletion from the C-terminal region
of VmwllO (Everett, 1988, 1989) was capable of inducing reactivation, while 
another VmwllO deletion mutant FXE (Everett, 1988, 1989) failed to induce
reactivation (Harris et al., 1989). FXE lacks 45 amino acids spanning the 
potential zinc finger domain essential for the transactivation of gene 
expression by VmwllO in transient expression assays (Everett, 1984; Gelman 
& Silverstein, 1985; O'Hare & Hayward, 1985) indicating that the events
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leading to reactivation are initiated by the activation of gene expression 
(Harris et al., 1989).
In vivo, VmwllO deletion mutants apparently vary in their ability to 
establish and reactivate from latency (Leib et al., 1989). VmwllO deletion
mutants dlX3A  and dlX0.7 are greatly impaired in their ability to reactivate by 
explantation compared to the wild type virus (Leib et al., 1989), while d/1403 
is capable of reactivation, although with a reduced efficiency than the wild 
type virus (Clements & Stow, 1989) or with a small reduction in efficiency 
(Leib et al., 1989). These differences may be a consequence of additional 
mutations in the LATs (Section 1.3.2.5), differences in sizes and locations of 
the deletions in VmwllO or reflect differences between strains. TK deficient 
mutants establish latent infections, but as they cannot replicate in neuronal 
cells, are not recovered as infectious virus during either acute infection or
explant reactivation (Leist et al., 1989; Tenser et al., 1989). The viral
transcriptional transactivator, Vmw65, is probably not involved in the
initiation events leading to reactivation as it is not expressed during latency 
and prior IE and L gene expression is required for its expression (Stevens et
al., 1987; Spivack & Fraser, 1987; Deatly et al., 1987,1988). Work with /«1814
(Ace et al., 1989) has shown that Vmw65 is not required for reactivation in  
vivo (Steiner et al., 1990) or in vitro (Harris & Preston, 1991).
By explantation, the LAT deficient mutant, 1704, was shown to 
reactivate with slower kinetics than the wild type virus (Steiner et al., 1989), 
while another LAT deficient mutant, d/LAT1.8, showed reduced reactivation 
(Leib et al., 1989). In contrast Sedarati et al. (1989) demonstrated that yet 
another LAT deficient mutant, KOS8117, reactivated with similar kinetics to 
the wild type virus, albeit with delayed lytic-phase transcription. The 
putative LAT promoter was deleted in the reactivation deficient mutants
dlLAT 1.8 and 1704, but remains intact in the LAT mutants which display wild 
type reactivation. This observation suggests that regions outwith the major 
and minor LATs may encode important information.
Hill et al. (1990) examined a spontaneous LAT deletion mutant and a 
recom binant LAT+ virus for epinephrine induced reactivation in the rabbit 
ocular model. Rabbits latently infected with the LAT+ virus showed 18/20 
reactivation events, while the LAT' virus showed only 3/22, after the 
iontophoresis of epinephrine. However, when the rates of spontaneous 
reactivation were compared, no differences between LAT' and LAT+ viruses 
were observed. Therefore, LATs are not absolutely required for reactivation, 
but do appear to have a function during epinephrine-induced reactivation 
(Hill et al., 1990; Trousdale et al., 1991).
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Agents which increase the intracellular levels of cAMP are also 
known to accelerate the reactivation of latent virus from explanted ganglia 
(Saiz de la Meza et al., 1989). Physiological stimuli such as fever, stress and 
trauma in addition to experimental reactivation inducing stimuli such as UV 
irradiation, epinephrine, prostoglandins and the application of retinoic acid, 
all increase the intracellular levels of cAMP either directly or indirectly 
through the action of catecholamines and/or arachidonic acid metabolites 
(Kimberg et al., 1972; Matsuzawa & Nurenberg, 1975; Rodbell, 1980; Levitzki, 
1988; Hu & Gudas, 1990). Indomethacin, a potent inhibitor of prostoglandin 
synthesis, reversibly inhibits HSV-1 reactivation from ganglia (Blyth et al., 
1976; Harbour et al., 1983; Kurane et al., 1984). Leib et al. (1991) identified a 
cAMP responsive element (CRE) at position -696 relative to the 5’ end of the 
major LAT. The CRE was responsive to a variety of modulators of cAMP levels 
and conferred the high level of basal activity of the LAT promoter in 
neuronal cells. Addition of cAMP analogues or adenylate cyclase activators 
accelerated reactivation of wild type KOS, but had little effect on a LAT 
deletion mutant lacking the CRE, d/LAT1.8 (Leib et al., 1991). The work of Leib 
et al. (1991), in conjunction with that of Hill et al. (1990) suggested a role for 
cAMP in the modulation of LAT promoter expression and control of viral 
re a c tiv a tio n .
The enhanced reactivation of latent HSV by hexam ethylene 
bisacetamide (HMBA) and dimethylsulphoxide (DMSO) is discussed in section 
1.4.
1.4 Hexamethylene bisacetamide
Hexamethylene bisacetamide (HMBA) belongs to a class of polar 
planar compounds, including dimethylsulphoxide (DMSO) (Figure 1.4), which 
have been shown to have a variety of effects on gene expression in a number 
of different systems.
Both HMBA and DMSO are potent inducers of terminal differentiation 
in F riend cells  (Friend, 1957). This v iru s-transfo rm ed  m urine 
erythroleukemic cell line (MELC), provides a model system for the study of 
the control of erythroid differentiation (Friend et al., 1971; Reuben et al., 
1976). HMBA can also induce terminal cell division in a number of rapidly 
proliferating tumour cell lines (Reuben et al., 1980; Collins et al., 1980; 
Rabson et al., 1977; Palfrey et al., 1977; Speers et al., 1979). Consequently, 
many groups are investigating the potential for HMBA as a chemotherapeutic 
agent in clinical trials as an anti-cancer therapy (Chun et al., 1986; Egorin e t  
al., 1987; Rowinsky et al., 1986; McGuire et al., 1987; Walsh et al., 1987).
HMBA and DMSO have also been shown to increase the speed and 
efficiency of reactivation of both HSV-1 and HSV-2 from the latent state in a 
number of animal latency models (Harbour et al., 1983; Stephanopoulos & 
Bernstein, 1986; Whitby et al., 1987). The growth of the HSV-1 Vmw65 
insertion mutant in 1814 (Ace et al., 1989) in HFL cells is complemented by the 
presence of 5mM HMBA in the tissue culture medium (McFarlane et al., 1992).
1.4.1 Chemical induction of erythroid d ifferentiation
MELCs provide suitable models for examining the coordinate 
modulation of gene expression during terminal erythroid differentiation 
(Takeshita & Benz, 1985; Tsiftoglou & Robinson, 1988). DMSO and HMBA belong 
to a group of polar planar compounds which are potent inducers of MELC 
differentiation (Friend et al., 1971; Reuben et al., 1976), HMBA acting at a 
concentration range 50 times lower than that of DMSO (Palfrey et al., 1977). 
Exposures of MELCs to a variety of other agents such as actinomycin D (Terada 
et al., 1978), hypoxanthine (Gusella & Houseman, 1976), short chain fatty 
acids (Takahashi et al., 1975), ouabain (Bernstein et al., 1976), inorganic 
selenium compounds (Ebert & Malnin, 1979) and several inhibitors of cAMP 
phosphodiesterase (Gazitt, 1978), also induces the expression of a 
developmental programme similar to that observed during normal terminal 
erythroid differentiation.
Figure 1.4 Chemical structures
The chemical structures of inducers of MELC differentiation, HMBA and 
DMSO and the newly synthesized rigid and flexible inducers, compound 
8 and suberic acid bisdimethylamine respectively (Breslow et al., 1991) 
are depicted. The chemical structures of the metabolites of HMBA, 
namely NADAH, DAH, AcHA and AmHA, are also shown.
The chemical symbols employed in the diagram are listed below:-
C c a rb o n
H h y d ro g e n  
N n i t ro g e n
O oxyg en
S s u lp h u r
benzene ring
Figure 1.4 Chemical Structures
O O
II II
HMBA CH3-C-NH-(CH2)6-NH-C-CH3
O
I I
DMSO CH3-S-CH3
O
I I
NADAH CH3-C-NH-(CH2)6-NH2
DAH H2N-(CH2)6-NH2
O
I I
AcHA CH3-C-NH-(CH2)6-COOH
A m H A H2N-(CH2)6-COOH
O O
II II
Flexible inducer CH3-NH-C-(CH2)6-C-NH-CH3
O O
II __  II
Rigid inducer H O -H N -C-/(^>C -N H -O H
The effects of the five known metabolites of HMBA on differentiation 
have also been investigated (Reuben et al., 1976, 1978, 1980; Meilhoc et al., 
1986; Snyder et al., 1988; Figures 1.4 and 1.5). The deacetylated primary 
metabolite N-acetyl-l,6-diam inohexane (NADAH), is also an inducer of 
differentiation in MELCs (Meilhoc et al., 1986), but is a more potent than 
HMBA in human promyelocytic leukemia cells (HL60) (Snyder et al., 1988). 
Neither 1,6-diaminohexane (DAH), 6-acetamidohexanoic acid (AcHA) nor 6- 
aminohexanoic acid (AmHA) are capable of inducing differentiation in 
MELCs and HL60 cells (Reuben et al., 1976, 1978, 1980; Snyder et al., 1988). 
However, both AcHA and AmHA can potentiate the activity of HMBA when 
used in combination (Snyder et al., 1988).
Breslow et al. (1991) recently synthesized a series of potent 
differentiating agents structurally related to HMBA, which appear to fall into 
two different mechanistic groups. Agents with flexible linear structures such 
as suberic acid bisdimethylamine (Figure 1.4) are approximately a hundred 
times more potent than HMBA, and are active differentiators of MELCs, HL-60
and HT-29 cells. In contrast, certain rigid bishydroxamic acids, containing
benzene ring spacers (Figure 1.4), are even more active towards MELCs but 
show poor activity towards HL-60 cells. The rigid molecules display different
geometric requirements as they do not act at the same site as HMBA and are 
not additive with HMBA in their effect. These findings support the idea that 
the rigid compounds have a different site of action from flexible inducers 
(Breslow et al., 1991).
Terminal erythroid differentiation is marked by the accumulation of
a -  and p-globins and heme-synthetic enzymes, the appearance of erythroid 
specific membrane antigens and a limited proliferative capacity (Marks & 
Rifkind, 1978; Tsiftislou & Robinson, 1985). HMBA-induced differentiation of
MELCs is a complex multistep process (Chen et al., 1982). In the early "latent" 
period (within 8-10h), HMBA initiates a number of early metabolic changes 
which precede irreversible commitment (Chen et al., 1982; Marks et al., 1985; 
Ramsay et al., 1986). These early events are compatible with cell proliferation
and are reversible upon removal of the inducer (Eisen et al., 1978). With more
prolonged exposure to HMBA, the MELCs become irreversibly committed to 
terminal erythroid differentiation. Commitment is defined by the expression 
of the differentiated phenotype without further exposure to the inducer 
(Gusella et al., 1976; Fibach et al., 1977; Nudel et al., 1977). Commitment to 
terminal differentiation is detected as early as 12h post exposure to HMBA, 
and by 48-60h over 95% of the cell population is committed to differentiation 
(Nudel et al., 1977). The commitment decision lim its the subsequent
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Figure 1.5 Pathway of metabolism of HMBA
Proposed scheme for the interconversion between HMBA and its known 
m etabolites. a , deacetylase; b, monoamine oxidase; c, aldehyde 
dehydrogenase or aldehyde oxidase; d, diamine oxidase and aldehyde 
oxidase.
Adapted from Snyder et al. (1988).
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proliferative capacity of the cell to no more than 5 cell divisions (Gusella e t
al., 1976; Fibach et al., 1977). The process of commitment appears to require
cellular DNA replication in the presence of the inducer (Levy et al., 1975; 
Friedman & Schildkraults, 1978; Tsiftoglou & Sarterelli, 1981). The kinetics of 
commitment are consistent with a stochastic or probablistic process which is 
not identical for all inducing agents (Gusella et al., 1976; Fibach et al., 1977;
Figure 1.6).
1.4 .2  A lteration  of gene exp ression  assoc ia ted  with
induction of MELC differentiation
As yet, no genes activiated as a primary response to induction by 
HMBA or DMSO have been identified, although it has been shown that 
transcription from a variety of promoters, on plasmids transfected into the 
cell by electroporation, is stimulated by the addition of inducing agents 
(Campbell et al., 1990). The induction response requires the continued 
presence of the inducer and also occurs when de no vo  protein synthesis is 
inhibited, suggesting that the mechanism involves a change in activity of a 
factor immediately involved in transcription, probably a post-translational 
modification. In addition, this effect was not cell-type specific, suggesting 
that the response may involve a ubiquitous mechanism (Campbell et a l., 
1990).
In the transient transfection system of Campbell et al. (1990) 
inducibility was shown to be conferred by sequences lying between or 
including the CCAAT and TATA boxes of the human a -  and p-globin genes and 
upstream from the cap site of the HSV TK gene. However, induction has been 
detected from rabbit p-globin and SV40 enhancer sequences containing only 
the TATA box and cap site, suggesting that sequences upstream of the TATA
box may not be required for induction in transient transfection assays 
(Campbell et al., 1990). This view is strengthened by the lack of correlation 
between upstream sequences and inducibility. Together these observations 
led to the proposition that HMBA-mediated induction in this system acts at a 
step intimately involved in transcription initiation.
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Figure 1.6 Working model for the effects of HMBA on
MELCs
The horizontal arrows represent the proposed sequence of events 
initiated by HMBA leading to terminal differentiation of MELCs. 
Modulation of gene expression is indicated as follows:-
(f )  HMBA leads to an increase in expression of this gene
(^) HMBA leads to a decrease in expression of this gene
(+) gene is actively transcribed in uninduced MELCs or at a
level comparable to that in uninduced cells 
( - )  gene not transcribed or transcribed at a very low level
Adapted from Marks et al. (1987).
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1.4.2.1 Modulation of c - m y c , c - m y b , c - f os  and p53 proto­
oncogene expression
Detectable changes in the expression of proto-oncogenes c - m y b , c -m yc , c-  
f o s  and p53 occur within 4 hours of their initial exposure to either 5mM 
HMBA or 1.5% DMSO (Ramsay et al., 1986; Todokoro & Ikawa, 1986). Although 
their precise functions are presently unknown, these nuclear proteins have 
been im plicated in the regulation of gene expression related to cell 
replication (Curran et al., 1984; Klempnauer et aL, 1984).
Within 1 hour of exposure to HMBA there is a rapid decrease in c-m yc  
mRNA levels and by 4 hours, there is a similar decrease in c-myb  mRNA, a 
rise in c-fos  mRNA, and a transient rise in p53 mRNA levels (Ramsay et al., 
1986; Richon et al., 1989). By 12 hours, both the c-m yc  and c-m yb  mRNA 
levels return to the levels seen in the uninduced cell, c-m yb  mRNA then falls 
to undetectable levels after 24 hours, whereas the expression of c - m y c  
remains at the uninduced level for 48 hours (Ramsay et al., 1986; Richon e t  
al., 1989).
The c-m yb  protein levels correlate with c-m yb  mRNA levels, except 
at 24h, where despite a decrease in c-myb  mRNA, the c-m yb  protein level was 
equivalent to that in the uninduced cell (Richon et al., 1989). The amount of 
c - m y c  protein correlated with the level of c - m y c  mRNA throughout the 
entire 48h period of induced differentiation (Richon et al., 1989). In contrast, 
the levels of p53 mRNA and protein are discordant. After the initial decrease, 
p53 mRNA levels rise to uninduced levels by 24-28h. However, the amount of 
p53 protein falls to a very low level by 4-8h, and remains suppressed 
throughout the remaining period of differentiation (Richon e t al., 1989). 
These differences in p53 mRNA and protein levels can be attributed to 
changes in the number of mRNAs engaged in translation, and are not due to a 
decrease in the half life of the p53 protein (Shen et al., 1983; Klochbin et al.,
1988).
The early induced changes in c-myc ,  c -myb ,  c- fos  and p53 mRNA 
levels are not associated with irreversible terminal differentiation and are 
not sufficient for commitment (Ramsay et al., 1986). Upon removal of HMBA 
from the MELC culture medium after lOh exposure, the early changes in c-  
myb ,  c -myc ,  c-fos  and p53 have already occurred. However, these cells are 
not committed to terminal differentiation (Richon et al., 1989). Exposure of 
MELCs to hemin blocks commitment to d ifferentiation  despite the 
accumulation of globin mRNAs. Hemin has no effect on either the early or
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late changes in c - m y c , c - m y b  or c - f o s  mRNA levels, but still inhibits 
expression of the full differentiated phenotype (Ramsay et al., 1986). The 
early decrease in expression of c - myc  and c - my b  genes is not blocked by 
cycloheximide, and may reflect alterations in the state of phosphorylation of 
the proteins involved in regulating the expression of these proto-oncogenes 
(Ramsay et al., 1986).
D exam ethasone is an inh ib ito r of H M BA -induced MELC 
differentiation which does not block the early suppression of c -myc  and p53 
proteins nor the increase in c- fos  mRNA. However, dexamethasone does 
retard the early decrease in c-myb  mRNA levels and allows it to reaccumulate 
by 12h to uninduced levels (Ramsay et al., 1986). Therefore, the continued 
suppression of c-myb  mRNA appears to be associated with commitment to 
differentiation (Ramsay et al., 1986). The introduction into MELCs of a plasmid 
constitu tively  expressing c - m y b  renders cells unresponsive to DMSO 
induction of differentiation (Clarke et al., 1988), thus confirming the
im portance of decreased c - m y b  expression during com m itm ent to 
differentiation. Constitutive expression of c - m y c  also delays or blocks 
chemically induced differentiation in MELCs (Copolla & Cole, 1986; 
Dmitrovsky et al., 1986; Lachman et al., 1986). By exposure to cycloheximide, 
the transient suppression of protein synthesis in these cells is sufficient to 
initiate commitment to terminal differentiation. The expression of c- myc  is 
associated with continuous proliferation (Marks et al., 1987). However, there
are examples of differentiation occurring in the absence of c - m y c  down- 
regulation (Dotto et a l,  1986; Schofield et al., 1987; Sheng-Ong et al., 1987) and 
reports of a transient decrease in c - m y c  mRNA levels in the absence of
differentiation (Blomhoff et al., 1987; Lomo et al., 1987). Darling et al. (1989) 
found that a DMSO-induced decrease in c-myc  mRNA levels occurred more 
frequently in tissue culture cells than previously thought. In all the cell
lines tested, there is no apparent correlation between the extent and level of 
transient DMSO-induced decrease in c-myc  mRNA and the reduction in cell 
growth. DMSO treatment did not induce a rapid transient decrease in c - m y c  
mRNA levels in a human colon carcinoma cell line or in HeLa cells (Darling 
et al., 1989).
The continued presence of HMBA is required for the suppression of 
c-myb  and p53 protein levels. If HMBA is withdrawn, even when more than 
90% of the MELCs are irreversibly committed, both proteins reaccumulate 
(Richon et al., 1989). Therefore, reexpression of c -myb  and p53 genes does 
not reverse the commitment process (Richon et al., 1989).
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1.4.2.2 Modulation of Protein Kinase C (PKC) activity
Other metabolic changes induced by HMBA during the latent period 
include alterations in membrane permeability involving Na+ , K+ and Ca2 + 
flux (Bernstein et al., 1979; Chapman, 1980), changes in cell volume (Gazitt et 
al., 1978), a transient rise in cAMP levels (Gazitt et al., 1978) and a suppression 
of rRNA synthesis (Reuben et al., 1980). Rapid changes in
phosphatidylinositol turnover are observed after induction, together with a 
decrease in PKC levels (Faletto et al., 1985; Melloni et al., 1987). Within 2h of 
exposure to the inducer, there is a significant decrease in the level of the 
phosphatidylinositol metabolites, inositol-triphosphate and diacylglycerol, 
which precede the early decrease in c - m y c  (Falleto et al., 1985). 
Diacylglycerols specifically activate native membrane bound PKC (Kishomoto 
et al., 1983) and also inhibits MELC differentiation. Interestingly, phorbol 
esters, such as 12-0-tetradeconyl-phorbol-13-acetate (TPA) and phorbol 12- 
myristate 13-acetate (PMA) mimic diacylglycerols in that they strongly 
inhibit MELC differentiation through the activation of PKC and the
subsequent reduction in phosphatidylinositol turnover (Faletto et al., 1985). 
Based on these observations, Faletto et al. (1985) suggested that the DMSO- 
induced reduction in diacylglycerol levels was related to the initiation of 
d iffe re n tia tio n .
Several groups have suggested a role for PKC in chemically induced 
MELC differentiation (Melloni et al., 1987). Induction by HMBA was shown by 
Marks et al. (1987) to be associated with the appearance of a soluble 
proteolytically activated form of PKC, PKM, in the cytosol. In addition, 
Melloni et al. (1987) showed that PKM activity is both Ca2+ and phospholipid 
independent. These changes in protein kinase distribution and activity occur 
within 30-45min of induction (Melloni et al., 1987; Balazovich et al., 1987).
Leupeptin is an inhibitor of calpain, an enzyme responsible for 
catalysing the conversion of membrane bound native PKC to the soluble 
activated PKM form (Melloni et al., 1982; Pontremoli et al., 1985). 
Interestingly, leupeptin also blocks HMBA-induced MELC differentiation 
(Melloni et al., 1987).
The tumour promoters TPA and PMA are potent inhibitors of HMBA-
induced differentiation (Yamaski et al., 1977). Treatment of MELCs with TPA
or PMA does not block the early changes in c-myb  and c-myc  mRNA levels, 
but does result in a marked decline in total PKC activity (Fibach et al., 1979; 
Melloni et al., 1987). Interestingly, after the removal of TPA or PMA, the
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restoration of HMBA sensitivity is correlated with the reaccumulation of PKC 
activity (Melloni et al., 1987). In addition, when MELCs are grown to density 
arrest, there is a marked decrease in PKC activity, rendering the cells 
resistant to induction with HMBA (Melloni et al., 1987).
Powell et al. (1992) recently separated the MELC PKC isozymes by 
hydroxylapatite chromotography and identified two species. This work 
confirmed that the major isozyme peak contains PK Ca, whereas the minor 
peak, previously thought to contain PKCp (Melloni et al., 1987) actually 
contains the Ca2+/phospholipid independent PKCe (Powell et al., 1992).
V incristine-resistan t MELC variants have been isolated which show 
increased sensitivity to induction by low concentrations of HMBA and 
commitment in the absence of any detectable latent period. These rapidly 
differentiating cells show approximately 25% greater PKCs activity than the
parental MELCs (Melloni et al., 1989) and are resistant to the inhibitory 
effects of both phorbol esters and dexamethasone (Melloni et al., 1988). In 
contrast, HMBA-resistance is associated with a relatively low PKCe activity 
(Melloni et al., 1989). Furthermore, the introduction of purified PKCe, but not
P K C a ,  into permeabilized MELCs increases the rate of HMBA-induced 
differentiation (Melloni et al., 1990). Therefore, it appears that PKCe has a
important role in the control of differentiation (Melloni et al., 1988, 1989, 
1990).
Several groups have proposed that an increase in responsiveness to 
HMBA may be due to the constitutive expression of a cellular factor(s) that is 
critical and rate limiting for an early event in the commitment programme 
(Melloni et al., 1988; Marks & Rifkind, 1989). For example, unlike the parental 
MELCs, HMBA-induced differentiation in vincristine-resistant variants is not 
blocked by the inhibition of protein synthesis by cycloheximide (Michaeli e t  
al., 1990) and it is therefore possible that PKCE may either activate or repress
a specific target protein through phosphorylation (Richon et al., 1991). 
Interestingly, PKCe is capable of phosphorylating histones in vitro (Powell e t
al., 1992).
1.4.2.3 Modulation of globin gene expression
The ultimate consequence of HMBA- or DMSO-induced MELC 
differentiation is a selective and dramatic increase in the transcription of a j -
and pmaJ-globin genes. The concentration of globin mRNAs steadily increases 
during HMBA-induced MELC differentiation to levels approaching 100 fold 
greater than those of uninduced cells (Ross et al., 1972). The a i -  and p maJ-
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globin mRNAs do not accumulate simultaneously. The a  i -globin is detected by 
12-24h (Sheffery et al., 1984) and is in 4 fold excess over (3maj-globin by 31h 
(Orkin et al., 1975). In contrast, pmaJ-globin transcription is not detected until 
24-36h and reaches levels equivalent to ai-globin by 96h (Orkin et ah, 1975; 
Salditt-Georgieff et al., 1984).
HMBA induces a number of changes in chromatin structure
detectable by 12-24h, which precedes the onset of accelerated transcription 
of the a i -  and pmaJ-globin genes. DNasel-hypersensitive sites appear within 
lOObp of both a i -  and pmaJ-globin genes (Sheffery et al., 1982, 1983, 1984; 
Cohen & Sheffery, 1985; Salditt-Geogieff et al., 1984) and approximately 
3000bp upstream of the pmaJ-globin gene cap site (Yu et al., 1983). The DNasel- 
hypersensitive site 5' of the second intron of the pmaJ-globin gene disappears 
upon exposure to HMBA. Nucleosome disruption is detected in the transcribed 
regions of a j -  and p maJ-globin genes domains. The importance of these 
changes in chromatin configuration during induced differentiation was 
highlighted by Sheffery et al. (1983). They demonstrated that a variant cell 
line which displayed some but not all of the HMBA-induced changes in 
chromatin structure, was resistant to HMBA-induced terminal cell division.
1.4.2.4 HMBA-induced hypomethylation of MELC genome
Exposure of MELCs to HMBA or DMSO results in a transient genome- 
wide demethylation, commencing at 3h after the addition of the inducer and 
reaching a maximum level at 6h (Razin et al., 1986, 1988). During this period 
more than 60% of the 5-methylcytosines are actively replaced by cytosine 
using enzymatic machinery already present in the uninduced cell (Razin et
al., 1988).
Several observations suggest that although hypom ethylation is 
essential, it is not sufficient for differentiation. For example, inhibition of 
HMBA-induced hypomethylation correlates with a comparable inhibition of 
differentiation (Razin et al., 1988). In addition, exposure of MELCs to 
cyclohexim ide 24h after induction with HMBA com pletely inhibits 
differentiation without significantly affecting the state of HMBA-induced
hypom ethylation (Razin et al., 1988). Hypomethylation is known to precede 
commitment and coincides with the first appearance o f DNasel- 
hypersensitive sites in the a i -  and p maJ-globin genes (Sheffery et al., 1984; 
Salditt-Georgieff et al., 1984).
1.4.3 Effect of HMBA on viral replication
Yura et al. (1991) investigated the effect of HMBA on the replication 
of HSV-1 and HSV-2 in HEp-2 epidermal cells, IMR-32 neuronal cells and a 
range of cells of lymphoid origin. They concluded that the replication of 
HSV-1 and HSV-2 in epidermal and neuronal cells was markedly enhanced by 
HMBA at clinical concentrations of l-2mM and was greater when infection 
was initiated at a low MOL In addition, the presence of the antiviral agent 
acyclovir, did not suppress the HMBA-mediated enhancement of replication 
in vitro in HEp-2 and IMR-32 cells (Yura et al., 1991). However, Bernstein & 
Kappes (1988) previously concluded that 5mM HMBA had no effect on 
productive HSV-2 infection in guinea-pig ganglia in vitro. These apparently 
contrasting results may reflect different effects of HMBA that depend upon 
the MOI. At the high MOI used to infect the ganglia, it is possible that
differences in titre between the presence or absence of HMBA are not
detected (Yura et al., 1991).
Lymphoblastoid cell lines latently infected with EBV can be induced 
to produce viral antigens and infectious mature particles upon exposure to a 
number of agents including TPA, which is an inhibitor o f MELC 
differentiation (Zur Hausen et al., 1978). In addition, exposure to DMSO, or a 
range o f related polar planar compounds, inhibited the TPA-mediated 
induction of EBV antigen (Bauer, 1983; Yanase & Sigawara, 1989). However, 
not all agents capable of inducing MELC differentiation are also inhibitors of 
EBV induction. The non-polar compounds, hypoxanthine and ouabain, 
capable of inducing MELC differentiation (Marks & Rifkind, 1978), are
ineffective inhibitors of TPA-mediated EBV induction (Yanase & Sigawara,
1989). In addition, the more potent the polar planar compound is at inducing 
MELC differentiation, the more effective it is at inhibiting EBV induction. 
These observations led Yanase & Sigawara (1989) to propose that the same 
m echanism  by which the polar planar compounds induce MELC 
differentiation operates for the inhibition of chemical EBV induction.
E xposure  of lym phoblasto id  cells in fec ted  w ith hum an 
immunodeficiency virus (HIV) to DMSO and other polar planar compounds 
capable o f inducing MELC differentiation, prevented the production of 
infectious HIV. The inhibition of HIV production required the continued 
presence of DMSO, and pre-exposure of cells to DMSO prior to HIV infection 
had only a transient inhibitory effect. This led Viza et al. (1989) to postulate
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that HIV replication is controlled by DMSO indirectly through unstable or 
transient modifications of host control mechanisms.
1.4.4 HMBA-mediated reactivation of latent HSV
The in vivo treatment of neuronal tissues with 5-azacytidine or DMSO 
enhances the recovery of HSV-1 from latently infected murine ganglia 
(Harbour et al., 1983; Whitby et al., 1987) and of HSV-2 from latently infected 
guinea pig neuronal tissues (Stephanopoulos & Bernstein, 1986). Another 
observation apparently linking hypomethylating agents with enhanced 
reactivation was made by Harbour et a l  (1983) who demonstrated that the 
application of DMSO to mouse skin resulted in the reactivation of HSV in the 
associated ganglia in vivo. Treatment of latently infected neuronal or 
peripheral tissues with HMBA or DMSO was then shown to enhance the 
reactivation of both HSV-1 and HSV-2 in animal latency models (Whitby et al., 
1987; Bernstein & Kappes, 1988; Leib et al., 1989).
Whitby et al. (1987) examined the effects of DNA hypomethylating 
agents on the reactivation of HSV from latently infected mouse ganglia i n 
vi tro.  The addition of either 200mM DMSO or 8pM 5-azacytidine, both 
inhibitors of DNA methylation, to the explant medium resulted in the earlier 
detection of reactivated virus. The presence of 5-azacytidine also increased 
the incidence of reactivation from either whole or dissected ganglia (Whitby 
et al., 1987). Bernstein & Kappes (1988) subsequently demonstrated that 
another hypomethylating agent, HMBA, (Razin et al., 1986) enhanced the 
reactivation of latent HSV-2 from guinea pig neural and peripheral tissues in 
vitro.  HSV-2 was also recovered earlier and from a greater percentage of 
ganglia treated with 5mM HMBA, than from the untreated control ganglia. 
After inoculation in the mouse eye and establishment of latency, the VmwllO 
deletion mutant d lX 3.1 could only be reactivated in the presence of DMSO 
(Leib et al., 1989). The effects of HMBA and DMSO in these systems had 
previously been attributed to demethylation as the addition of 5-azacytidine 
or L-ethionine also improved reactivation of latent HSV (Whitby et al., 1987; 
Stephanopoulos et al., 1988) and because there is a transient decrease in 5- 
methylcytosine levels during induction of MELC cells (Razin et al., 1988).
The extent of methylation of cytosine residues in the genome has 
been implicated in the control of mammalian gene expression (Doerfler, 
1981; Mohandas et al., 1981), where DNA methylation is correlated with 
transcriptional inactivity (Ehrlich & Yang, 1981; Yisraeli & Szyf, 1984). This 
relationship has also been observed in the control of certain viral genes. The
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genome of herpes virus saimiri is hypermethylated in non-permissive cells 
and undermethylated in permissive cell lines (Desrosiers et al., 1979).
Treatment of a transformed cell line containing a non-expressed HSV TK 
gene with the hypomethylating agent 5-azacytidine results in the activation 
of TK expression (Clough et al., 1982)). Youssoufian et al. (1982) examined the 
state of methylation of the HSV genome in the persistently infected cell line 
CEM, and found that during non-productive periods the viral DNA was 
hypermethylated whereas during productive viral replication the viral DNA 
was not extensively methylated.
Whether the degree of methylation of the latent viral genome
determines the occurrence of reactivation or not is a controversial matter. It 
has not been proved that the effects of DMSO and 5-azacytidine are solely 
limited to demethylation (Kolata, 1985). However, as latently infected DNA in 
the mouse CNS is not extensively methylated (Dressier et al., 1987) it is 
possible that HMBA actually demethylates and induces the expression of a
cellular function(s) necessary for reactivation or completion of the lytic 
cycle (Whitby et al., 1987; Bernstein & Kappes, 1988). McFarlane et al. (1992) 
recently demonstrated that HMBA increases IE gene expression and proposed 
that a direct stimulation of IE transcription, rather than demethylating 
activity, accounts for the improvement in reactivation of latent HSV.
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1.5 Eukaryotic gene expression
1.5.1 C i s -acting DNA control elements
Most known promoters recognised by RNA polymerase II contain an 
AT-rich region or TATA box approximately 25 to 30 base pairs upstream of 
the site of transcription initiation (Maniatis et al., 1987). Mutational analyses 
have revealed that the TATA box is an important determinant for both the
accurate positioning of the initiation site and the basal level of promoter 
activity (Nakajima et al., 1988). Between positions -40 and -100, upstream 
promoter elements (UPE) such as the CCAAT box and GGGCGG motif have also 
been identified. UPEs function to increase the basal level of transcriptional
activity and both the number and type of UPEs present determine the 
resulting degree of transcriptional activity (Maniatis et al., 1987). Analyses of 
promoters have revealed that the level of transcription often progressively
decreases as the distance of the UPE from the TATA box is increased. This 
suggests that some interaction occurs between upstream  transcription
factors and the basic transcriptional machinery which is favoured when the 
binding sites are in close proximity (McKnight, 1982; Wirth et al., 1987; 
Chodosh et al., 1987; Ruden et al., 1988; Lin et al., 1989; Lennard et al., 1989).
DNasel footprinting (Galas & Schmitz, 1978) and gel retardation
assays (Fried & Crothers, 1981) have identified proteins or transcription 
factors which specifically bind to UPEs. The cellular factor Spl binds 
specifically to GGGCGG sequence motifs found, for example, in the 21 base pair 
repeats of the SV40 early promoter. As related transcription factors can bind 
independently to the same motif, a limited number of transcription factors 
and UPEs can combine in orders and numbers to produce both temporal and 
gene specific regulation.
Grosschedl and Birnstiel (1980) found that sequences further than 
100 base pairs upstream of the histone H2A gene could act in either
orientation to restore efficient transcriptional activity  to a minimal 
promoter. Similarly, sequences further than 100 base pairs upstream of the 
major early cap site of SV40 were shown by deletion analysis to be essential 
for expression (Bernoist & Chambon, 1981). These sequence elements, denoted 
enhancers, dram atically increase the rate of transcrip tion  from the
associated promoter. Enhancers display exceptional positional flexibility as 
they are able to act from distances greater than 1000 base pairs, are
orientation independent and can function either 5' or 3' to the end of the 
gene (Moreau et al., 1981; Benerji et al., 1981; Fromm & Berg, 1983).
Enhancers have a modular structure, being composed of a plethora of 
short sequence motifs (Serfling et al., 1985). Functional dissection of the SV40 
enhancer identified three separate domains denoted A, B and C, each of which 
is in turn composed of multiple subunits (Zenke et al., 1986; Fromental et al., 
1988). Domains A and B alone have weak enhancer activity but duplication of 
either domain separately or in combination increases the strength of the 
enhancer (Zenke et al., 1986; Herr & Clarke, 1986). This synergistic effect is 
independent of the relative positions or orientation of domains A and B
(Maniatis et al., 1987). The SV40 octamer motif alone does not possess any 
enhancer activity, but the level of transcriptional activation increases upon 
duplication of this element and with the number of copies present (Schirm e t  
al., 1987; Ondek et al., 1987). Multiple copies of the glutocorticoid response 
element (GRE) also result in a similar additive increase in the transcriptional 
activity (Toohey et al., 1986). A single heat shock UPE does not act over a great 
distance, although duplication of this motif generates an enhancer-like 
activity (Bienz & Pelham, 1986). However, the duplication of CCAAT boxes in 
the far upstream  regions of heat shock promoters does not generate 
enhancer-like activity (Beinz & Pelham, 1986). Therefore enhancer activity 
increases with the repetition of certain motifs. In addition, a number of 
sequence motifs present in promoters and enhancers are functionally 
in terchangeable. For exam ple, the octam er m otif presen t in the 
immunoglobulin enhancer is also seen in a number of promoters (Bohmann
et al., 1987).
The activity of different enhancers varies greatly in a condition 
dependent manner. Certain enhancers, such as the SV40 enhancer, are 
constitutively active in a wide range of cell types while those of another
group, including the immunoglobulin and p-globin enhancers, are both cell 
type specific and developmentally regulated (Bohmann et al., 1987). Other 
enhancers enable genes such as c - fos  (Triesman, 1985) and interferon 
(Goodbourn et al., 1985) to be induced immediately upon exposure to growth 
factors and viral infection respectively. Finally, the m etallothioneine 
enhancer represents those which are both constitutively active and 
inducible (Maniatis et al., 1987).
Like promoters, the different sequence motifs within an enhancer,
represent binding sites for cellular factors. Elucidation of the mode of 
interaction of the transcription factors bound at the UPEs or enhancers with 
the basic transcriptional machinery at the TATA box would help our
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^T FIID  is a multisubunit complex containing a small TATA-binding 
protein (TBP) and other TBP associated factors (TAFs) (Dynlacht e t  
aL, 1991; Tanese et al., 1991; Takada et al., 1992)
understanding of the mechanisms involved in transcriptional activation. 
Maniatis et al., (1987) proposed that there are protein protein interactions 
between factors bound at the enhancers and promoters, resulting in the 
looping of the intervening DNA.
1.5.2 Eukaryotic transcription factors
Eukaryotic cells contain three distinct nuclear DNA-dependent RNA 
polymerases that are responsible for the transcription of different classes of 
genes (Roeder, 1976). RNA polymerase I catalyses the synthesis of ribosomal 
RNA precursors within the nucleolus, and represents approximately half the 
total transcriptional activity within the cell. RNA polymerase II transcribes 
protein encoding genes, and the elucidation of the mechanisms regulating 
this activity is central to our understanding of both cellular differentiation 
and the development of the organism as a whole. As a consequence of this 
pivotal role in gene expression, most studies have focussed on transcription 
by RNA polymerase II. RNA polymerase III is responsible for the synthesis of 
transfer RNA, 5S RNA and snRNAs.
RNA polymerase II alone is unable to initiate accurate transcription 
in vitro. The polymerase associates with a set of general transcription factors 
that provide both recognition of, and specificity for, minimal promoter
sequences (Matsui et al., 1980). TBP binds specifically to the TATA box and 
prevents nucleosome-mediated repression of promoter activity (Workman &
Roeder, 1987). TFIID itself is necessary and sufficient for the commitment of a 
template to the transcriptional process (Van Dyke et al., 1989; Conway & 
Conway, 1989). However, when the concentration of TFIID is low, the 
formation of stable complexes appears to be facilitated by TFIIA (Davison et
al., 1983; Reinberg et al., 1987; Samuels & Sharp, 1986).
Following initiation of transcription, a post-initiation complex, 
containing TFIID and possibly other factors, remains at the promoter (Van
Dyke et al., 1988; Hawley & Roeder, 1987; Van Dyke & Sawadago, 1990) 
suggesting that reinitiations of transcription may proceed by a different 
mechanism from initiation of transcription. Sawadago & Roeder (1985) and
Carcamo et al., (1989) found a regular pattern of decreasing-length 
transcripts, which was detected after in vitro transcription of a guanosine-
free template, and proposed to be due to reinitiations. Szentirmay and 
Sawadago (1991) subsequently identified a reinitiation transcription factor
(RTF) essential for efficient reinitiation by HeLa RNA polymerase II in vitro.
The basal level of transcriptional activity is greatly enhanced by a 
class of promoter-specific transcription factors which bind in a sequence- 
specific manner to UPEs. The binding of transcription factors to UPEs can 
direct tissue-specific or constitutive expression or confer inducibility . on the 
associated gene. The transcription factor Spl specifically binds to GGGCGG 
motifs present in the upstream regulatory regions of many promoters,
including the SV40 early and HSV TK promoters (Jones et al., 1985). In vitro,
the GGGCGG motif in closest proximity to the promoter confers the strongest 
stimulation upon the addition of Spl. For example, although the HSV IE-3 
promoter contains five Spl binding sites, a truncated promoter retaining 
only one Spl binding site is still stimulated by the addition of Spl (Jones & 
Tjian, 1985). The DNA binding domain of Spl contains three zinc finger 
motifs, which is consistent with its requirement for Zn2+ to bind DNA (Jones 
et al., 1987).
Different trans-acting factors can bind to the same motif. For 
example there is a family of transcription factors all of which recognise the
CCAAT box. The octamer motif, ATGCAAAT, is a target ubiquitous, cell-cycle 
specific and cell type specific transcription factors. Oct-1 is present in all cell 
types and has a ubiquitous role in gene activation, whereas Oct-2 expression 
is restricted to B-cells and neuronal and is responsible for both the tissue- 
specific expression and activation of immunoglobulin genes. It is Oct-1,
rather than Oct-2, that mediates the induction of HSV IE genes (Gerster & 
Roeder, 1988). Oct-1 is also involved in the cell-cycle regulated expression of 
human histone H4 and H2B genes (Heintz & Roeder, 1984; Sive & Roeder, 1986; 
Fletcher et al., 1987).
The nuclear proto-oncogene c-fos  forms a heterodimer 
with c- jun  at regulatory sequences, which is stabilized by a leucine zipper 
(Chiu et al., 1988).
P ro te in -p ro te in  in te rac tions betw een reg u la to ry  and basal 
transcription factors are thought to mediate transcriptional activation. This 
may occur by direct interaction with, or modulation of, the activity of one or 
more of the basal transcription factors. Alternatively it may function 
through intermediary proteins known as co-activators or adaptors (Berger et  
al., 1990; Kelleher et al., 1990; Pugh & Tjian, 1990).
Pugh and Tjian (1990) demonstrated that the addition of Spl to a 
partia lly  purified preparation of RNA polym erase II and general 
transcription factors, including TFIID, resulted in a five-fold increase in 
transcription. In contrast, following the replacement of partially purified 
TFIID with either cloned Drosophi la  or yeast TFIID or a truncated protein
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containing only the C-terminal region, the subsequent addition of Spl failed 
to support induced transcription (Pugh & Tjian, 1990). These observations 
suggest that a component present in the crude fraction of D ro so p h ila  TFIID 
facilitated an indirect interaction between Spl and the variable N-terminal 
tail of TFIID in the basal apparatus (Pugh & Tjian, 1990).
It is likely that a series of co-activator molecules exist, each of which 
connects different transcription factors with the basal apparatus. In support
of this hypothesis, Pugh and Tjian (1990) showed that the ability of CTF to
support induced transcription via the CCAAT box required a component of the 
crude human TFIID fraction, which could not however be functionally 
substituted by the Drosophila  TFIID fraction containing the Spl co-activator. 
Verification of a role for these co-activators in gene expression requires 
their purification or cloning.
Several lines of evidence indicate that TFIID provides a target in the 
basal apparatus for transcriptional activators. Both ATF and the pseudorabies 
virus IE protein assist the binding of TFIID to DNA (Horikoshi et al., 1988b; 
Workman et al., 1988). Using affinity chromatography, Stringer et al. (1990) 
demonstrated that Vmw65 has the ability to interact directly with TFIID, and 
further showed that mutations affecting the activation capacity of Vmw65
also abolish the retention of TFIID. However, these workers did not 
investigate whether any other transcription factors were also retained (Lin 
& Green, 1991). The nature of the proposed interaction between an acidic 
activation domain and TFIID is open to question. Evidence from several 
groups has suggested that the direct target for an acidic activator is not TFIID, 
but is an adaptor or co-activator molecule (Pugh & Tjian, 1990; Berger et al., 
1990; Kelleher et al., 1990). This molecule would facilitate the interaction 
between one of the general transcription factors and the activator domain 
(Lewin, 1990; Ptashne & Gann, 1990). Berger et al. (1990) compared the effect 
of the chimeric activator GAL4-Vmw65, containing the GAL4 DNA binding
domain fused to the activation domain of Vmw65, on a basal promoter and on 
promoters containing the GAL4 upstream activating sequence (denoted GAL4 
UAS) or a T-rich upstream activating sequence (denoted dA:dT UAS). Using a 
crude fraction, transcription from the dA:dT UAS promoter appeared to be 
activated, being 5 to 10 fold greater than the basal GAL4 UAS level. The 
addition of GAL4-Vmw65 to a GAL4 UAS promoter resulted in a 100 fold 
increase in transcriptional activity, but had an inhibitory effect on 
transcription from a dA:dT UAS promoter (Berger et al., 1990). Mutations 
which reduce the effectiveness of the acidic activation domain of Vmw65 also 
showed a reduced inhibitory effect on the dA:dT UAS promoter. As the
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addition of oligonucleotides containing GAL4 binding sites restored basal, but 
not induced, transcription, Berger et al. (1990) proposed that a co-activator
required for activated transcription is sequestered by GAL4-Vmw65. In
agreement with this conclusion, Kelleher et al. (1990) demonstrated that 
GAL4-Vmw65 mediated inhibition of transcription from a dA:dT UAS promoter 
was relieved upon the addition of a crude yeast nuclear extract, but not by 
any of the known purified transcription factors such as TFIID. Gill and 
Ptashne (1988) also showed that the over expression of GAL4 led to a 
corresponding decrease in expression of genes lacking GAL4 binding sites.
This phenomenon, denoted "squelching", was attributed to the titration by
GAL4 of another factor with which it interacts (Gill & Ptashne, 1988).
Horikoshi et a l  (1992), using permuted binding site/gel retardation 
assays with recombinant yeast and human TFIID, demonstrated that TFIID 
binding to the Ad MLP induces DNA bending around the TATA element. Based 
on these observations, they proposed that TFIID-induced bending may either 
stabilize interactions with other general transcription factors in the pre- 
initiation complex, or facilitate contacts between general and upstream 
regulatory factors.
In contrast, Lin and Green (1991) demonstrated, using affinity 
chromatography, a specific interaction between the acidic activation domain 
of Vmw65 and TFIIB. This is a highly specific interaction, as substitution of a 
single amino acid within the acidic domain dramatically reduces both 
activation (Cress & Triezenberg, 1990; Berger et al., 1990) and TFIIB binding 
(Lin & Green, 1991). GAL4 (Horikoshi et al., 1988a) and ATF (Horikoshi et a l ,  
1988b) were previously shown quantitatively to alter the DNase I footprint of 
TFIID on the TATA box. However, it is feasible that these changes are due to an 
additional factor, as the major footprint is downstream of the initiation site 
(Horikoshi et a l ,  1988a, 1988b), in a region normally protected by TFIIB in 
pre-initiation complexes (Buratowski et al., 1988; Malderaldo et a l ,  1990).
Taking into consideration all the available evidence (Reinberg et al., 
1987; Reinberg & Roeder, 1987a,1987b; Buratowski et a l ,  1988), Lin and Green 
(1990) proposed a model to explain how the acidic activator GAL4-AH,
containing the DNA binding domain of GAL4 fused to a synthetic amphipathic
helix, stimulated transcription in v itro .  They suggested that following the 
interaction of TFIID and GAL4-AH with their respective binding sites, GAL4- 
AH enhances the recruitment of TFIIB to this complex. The remaining 
transcription factors and RNA polymerase II can then bind to form a stable
pre-initiation complex. Therefore, by enhancing the binding of TFIIB, GAL4-
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AH indirectly recruits RNA polymerase II to the promoter (Lin & Green, 
1991).
A dramatic and synergistic increase in transcription occurs with the
strong activator GAL4-Vmw65 upon duplication of GAL4 binding sites (Carey 
et al., 1990). It was previously suggested that this increase was due to the
simultaneous interaction of two GAL4-Vmw65 molecules with a single basal 
transcriptional component, presumably TFIID (Carey et al., 1990; Lin et al., 
1990). However, it is possible that this effect may be due to the association of 
one of the bound activators with TFIIB and the other with TFIID.
1.5.3 Chromatin structure
The importance of chromatin structure should not be overlooked
when considering the control of eukaryotic gene expression. Eukaryotic DNA 
is packaged into a number of levels of chromatin structure, the basic unit
being the nucleosome. Approximately 145 base pairs of chromosomal DNA are 
wound around a nucleosomal core composed of an octamer of histones,
containing two molecules each of H2A, H2B, H3 and H4. Histones are small 
proteins which contain a high proportion of positively charged residues and 
thus promote a tight interaction with the negatively charged DNA. This 
"beads on a string" structure is condensed to form a 100A fibre in which the 
nucleosomes are loosely packaged. The 100A fibre can undergo further
condensation, facilitated by the cooperative binding of non-histone H I, to 
form a more compact 300A filament (Allan et al., 1982). Histone HI is bound to 
inactive chromatin and is considered to be a generalised repressor of gene 
activ ity .
Transcriptional activity correlates with an extended chromatin 
configuration, whereas inactive genes are relatively condensed (Pederson e t 
al., 1986; Yanir & Cereghini, 1986). DNasel-hypersensitive sites are 
invariably associated with active genes and are thought to reflect the 
exclusion of nucleosomes from promoters by sequence-specific transcription 
factors at c/s-acting DNA sequences (Elgin, 1988; Gross & Gerard, 1988).
Evidence suggests that the interaction of certain transcription factors with 
ci s -acting elements may only be required to establish transcriptionally
poised chromatin. For example, the immunoglobulin enhancer is required to 
establish the expression of transfected genes in precursor B-cells but not 
once lymphocyte maturation has commenced (Wang & Calame, 1987). In 
addition, DNase I hypersensitive sites associated with the chicken p -g lo b in
domain persist even after the removal of the inducing stimuli and cessation 
of expression (Weintraub, 1985).
Locus control regions (LCR), previously named dominant control 
regions (DCR), are c i s - acting DNA sequences which confer position 
independent expression upon associated genes (Grosveld et al., 1987; Forester 
et al., 1987; Evans et al., 1990; Townes & Bohringer, 1990). For example, the 
LCR associated with the p-globin gene cluster is marked by four nuclease 
sensitive domains 10 to 20 kbp upstream of the genes (Tuan et al., 1985;
G ro sv e ld  et al., 1987; Forester et al., 1987). If this LCR is coupled to the
promoter and coding sequences of the p-globin gene, then introduced into 
transgenic mice, globin mRNA is expressed in proportion to the number of 
gene copies, suggesting that expression is independent of the chromatin 
environment at the site of integration. In contrast, without the LCR, globin 
mRNA expression is extremely low and bears little or no relation to the 
number of integrated genes. Not all human p-globin LCRs function as 
enhancers in transient assays, despite containing a wealth of transcription 
factor binding sites. These LCRs only enhance transcriptional activity when 
integrated into the cellular genome, suggesting that this activity is associated
with the alterations in chromatin structure (Tuan et al., 1989; Talbot et a l.,  
1990; Phillipsen et al., 1990; Talbot & Grosveld, 1991). Reitman et al. (1990) 
identified an element within the chicken p-globin gene cluster which 
confers position independence without high levels of expression, indicating 
that the stimulatory and position independence effects of LCRs may be 
separab le .
The 200 base pair promoter region immediately 5' of the adult 
chicken p-globin gene is a tissue-specific DNase I hypersensitive site which, 
despite being free of nucleosomes, contains a small protected region due to 
the association  of tissue-specific  transcrip tion  factors. In vitro, 
hypersensitivity of this site is not induced by transcription factors once
nucleosomes have formed in the promoter region (Ermersen et al., 1985). 
Initiation of transcription in vitro is also inhibited if eukaryotic promoters 
are assembled into nucleosomes (Knezetic & Luse, 1986; Losa & Brown, 1987). 
However, assembly of the preinitiation complex at the promoter prior to 
nucleosome assembly prevents repression (Gottesfeld & Bloomer, 1982; 
Bogenhagen et al., 1982; Lorch et al., 1987; Matsui, 1987; Workman & Roeder, 
1987; Felts et al., 1990). In fact, a TFIID-enriched nuclear fraction was 
sufficient to protect the Ad MLP against nucleosome binding (Workman & 
Roeder, 1987).
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Workman et al. (1991), using GAL4 derivatives GAL4-Vmw65 and 
GAL4-AH, demonstrated that the presence of an acidic activating domain 
alleviated the repression of promoters during nucleosome assembly and 
facilitated the formation of preinitiation complexes after nucleosome 
assembly. This effect was shown to be a function of the transaCtivating 
domain, as the deletion mutant GAL4(l-94), which contains only the N- 
terminal DNA binding and dimerization domains (Keegan et al., 1986; Ma & 
Ptashne, 1987; Carey et al., 1989), does not preclude nucleosome inactivation 
despite binding to the promoter region (Workman et al., 1991). Based on the 
available data, Workman et al. (1991) proposed that an acidic activation 
domain stim ulates transcription by enhancing the ability of basal
transcription factors to compete with nucleosomes for occupancy of the
prom oter.
Control of the transition from condensed inactive chromatin to a
transcriptionally poised template is thought to be modulated by the 
d ifferential binding of various chrom atin proteins (Jackson, 1986; 
Weintraub, 1988). For example, active chromatin is frequently enriched in 
HMG 14 and 17 and certain histone variants. Histone HI is depleted, while 
post-translational modifications such as histone acetylation is detected. In 
addition, ubiquitin is known to associate preferentially with H2A in active 
genes, although the importance of this modification is not fully understood.
The degree of methylation of cytosine residues also plays a major role in the 
control of gene expression (Doerfler, 1981) and such DNA methylation has 
been associated with the maintenance of the repressed chromatin state (Gross 
& Garrard, 1987).
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2. MATERIALS
2.1 Tissue Culture
2.1.1 Tissue culture media
ETC  io  - Glasgow modified Eagles medium (GMEM), 10% newborn calf serum, 
10% tryptose phosphate broth, 4mM L-glutamine, lOOunits/ml penicillin and 
lOOpg/ml streptomycin.
E H u 5  - GMEM, 5% human serum, 10% tryptose phosphate broth, 4mM L- 
glutamine, lOOunits/ml penicillin and lOOpg/ml streptomycin.
E F io  - GMEM, 10% foetal calf serum (FCS), 4mM L-glutamine, lOOunits/ml 
penicillin and lOOpg/ml streptomycin.
HeLa medium - Dulbecco’s modified Eagles medium (DMEM), 10% FCS, 4mM 
L-glutamine, lOOunits/ml penicillin and 100|ig/ml streptomycin.
293 medium - DMEM, 10% FCS, 4mM L-glutamine, lOOunits/ml penicillin and 
1 0 0 pg/ml streptomycin.
143TK" medium - DMEM, 10% FCS, 4mM L-glutamine, lOOunits/ml penicillin 
and 100pg/ml streptomycin, 50pg/ml bromodeoxyuridine (BrdUrd).
HAT medium - DMEM, 10% FCS, 4mM L-glutamine, lOOunits/ml penicillin 
and lOOpg/ml streptomycin, lOOpM hypoxanthine, 0.4pM aminopterin, 16|iM 
thymidine, 3|iM glycine.
Other media routinely used during tissue culture are detailed below:-
Phosphate bufferedyi70mM NaCl; 3.4mM KC1; ImM Na2HP04; 2mM KH2 PO4 and 
saline (PBS) A buffered to pH7.2.
PBS B 6 .8mM CaCl2
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PBS C 4.9mM MgCl2
PBS 8 parts PBS A : 1 part PBS B : 1 part PBS C
PBS Tris-saline 140mM NaCl; lOmM KC1; lOmM Tris-HCl; ImM MgCl2 ,
pH7.0
T ry p sin 0.25% (w/v) trypsin (Difco) dissolved in 140mM NaCl; 
30mM KC1; 280mM Na2HP04; 1 mg/ml glucose; 25mM 
Tris-HCl (pH7.4); 0.001% (vw/v) phenol red; lOOunits/ml 
penicillin; lOOmg/ml streptomycin.
V ersene 0.6M EDTA in PBS A containing 0.0015% (w/v) phenol 
red.
Adenovirus agar Eagles agar overlay medium without phenol red; 
o v e rla y  0.65% Noble agar; 0.02% FCS; 1.25pM MgCl2 -
2.1.2 Tissue culture cells
Baby hamster kidney (BHK) cells
BHK-21 clone 13 cells (Macpherson & Stoker, 1961) were kindly 
provided by Dr. C.M. Preston. BHK cells were used for the titration and 
generation of HSV stocks and for calcium phosphate transfections.
Human foetal lung (HFL) cells
Flow 2002 HFL cells were obtained from Flow Laboratories. HFL 
monolayers were used to study the effect of HMBA on the plaquing of r/z 1814.
HeLa cells
HeLa cells were obtained from Flow Laboratories. Whole cell and 
nuclear extracts were prepared using HeLa cells for in vitro transcription 
and gel retardation analyses respectively.
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293 cells
293 cells were derived from a human cell line by transformation by 
the E la  region of adenovirus type 5 (Graham et al, 1977) and were a kind gift 
from Dr V. Mautner. 293 cells were used to titrate d/312, an Ad5 E la  deletion 
m u tan t.
143 TK" cells
143 thymidine kinase n eg a tiv e  human cells were derived from the
murine sarcoma virus transformed line R970-5/5 by selection with BrdUrd at
50|ig/m l. 143TK" cells were used to generate TK+ transformed cell lines and
were kindly provided by Dr. K. Page.
p T K + transformed cell lines
The TK+ transformed cell lines, 143TK1, 143TKN and 143TKTaqA were 
generated from the parental 143TK" cell line. They were used to study the
effect of HMBA on the expression of the HSV-1 TK, HSV-1 IE-3 and the HSV-1 
IE-4/5 promoters, respectively, in the cellular genome.
2.2 Virus Stocks
The following viruses were used in this study:- HSV-1 wt strain 17+ 
and mutant tsK (Marsden et a l,  1976); UV-irradiated tsK (Notarianni & 
Preston, 1982); Vmw65 insertion mutant /nl814 and rescued 'revertant' 1814R
(Ace et a l,  1989); in 1825 contains the Moloney murine leukaemia virus 
enhancer and promoter (Lang et al, 1983) in place of the VmwllO promoter 
in an otherwise wt HSV-1 genome; in 1820 has both the Moloney murine 
leukaemia virus enhancer and promoter driving Vm wllO and in 18 14 
insertion; /n l827 has the HCMV enhancer driving VmwllO in the in i  814  
backg ro u n d ; in  1833 has the SV40 prom oter/enhancer driving p -
galactosidase; in 1411 contains an amber insertion in Vmwl75, such that no 
functional Vmwl75 is produced. All these viruses were generously provided 
by Dr. C.M. Preston. VmwllO deletion mutant, d/1403 (Stow & Stow, 1986), was a 
gift from Dr. N. Stow. Wild type Ad5 and E la deletion mutant, d/312 (Jones &
Shenk, 1979), were kindly provided by Dr. V. Mautner.
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12.3 Host bacteria
Plasmids were propagated in the E.coli strain K12 DH-1 (recA l; na/A ; 
r R - ;  m R - ;  e n d o I", B“; re lA l) .  Bacterial cultures were routinely grown in
suspension at 37°C in L-broth (1% (w/v) NaCl; 1% (w/v) bactopeptone; 0.5% 
(w/v) yeast extract.
2.4 Plasmids
Clones were grown from seed stocks supplied by Dr. C.M. Preston and 
Dr. R. Everett.
pA 7436- S s tl/B bv l  fragment of pJR3, containing the VmwllO regulatory and 
coding sequences, inserted between SsrI and Sphl sites of pUC18. (vfl? SflJQOcli /  \
p IE 3 C A T - -331 to +26 of IE3 promoter fused to CAT gene in a vector derived 
from pBLW2 (Stow, 1986).
p J R 3 -  Fragment containing Vm wllO regulatory and coding sequences 
inserted into a pUC9 derivative, in which the H incll  site was converted to an 
Sstl site (Everett, 1984a).
p g D C A T - gD promoter linked to CAT coding region and a polyadenylation 
signal (Everett, 1986).
p L W F U 1 7 -  Vmw68  coding and regulatory sequences, including upstream 
T A AT GAR AT sequence. (<&£ A pp en d ix  ])
p L W P -  Vmw68  coding and regulatory sequences, minus upstream  
T A AT GAR AT sequence. C}e£ AfjP2 /d l>  0
p M C l-  comprises a 2.7kbp fragment containing the Vmw65 coding sequence 
in a pUC9 vector (Campbell et al., 1984).
pH C M V IE - HCMV IE promoter (Towne strain). &££ P ^ercL< X  0  
p M L (C 2A T ) i9 - Ad MLP driving G-less cassette (Savadogo et al., 1985).
(S22 Aj5p*/idix 0
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2.4 Plasmids (cont.)
p R R 5 5 -  IE promoter and enhancer of HCMV strain AD 169 driving CAT 
(Fickenscher et al., 1989).
p T K l-  HSV-1 Bam  HI p fragment, containing the HSV-1 TK gene, inserted 
into the corresponding site in the vector pAT153 (Wilkie et al, 1979).
p T K C A T - B am H l-B glll  region of HSV-1 BamHl p fragment containing the TK 
promoter (+53 to -650), cloned into BamHl site of pBLW2 (Everett, 1986).
p T K N - HSV-1 IE-3 promoter linked to the HSV-1 TK coding sequences, with 
the non-selected expression of IE-4.
pT K T aqA - HSV-1 IE-4 promoter linked to the HSV-1 TK gene.
2.5 Oligonucleotides
The oligonucleotides used in this study were synthesized by Dr. J. 
McLauchlan using a Biosearch 8600 DNA synthesizer. The sequences of the 
top strand of these double stranded oligonucleotides are listed below:-
JD 1/JD2 5' AGCTTGCCrCATGAGTGCGGTAATGAGATACGACTG3'
CC1/CC2 5’ AGCTTGCGTCrrGTCATTGGCGAATrCGAACACG3'
L 1 /L2 5’ AGCTTGGTTTATAGGTGTAGGCCACGTGACCGGGTG3'
TATA 5’ GATCCGGCTAAACTTATACCCCACGCA3'
027/028 5' AGCTTGCCTCATGAGTATGCTAATGATATTCGACTG 3'
01/01 5’ AGCTTGCCTCATGAGTATGCAAATCATGTGCGACTG 3’
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2.6 Enzymes
Restriction endonucleases were obtained from Boehinger Mannheim 
and Bethesda Research Ltd. Boehinger Mannheim also supplied DNA 
polymerase I (Klenow fragment) and proteinase K. Bovine pancreas RNaseA 
and lysozyme were purchased from The Sigma Chemical Company Ltd.
2.7 Chemical reagents
The chemical suppliers are as follows:- BDH Chemicals; Beecham 
Research Laboratories; Bethesda Research Laboratories; Bio-Rad Research 
Laboratories; Fluka; Kochlight Ltd; May & Baker; Melford Laboratories; 
Pharmacia Chemicals; Sigma Chemical Company.
2.8 Radiochemicals
All the radiochemicals used in this study were supplied by Amersham 
International PLC. The specific activities were 450pCi/mmol for [ ^ C ] -  
chloramphenicol; 800 Ci/mmol for [^^S]-methionine, 4,000 Ci/mmol for a -  
[ 3 2 p ] _ c T P ;  3,000 Ci/mmol for a - [ 3 2 P]-dNTPs, 40-60 Ci/mmol for [3 H ]-  
th y m id in e .
2.9 Electrophoresis buffers
\
3X boiling mix (BM): 50mM Tris-HCl (pH6.7); 0.4% SDS; 30% (v/v)
glycerol; 5% (v/v) p-mercaptoethanol; 0.1% (w/v) 
bromophenol blue (BPB).
10X electroelution: 
(EEB)
5mM sodium acetate; ImM EDTA; buffer 
40mM Tris-HCl (pH7.8).
Gel-elution buffer: 500mM ammonium acetate; 20mM Tris-HCl 
(pH7.4); 2.5mM EDTA.
Gel buffer: 
(GB)
1.5M Tris-HCl (pH8.9); 0.4% SDS.
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2.9 Electrophoresis buffers (cont.)
Stacking gel buffer: 
(SGB)
0.5M Tris-HCl (pH6.7); 0.4% SDS.
Tank buffer: 52mM Tris; 53mM glycine; 0.1% SDS.
10X TBE buffer: 90mM Tris; ImM EDTA; 90mM boric acid (pH8.3).
5X TBE loading: 5X TBE; 1% (w/v) SDS; 50% (v/v) glycerol; 0.1% 
(w/v) BPB.
Loading Dye: 
(Promega Kit)
98% (v/v) formamide; lOmM EDTA; 0.1% (w/v) 
xylene cyanol; 0.1% (w/v) BPB.
2.10 Lysis buffers
Cell lysis buffer: 20mM Tris-HCl; 0.5% SDS; 2.5mM EDTA (CLB) 
(pH7.5); 0.25mg/ml proteinase K.
Guanidium : 
thiocyanate (GSCN)
4M GSCN; 50mM Tris-HCl (pH7.5); 0.5%
(w/v) N-lauryl sarcosine; 2mM EDTA b u ffe r  
(pH7.5); lOOmM p-mercaptoethanol; 0.3% (v/v) 
antifoam A.
TK lysis buffer: 20mM Tris-HCl (pH7.5); 2mM MgCl2 ; 10mM NaCl; 
0.5% (v/v) Nonidet P40.
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2.11 Nuclear and whole cell extract buffers
Buffer A: lOmM HEPES (pH7.9); 1.5mM MgCl2 ; 10mM KC1; 0.5mM DTT.
Buffer B: 0.3M HEPES (pH7.9); 1.4M KC1; 30mM DTT.
Buffer C: 20mM HEPES (pH7.9); 25% (v/v) glycerol; 0.42M NaCl; 1.5mM
M gCl2 ; 0.2mM EDTA; 0.5mM phenylmethylsulfonyl flouride 
(PMSF); 0.5mM DTT.
Buffer D: 20mM HEPES (pH7.9); 20% (v/v) glycerol; 0.1M KC1; 0.2mM
EDTA, 0.5mM PMSF; 0.5mM DTT.
Buffer 1: lOmM Tris-HCl (pH7.9); ImM EDTA; 5mM DTT.
Buffer 2: 50mM Tris-HCl (pH7.9); lOmM MgCl2 ; 2mM DTT; 25% (w/v)
sucrose; 50% (v/v) glycerol.
Buffer 3: 25mM HEPES (pH7.9); lOOmM KC1; 12mM MgCl2; 0.5M EDTA;
2mM DTT; 17% (v/v) glycerol.
2.12 In vitro transcription solutions
Transcription buffer: 20mM HEPES (pH7.9); lOOmM KC1; 0.2mM EDTA;
0.5mM DTT; 20% (v/v) glycerol
Stop solution: 0.3M Tris-HCl (pH7.4); 0.3M sodium acetate; 0.5%
SDS; 2mM EDTA; 3^g/ml tRNA
2.13 Southern/Northern transfer and hybridisation  
s o lu t io n s
Alkaline transfer: 0.4M NaOH; 0.6M NaCl
so lu tion
50X Denhardts: 1% (w/v) ficoll; 1% (w/v) bovine serum albumin
so lu tion  (BSA) fraction V; 1% (w/v)
poly v in y lp y ro lli done.
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2.13 Southern/Northern transfer and hybridisation  
solutions (cont.)
Neutralising solution: 0.5M Tris-HCl (pH7.0); 1M NaCl
20XSSC: 3M NaCl; 0.3M sodium citrate
Prehybridisation mix: 0.5M sodium phosphate buffer (pH7.0); 0.5%
(w/v) SDS.
Hybridisation mix: 0.5M sodium phosphate buffer (pH7.0); 0.5%
(w/v) SDS; radiolabelled DNA probe.
2.14 Other solutions
Oligo reaction mix: 250mM Tris-HCl + 25mM MgCl2 buffered to pH8.0,
50mM p-mercaptoethanol; 1M HEPES (pH6 .6 ); 30 OD 
units/ml pol (N6 ).
D estain: 5% (v/v) methanol; 3.5% (v/v) glacial acetic
acid.
Fix: 1% (v/v) glacial acetic acid; 9% (v/v) methanol.
Geimsa: 1.5% (v/v) suspension of geimsa stain in glycerol
heated to 56°C for 2h and diluted with an equal 
volume of methanol.
TE: lOmM Tris-HCl; ImM EDTA (pH7.5).
TNE: 20mM Tris-HCl; lOOmM NaCl; ImM EDTA (pH7.5).
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3. METHODS
3.1 Tissue Culture
All cell types were grown as monolayers at 37°C in an atmosphere of 
95% air and 5% CO2 , and routinely passaged every 3-4 days. Cells from 
confluent monolayers were harvested in 2 0 ml medium after the addition of 
10ml 1:1 mix of versene:trypsin then 10ml fresh EFjo- This cell suspension 
was then used to seed subsequent monolayers.
HFL cells were propagated in EF10 and routinely split 1:4. A confluent 
HFL monolayer in a 35mm diameter petri dish contained approximately 10^ 
cells.
BHK cells were propagated in ETC10 an(* routinely split 1:10. A 
confluent monolayer in a 35mm diameter petri dish contained approximately 
1 0 ^ cells.
HeLa cells were propagated in HeLa medium and routinely split 1:6. A 
confluent monolayer in a 50mm diameter petri dish contained approximately 
3 X 106 cells.
293 cells were passaged after using only 10ml versene to remove the 
cells from the surface of the tissue culture flasks. 293 cells were routinely 
split 1 :6 .
The 143TK" cell line was routinely grown in 143TK- medium and split 
1:10. The pTK+ transformed cell lines derived from the 143TK' cells were 
grown in HAT selective medium and routinely split 1:10.
3.2 Herpes simplex virus
3.2.1 Preparation of virus stocks
M (dki koHU
50-80% confluent BHK cells ^  were inoculated with 2 X lO^p.f.u. of 
appropriate virus seed stock and returned to 37°C for 2-3 days, until c.p.e. had 
occurred. Roller bottles were shaken vigorously to disperse cells. Cells were 
pelleted by centrifugation at 3000 revolutions per minute (rpm) for lOmin at 
4 ° C  in a Sorvall GSA rotor. The supernatant was decanted into fresh 
centrifuge tubes and provided a source for both cell released virus (CRV) and 
viral DNA.
3.2.2 Cell associated virus (CAV)
(lA S O A lC G h fc A
The cell pellet was resuspended in 15ml ETCio aQd sonicated A for two 
30sec bursts to release the CAV. The cell debris was pelleted by centrifugation 
at 2,500 rpm in a Beckman GPR centrifuge for 15min at 4°C. The supernatant, 
containing the CAV, was dispensed into 1ml samples, frozen on dry ice and 
stored at -70°C.
3.2.3 Cell released virus (CRV)
CRV was prepared by centrifugation of the original supernatant at
12,000 rpm for 2h at 4°C  in a Sorvall GSA rotor. The viral pellet was 
resuspended in 8ml ETCio and divided into 1ml aliquots and stored at -70°C.
3.2.4 Preparation of viral DNA
The viral pellet obtained after centrifugation ^jof the infected cell 
supernatant was resuspended in 10ml lOf^M Tris-HClj\lpM EDTA, 0.1M NaCl, 
0.1% SDS and 0.25 mg/ml proteinase K. The sample was rotated at 37°C for 16h 
and two phenol/chloroform extractions, followed by one chloroform only 
extraction were carried out. Samples were centrifuged at 2,500 rpm for 15min 
in a Beckman GPR centrifuge to separate aqueous and organic phases^ 
viral DNA was precipitated by the addition of 2.5 volumes of ethanol/1 and 
pelleted by centrifugation at 2,500 rpm in a Beckman GPR centrifuge for 
lOmin. The viral DNA was washed in ethanol before lyophilization and 
resuspension in 400pl TE at 4°C  overnight. The viral DNA was stored in 
aliquots at -20°C.
3.2.5 Titration of HSV stocks
HSV stocks were titrated on 30mm confluent BHK monolayers. The 
overlying medium was removed by aspiration and 0 .2 ml of a virus dilution 
was added to the monolayers. Virus adsorption and penetration was carried 
out at 37°C for lh. The plates were rocked gently every 15min, then overlaid 
with 2ml EHu2 to neutralise unadsorbed virus and prevent the formation of 
secondary HSV plaques. After 2 days at 37°C, the medium was removed and 
cells fixed and stained with Geimsa. Visible plaques were counted under the 
m ic ro sco p e , and the co rre sp o n d in g  t itre  thus d e te rm in ed .
7 2
3.3 Adenovirus
3.3.1 Preparation of adenovirus stock
HeLe
Adenovirus infected/cells were scraped into the overlying medium 
and transferred to a 15ml Falcon tube. Samples were centrifuged at 2,000 rpm 
for lOmin in a Beckman GPR centrifuge. The supernatant was discarded and 
the cell pellet resuspended in 500pl PBS Tris-saline. Samples were transferred 
to a 1.5ml reaction vial and subjected to three freeze thaw cycles (-70° to
37°C ). The cell debris was pelleted as above and the supernatant containing
the virus stock was transferred to a fresh vial. Adenovirus stocks were stored 
at -20°C.
3.3.2 Titration of adenovirus stock
Confluent 50mm Petri dishes of HeLa cells were infected with lOOpl of 
the appropriate dilution of adenovirus in PBS Tris-saline. Adsorption was 
carried out at 37°C for lh. Cells were overlaid with 5ml medium in the
presence or absence of 5mM HMBA, and incubated at 37° C overnight. The
following day the medium was replaced with 5ml agar overlay, left to set at 
room temperature (RT), and returned to 37°C. At days 5,7 and 8 a further 
l-2ml of agar overlay was added. At day 10 plaques were ready to be counted. 
Cells were fixed with 2ml 1:1 gluteraldehyde:PBS overnight at RT. The agar 
overlay was then "flipped" off and the fixed cells stained with Geims^i.
3.4 Introduction of DNA into tissue culture cells
3.4.1 Calcium phosphate mediated transfection  of viral 
DNA
T h e  method employed was essentially as described by Stow & Wilkie 
(1976). 30mm plates were seeded with 5 X 10^ BHK cells, using a 
haem ocytom eter to determine the concentration o f the cells in the 
suspension. O .lpg viral DNA and 1.25pg calf thymus carrier DNA were 
brought up to 57pl with the addition of distilled water (DW). 6 6pl 2X HEBS and 
9pl 2 M CaCl2 were added to form a precipitate. The medium was aspirated from 
the monolayers and the calcium phosphate/DNA precipitate was gently added 
dropwise to the cell monolayer. Plates were transferred to 37° C and rocked 
gently every 15min. After 45min, 2ml medium was added and the cells
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returned to 37°C for 3-4h. The medium was removed and 25% v/v DMSO in IX 
HEBS was applied at RT for 4min (Stow & Wilkie, 1976). The DMSO was removed 
and the monolayers washed twice with ETCio. 2 ml medium was added and the 
monolayers were incubated at 37°C for 16h.
3.4.2 Calcium phosphate mediated transfection of plasmid 
DNA
Plasmid DNA was adjusted to the appropriate quantity of total DNA by 
the addition of pUC9 to give a volume of 57pl. 66pl 2 X HEBS and 9|il^CaCl2 were 
added and the sample vortexed briefly. The medium was aspirated from the 
plate using a Pasteur pipette, before the gentle dropwise addition o f the 
precipitate. The plates were incubated at 37°C and rocked gently every 15min 
for 45min, at which time 2ml of "plating medium" (2 0 ml used ETCio; 17.8ml 
fresh ETCio; 2ml HEBS; 0.25ml 2M CaCl2) was added. A 4min 25% DMSO boost 
was carried out 3-4 h later as described in 3.4.1.
3.4.3 Lipofection of plasmid DNA
Lipofection Reagent is a 1:1 (w/w) liposome formulation of N-[l-(2,3- 
dioleyloxy) propyl] -N,N,N -trimethylammonium chloride (DOTMA), a cationic 
lipid and dioleoyl phosphatidylethanolamine (DOPE) in membrane filtered 
water. This reagent spontaneously interacts with DNA forming a lipid-DNA 
complex resulting in the entrapment of the DNA. Subsequent fusion o f the 
complex with the cell membrane results in efficient uptake and expression of 
the DNA.
ljig  DNA and lOpl Lipofection Reagent were separately diluted to 20pl 
in DW, then combined in a polystyrene tube and left to stand at RT for 15min. 
80-85% confluent HFL cell monolayers were washed twice with Opti-MEMl, a 
cell culture medium lacking serum. 1ml Opti-MEMl was then added to the 
cells, while gently rocking the plates. 40pl of the lipid-DNA complex was 
added dropwise, as uniformly as possible to the cells. Cells cultures were 
incubated for l-5h at 37°C before ending the lipofection with the addition of 
lml EF i q . The medium was changed after 24h and the cells harvested at 48h.
3.5 Extraction of cellular and viral nucleic acids
3.5.1 Extraction of whole cell DNA
Cells were scraped into 1ml medium and pelleted by centrifugation at
5.000 rpm in a benchtop microfuge for 15min, before being resuspended in 
2ml CLB containing 0.25mg/ml proteinase K, and incubated at 37°C for 3-5h. 
15 Opil 5M NaCl and 2ml phenol/chloroform was added to each sample, vortexed 
briefly then centrifuged at 5,000 rpm in a benchtop microfuge for lOmin. 
The upper phase was removed and 2.5 vols ethanol and sodium acetate to 0.3M 
were added. The tubes were inverted a few times resulting in the 
precipitation of DNA which was pelleted by centrifugation at 13,000 rpm for 
lOmin in a benchtop microfuge. Once dry, the DNA was resuspended in 500|il 
of TE or DW (Stow et al., 1986).
3.5.2 Separation of nuclear and cytoplasmic DNA
Cells were scraped into 1ml PBS and pelleted by centrifugation at
13.000 rpm in a benchtop microfuge for 2min. The overlying supernatant 
was discarded and the cell pellet was vortexed before the addition of 0.1ml TK 
lysis buffer. After another brief vortex, the samples were incubated on ice 
for 5min, vortexed again, then centrifuged at 13,000 rpm in a benchtop 
microfuge for 2min. The pellet contained the nuclear DNA and the 
supernatant contained the cytoplasmic DNA. DNA extractions of , both the 
pellet and the supernatant were carried out as described in 3.5.1.
3.5.3 Extraction of cytoplasmic RNA
The procedure employed for the extraction of RNA from either mock 
or virus infected cells is essentially as detailed by Ace et al. (1989). The 
protocol described here refers to 60mm diameter Petri dishes of confluent 
cells. The overlying medium was removed by aspiration and the cells washed 
with 5ml ice cold PBS. The cells were then scraped into 1ml PBS and 
centrifuged at 5,000 rpm in a benchtop microfuge for 30sec. The cell pellet 
was resuspended in 45p.l cold lOmM Tris-HCl; ImM EDTA, and 5jil 5% NP40 was 
added. The samples were vortexed and incubated on ice for 5min, followed by 
the addition of a further 5p.l 5% NP40. After another brief vortex, the samples 
were centrifuged at 5,000 rpm in a benchtop microfuge for 2.5min. The
supernatant, containing the RNA, was transferred to a sterile vial containing 
3Oj-il 20X SSC and 20pl formaldehyde. Samples were incubated at 60°C for 
15min, and stored at 70° C until required. The absorbance at 260nm was 
measured to determine the concentration of the RNA.
3.5.4 Extraction of whole cell RNA
Whole cell RNA was extracted essentially  as described by 
Chomczynski & Sacchi (1987). 90mm diameter Petri dishes of cells were
harvested in 3ml PBS and transferred to a 10ml Sarstedt tube. Cells were
pelleted by centrifugation at 2,000 rpm for 15min in the outer ring of a
Sorvall SM24 rotor. The supernatant was discarded, and the cell pellet
resuspended in 1.8ml GSCN buffer with vortexing. 120jil 2M sodium acetate 
pH4.0, 1.8ml water saturated phenol and 180pl chloroform /isoam ylalcohol 
(49:1) were added, and the samples vortexed after the addition of each
solution. The samples were vortexed for lOsec and incubated on ice for 15min.
The phases were separated by centrifugation at 10,000 rpm for 15min at 4°C 
in a Sorvall SM24 rotor. The aqueous phase was transferred to a fresh tube, 
leaving behind the interphase because at pH4.0 DNA enters the phenol phase. 
1.8ml isopropanol was added and the samples inverted before precipitation at
-20°C for lh. The RNA was pelleted by centrifugation at 10,000 rpm for 15min 
in a Sorvall SM24 rotor, and resuspended in 300pl GSCN buffer and 300pl
isopropanol. The samples were reprecipilated at -20°C for lh  and pelleted as 
above. Pellets were resuspended in 20Qpl nuclease free DW, and .20^1 3M 
sodium acetate and 600pl ethanol was added. After vortexing the samples were 
left at -20°C at least 16h. The RNA was stored as a precipitate until required. 
When needed, the RNA was pelleted as above, washed twice with 70% ethanol 
then cU icd. Finally the RNA was resuspended in 50jnl nuclease free DW 
and the absorbance determined at both 260nm and 280nm.
3.6 Manipulation of plasmid DNA
3.6.1 Large scale preparation o f  plasmid DNA
Large scale preparations of plasmid DNA were made using a 
modification of the protocol by Guerry et al. (1973). 5pl of the appropriate
glycerol stock of bacteria was inoculated into 10ml L-broth containing
50pg/ml ampicillin and left shaking at 37°C overnight. The overnight culture 
was added to 200ml L-broth containing ampicillin and shaken at 37°C for
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approximately 8h. Chloramphenicol was added to a final concentration of 
25pg/m l and incubation continued overnight. The cultures were pelleted by 
centrifugation at 8,000 rpm for lOmin in a Sorvall GSA rotor and resuspended 
in 5ml 25% sucrose; 50mM Tris-HCl (pH8.0). 2.5ml fresh 5mg/ml lysozyme was
added, mixed and left on ice for 30min. 2ml 250mM EDTA pH 7.5-8.0 was added
and the samples were incubated on ice for 5min. 1.5ml of both 5M NaCl and 
20% SDS were added and the samples thoroughly mixed and left on ice for 2- 
3h. The cell debris was removed by centrifugation at 20,000 rpm in a Sorvall 
SS34 rotor for lh  at 4°C. The supernatant was extracted twice with 20ml 
phenol/chloroform and once with 15ml chloroform. The upper aqueous
phase was precipitated by the addition of 2 volumes of ethanol at -2 0 ° C for lh 
or overnight. Samples were centrifuged at 2,500 rpm for 15min in a Beckman 
GPR centrifuge, and the resultant soft pellet freeze dried. The pellet was 
dissolved in 9ml TNE containing 20pl 5mg/ml RNaseA and incubated either at 
37°C  for 2-4h or 30°C overnight. 0.5ml of 100p,g/ml proteinase K solution was 
added, and the incubation was continued at 37° C for 2-16h. Two 
phenol/chloroform  and one chloroform extractions were carried out as
described above. The volume of the final aqueous phase was adjusted to 9ml
with DW and 1ml 3M sodium acetate (pH7.0) and 5ml isopropanol were added. 
After mixing, samples were left to stand at RT for 2h, and centrifuged at 2,500 
rpm for 15min at 20°C in a Beckman GPR centrifuge. The supernatant was
discarded and the pellet allowed to dry at RT overnight, before being 
dissolved in 300|il DW. Serial dilutions of the plasmid were run on a mini-gel
along side a known standard to quantitate the DNA. ,
3.6.2 Preparation of ’’mini-prep” DNA
Colonies for analysis were picked using a sterile toothpick, 
transferred to a universal containing 2ml L-broth with 50pg/m l am picillin 
and placed in an orbital 37°C incubator overnight. 1.5ml was decanted into 
1.5ml vial and the bacteria pelleted by centrifugation at 5,000 rpm in a 
benchtop microfuge for 2min. The medium was removed by aspiration and 
the pellet resuspended in 100pl STET containing 1 mg/ml lysozyme. Samples 
were then placed in a boiling water bath for 1.25min and centrifuged for 
lOmin at 13,000 rpm in a benchtop microfuge. The supernatant was 
transferred to a vial containing 400pl 0.3M sodium acetate (pH7.0). 0.5ml 
isopropanol was added and the samples were incubated at -20°C for lh. DNA 
was pelleted by centrifugation at 13,000 rpm in a benchtop microfuge for 
5min, -<Aricd.f before resuspension in 33|il DW. Finally, DNA was analysed
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by cleavage with the appropriate restriction enzyme, in the presence of
0.5|xg/ml ribonuclease (RNaseA).
3.6.3 Restriction enzyme digests
Restriction enzyme digests were carried out at 37°C for the required 
time in the appropriate commercial buffer. The number of units of enzymes 
added was dependant on the activity of the enzyme and the amount of DNA to 
be cleaved.
3.6.4 Electroelution of DNA from agarose gels
Using a sterile scalpel, the required band was excised from the gel as 
visualised under long wave UV light. The DNA was isolated by electroelution 
in IX EEB at 20mA per sample for 1.5h at 4°C, using equipment designed for 
this purpose. The DNA was removed in 2 0 0 (4.1 IX EEB and transferred to a fresh 
vial containing 160(1,1 DW; 40(il 3M sodium acetate; lp.1 E.coli rRNA. A 0.5ml 
phenol/chloroform and a 0.4ml chloroform extraction were carried out. The 
DNA was precipitated in an equal volume of isopropanol at RT for lh. The DNA 
was pelleted by centrifugation at 13,000 rpm in a benchtop microfuge and the 
salt removed by a 70% ethanol wash. The pellet was dried and resuspended in 
the appropriate volume of DW.
3.6.5 Ligation of plasmid DNA
Ligations were performed using 50ng of linearised vector DNA and
200-500ng of purified fragment in 20mM Tris-HCl (pH7.6), lOmM MgCl2 , lOmM 
dithiothreitol (DDT) and 0.6mM ATP and catalysed by lOunits T4 DNA ligase. 
Reactions were incubated at 15°C for 16h.
3.6.6 Preparation of competent bacteria and transfection  
of plasmid DNA
10ml L-broth was inoculated with 5(tl of a glycerol stock of E.coli DH-
1, and placed in an orbital incubator at 37° C overnight. 2ml of this culture
was added to 80ml L-broth and shaken at 37°C until an OD of 0.2 was reached.
The bacteria were pelleted by centrifugation at 5,000 rpm for 10 min in a 
Beckman GPR centrifuge, resuspended in 40ml ice cold lOOmM CaCl2 , and
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placed on ice for lh. The competent bacteria were pelleted as above and 
resuspended in 0.8ml ice cold lOOmM CaCl2 -
2 pl ligation mix was added to 100p.l competent bacteria and put on ice 
for lh. Samples were heat shocked for 1.5min at 42°C and transferred to a 
universal containing 1ml L-broth and shaken at 3 7 °C for 1-1.5h. 150pl
aliquots were spread on agar plates containing 50p.g/ml am picillin and 
returned to 37°C overnight.
3.6.7 Ampicillin agar plates
L-broth agar was melted then left to cool until hand hot, at which 
time ampicillin was added to a final concentration of 50p.g/ml. The agar was 
then poured into 90mm sterile Petri dishes and allowed to set. Plates were 
dried in an inverted position at 37°C for lh before use and stored at 4°C until 
req u ired .
3.6.8 Preparation of bacterial glycerol stocks
5ml L-broth was inoculated with a particular bacterial isolate, and 
placed in an orbital incubator at 37° C overnight. 1ml of the culture was 
centrifuged at 5,000 rpm in a benchtop microfuge for lmin. The supernatant 
was discarded and the pellet resuspended in 0.5ml 2% bactone peptone and 
0.5ml 80% glycerol. Glycerol stocks were stored at -20°C.
3.7 Electrophoretic separation of nucleic acids
3.7.1 Agarose minigels
Rapid examination of small quantities of DNA was achieved using 
mini-gels (100mm X 70mm X 7mm) consisting of 30ml 0.8% agarose in IX TBE. 
lO pl samples were loaded in IX TBE loading buffer and electrophoresed at 
40mA for approximately lh. 5p.g ethidium bromide was added to the running 
buffer and the samples were visualized by exposure to UV light and 
photographed on type 667 Poloroid film.
3.7.2 Large agarose gels
DNA restriction fragments were analysed and prepared using 300ml 
horizontal 0.8% agarose gels (260mm X 160mm X 7.5mm) containing 0.5pg/ml
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ethidium bromide in a |X TBE running buffer. DNA samples were mixed with 
IX TBE loading buffer before electrophoresis at 40mA for 3-4h.
3.7.3 Non-denaturing polyacrylamide gels
Gel retardation assays and the purification of radiolabelled  
oligonucleotides were carried out using vertical gels (260mm X 160mm X 
1mm) and the appropriate concentrations of acrylamide in 0.5X TBE. 50ml of 
8 % acrylamide was prepared from a stock solution of 2 0 % acrylamide and 1% 
N-N' methylene bisacrylamide, with 0.5X TBE. Gels were polymerised with the 
addition of 0.5ml freshly prepared 10% ammonium persulphate and 50pl 
TEMED. Samples were loaded in IX TBE loading buffer using a capillary tube. 
Electrophoresis was carried out at 250V for 1-1.5h, until the bromophenol 
blue (BPB) band was 2" from the bottom of the gel.
3.7.4 Denaturing urea/polyacrylamide gels
The RNA products from in vitro transcription reactions were 
analysed on denaturing 7M urea 6 % polyacrylamide gels. 6 % acrylamide was 
prepared from a stock solution of 20% acrylamide, 7M urea in IX TBE, using 
10M urea to bring the solution to the required volume. Catalysts were added as 
previously described. (Section 3.7.3) The gel was pre-run in IX TBE for lOmin 
at 250V. The wells were flushed with IX TBE buffer and the samples loaded. 
Electrophoresis was continued at 250V for 3-4h, until the BPB dye just ran off
t
the gel. The gels were dried under vacuum, then subjected to 
au to rad io g rap h y .
3.7.5 SDS-polyacrylamide gel electrophoresis (PAGE)
SDS-PAGE was employed to analyse the viral polypeptides produced 
after infection of tissue culture cells at both immediate early (IE) and late (L) 
times. Glass plates were soaked overnight in dilute HC1, then rinsed in DW 
before use. A 12% acrylamide gel was poured into a prepared gel sandwich 
(260mm X 160mm X 1mm) and overlaid with 0.25X gel buffer (GB) until 
polymerised. The 0.25X GB was poured off and the interface washed twice with 
stacking gel (SG). The SG was added and a teflon well former inserted to form 
sample wells. Once polymerised, the wells were washed out with tank buffer. 
Gels were run in tank buffer at 35mA for 3h. Gels were soaked overnight in a
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50:50 mix of gel fix:gel stain, and dried under vacuum then subjected to
au to rad io g rap h y .
3.7.6 Denaturing agarose/formaldehyde gels
RNA extracted from TK+ transformed cell lines under various
conditions was prepared for Northern blotting by electrophoresis on 
denaturing formaldehyde agarose gels (260mm X 160mm X 5mm). The 
formaldehyde gel was prepared by boiling 3.6g agarose in 261ml nuclease
free DW. The agarose was cooled to 55°C then 30ml 10X MOPS and 9ml
formaldehyde was added, and the gel was poured immediately. 5pl 10X MOPS 
and 8.75pl formaldehyde was added to 12pl RNA samples and incubated at 65°C 
for 15min. 10pl loading dye (0.25% BPB; 0.25% xylene cyanol; ImM EDTA; 50% 
glycerol) and lp l 1 mg/ml EtBr was added, and the samples loaded directly into 
the wells. Electrophoresis was carried out at 70-80V in a fume hood, until the
BPB band had travelled 10cm from the wells.
3.8 Analysis of viral protein synthesis
3.8.1 Viral IE-protein synthesis
IE polypeptides were generated at 38.5°C as described by Preston et al. 
(1978). HFL cells were infected with 500 particles of virus per cell, in the 
presence of 25pg/ml cycloheximide. Plates were transferred to 38.5°C for 3h 
post-adsorption, before the release of the cycloheximide block by three 
1.5min washes with fresh prewarmed culture medium. Polypeptides were
radiolabelled with^ medium containing 0.3ml of 50pCi/ml [3 5 S]-methionine in 
the presence of lpg/m l actinomycin D for 90 min. At the end of the labelling 
period, the supernatant was removed and the cultures lysed and harvested as 
described by Marsden et al. (1978). Cells were washed with 2ml ice cold PBS, 
followed by 1ml ice cold DW. 200pl ice cold lOmM Tris-HCl (pH7.5); 5mM EDTA 
was added and the plates left on ice for 5min. Cells were removed from the 
plates by squirting the Tris-HCl/EDTA over them, before transfer to a vial 
containing lOOpl 3X boiling mix. Samples were heated at 95°C for 15min, with 
occasional mixing, to shear the DNA and hence reduce the viscosity. 5pl 
samples were spotted on a Whatman No.l disc for a trichloroacetic acid (TCA) 
wash in order to determine the percentage incorporation of [3 5 s ] - 
methionine (See 3.11.3). Radiolabelled proteins were analysed , by SDS-PAGE.
3.8.2 Late viral protein synthesis
HFL cells were infected with 20 p.f.u. virus at 37°C, in the absence of. , , i *r f o / a o t io  o f
cycloheximide. Polypeptides were radiolabelled at 8 h post-adsorption A and QC*nt*!Jhi 
harvested as previously described (See 3.8.1).
3.9 Preparation of cell extracts
3.9.1 Preparation of nuclear extracts
HeLa cell nuclear extracts were prepared using a modification of the 
procedure described by Dignam et al. (1983). Cells were washed with 10ml ice 
cold PBS and scraped into 5ml PBS. Cells were pelleted by centrifugation at
2,000 rpm for 5min in a Beckman GPR centrifuge and resuspended in 0.5ml 
PBS, before transfer to a 1.5 ml vial. Samples were centrifuged at 5,000 rpm in 
a benchtop microfuge for 2min. The supernatant was discarded and the cell 
pellet resuspended in 50pl buffer A, placed on ice for 5min, vortexed, 
returned to the ice for a further 5min, and vortexed again. The nuclei were 
pelleted by centrifugation at 4,000 rpm in a Sorvall SS34 rotor for 5min, the 
cytoplasmic fraction was removed and the nuclei packed down again by 
centrifugation at 15,000 rpm in a Sorvall SS34 rotor for 15min. Any 
remaining supernatant was removed and the nuclei were resuspended in 2 0 |il 
buffer C. Samples were incubated on ice for 20min with frequent mixing and 
centrifuged at 15,000 rpm in a Sorvall SS34 rotor for 15min to pellet the 
nuclear debris. The resulting supernatant was retained to be used as the 
nuclear extract, and the protein concentration determined (See 3.9.5).
3.9.1.1 Gel retardation assays
The reaction mixes used to analyse protein-DNA complex formation 
contained lOmM HEPES (pH 7.9); 0.6mM DTT; 2.3mM MgCl2 ; 94mM NaCl; O.lmM 
PMSF; O.lmg/ml BSA; 4% v/v glycerol; 2p.g poly(dI)-poly(dC); 0.2-1.0ng [32pj- 
3'-end labelled DNA fragment and 5.0pg infected or mock infected HeLa cell 
extract. 0.3-1.0pg virion extract was added where appropriate. Samples were 
incubated at 25°C for 30min then loaded directly onto a 3.5% polyacrylamide 
gel. Electrophoresis was carried out in 0.5X TBE at 20mA for 3-4h. Gels were 
dried under vacuum, then exposed for autoradiography (Preston et al., 1988).
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3.9.2 Preparation of transcriptionally active whole cell 
e x t r a c t
Whole cell HeLa extracts were prepared using the procedure 
described by Manley et al  (1980). All stages were carried out at 4°C. Cells were 
washed with 10ml ice cold PBS, before being scraped into 5ml PBS. The cells 
were pelleted at 2,000 rpm in a Beckman GPR centrifuge for 5min, and 
resuspended in four packed cell volumes (PCV) of lOmM Tris-HCl (pH7.9); 
ImM EDTA, and 5mM DTT. After 20min the cells were lysed by homogenization 
in a Dounce homogeniser with eight strokes using a "B" type pestle. Four PCV 
of 50mM Tris-HCl (pH7.9); lOmM MgCl2 ; 2mM DTT; 25% sucrose and 50% 
glycerol were added, and the suspension gently mixed. With continued gentle 
stirring, one PCV of saturated (NH4 )2 SC>4 was added dropwise to produce a 
highly viscous lysate. Stirring was continued for a further 30min and had to 
be gentle to prevent shearing of DNA, which would interfere with its 
removal at the next stage. This extremely viscous extract was carefully 
poured into polycarbonate tubes and centrifuged at 45,000rpm for 3h in a 
Beckman Tioo rotor. The resulting supernatant was carefully decanted and 
the protein and nucleic acids were precipitated by the addition of solid 
(N H 4)2S04 (0.33mg/ml solution). 1M NaOH (O.lml/lOmg solid (NH4 )2 SC>4 ) was 
added and the suspension stirred for another 30min. The precipitate was 
collected by centrifugation at 15,000 rpm in a Sorvall SS34 rotor for 20min, 
and resuspended in 5% of the volume of the high speed supernatant with 
25mM HEPES (pH7.9); lOOmM KC1; 12mM MgCl2 ; 500mM EDTA; 2mM DTT and 
17% glycerol. The suspension was dialysed against two changes of 50-100 
volumes each of the resuspension buffer for a total of 8-12h. The dialysate 
was then centrifuged at 10,000 rpm for lOmin in a Sorvall SS34 rotor to
remove insoluble material. The supernatant was dispensed into 0.2-0.5ml 
portions, frozen on dry ice and stored at -70°C .
3.9.2.1 In vitro transcription assays (whole cell extract)
A typical 20pl reaction contained 60% (v/v) whole cell extract; 0.2-
1.5pg template DNA; 50pM ATP; 50pM GTP; 50pM CTP; 5pM UTP; 5mM creatine
phosphate; and lOpCi [a-^^P]UTP. The samples were incubated at 30°C for 2h 
and the reaction was terminated with the addition of 400pl of 0.3M sodium
acetate; lOmM EDTA; lOmM Tris-HCl pH7.9; 0.5% SDS. lOpg yeast RNA was added 
then two phenol/chloroform and one chloroform extractions were carried 
out. Radiolabelled RNA was precipitated by the addition of 2.5vols ethanol and
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storage at -20° C for at least 2h. Following a 70% ethanol wash, the RNA pellets 
were resuspended in 30p.l 95% formamide; 0.5% 0.5X TBE. lp.1 of each reaction 
was spotted onto a Whatman No.l to determine the percentage incorporation 
of the radiolabel (See 3.11.3). The samples were heated for 2-3min on a 
heating block at 100°C, then loaded onto a 3.5% acrylamide; 7M urea gel. The 
gel was run at 150V for 3-4h, dried under vacuum, and exposed to 
autoradiographic film.
3.9.2.2 In vitro t r a n s c r ip t io n  a ssa y -P r o m e g a  n u c lea r
e x t r a c t
Mixtures containing ( l l -x )p l  transcription buffer (where x=volume 
nuclear extract); 1.5p.l 50mM MgCl2 ; 0.4mM of each ATP, GTP and TTP; 4pl 
linear DNA template; lp l [a-^^P]CTP (lOmCi/ml) were assembled in a 1.5ml 
reaction vial. Nuclease free DW and 8units (xpl) of nuclear extract were added 
to bring the volume to 25|il. Reactions were briefly vortexed and incubated at 
30°C  for 60min. 175(il of stop solution was added to terminate the reaction. 
RNA was extracted with 200|il phenol:chloroform :isoamylalcohol (25:24:1), 
vortexed for lOsec, then the phases separated by centrifugation at 13,000 rpm 
for 5 min in a benchtop microfuge. The upper aqueous phase was transferred 
to a fresh tube and 100|il 100% ethanol was added. The samples were mixed by 
vortexing then placed on ice for 15min. RNA was pelleted by centrifugation 
at 13,000 rpm for lOmin in a benchtop microfuge, the supernatant was 
decanted and the pellet dried in a vacuum desiccator. RNA was resuspended in 
20|o.l nuclease free DW and 20pl Promega loading dye. Samples were heated to 
90°C for lOmin just prior to loading onto a gel.
3.9.3 H arvest and preparation  of cell extracts for 
chloramphenicol acetytransferase (CAT) assays
The overlying medium was aspirated off using a Pasteur pipette and 
the cell monolayer washed with 2ml cold PBS. Cells were then scraped into 
2ml TNE (lOmM Tris-HCl; lOOmM NaCl; ImM EDTA (pH7.5)) and transferred to a 
sterile 15ml Falcon tube. A further 1ml TNE was added to the plate in order to 
remove any remaining cells. The cells were then pelleted by centrifugation 
at 2,000 rpm for lmin in a Beckman GRP centrifuge, and left in an inverted 
position to dry. 75|il of 250mM Tris-HCl pH7.8 was added and the tubes vortexed 
to resuspend the cells. Samples were sonicated for a series of 15sec bursts, 
until the suspension appeared slightly  opaque. Samples were
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transferred to a 1.5ml reaction vial and the cell debris pelleted by 
centrifugation at 13,000 rpm in a benchtop microfuge for 2min. The 
resulting supernatant contained CAT activity and was stored at -70°C .
3.9.3.1 CAT assays
Each reaction contained ljxl 50mM acetyl coenzyme A; 0.5pl stock ^ C -  
chloram phenicol; 14|il DW and 25|il of cell extract. The reactions were 
initiated by vortexing and incubated for lh  at 37°C. Reactions were stopped 
by the addition of 200pl ethyl acetate. After vortexing briefly the tubes were 
centrifuged at 13,000 rpm for lmin in a benchtop microfuge. The upper layer 
was transferred to a fresh tube, and vacuum dried. The pellet was dissolved in 
2 0 p i ethyl acetate by vortexing. Samples were spotted on a thin layer 
chromatography (TLC) plate, no closer than 1cm apart and 2cm from the 
base. The TLC plate was placed in a chromatography tank containing 5% 
methanol; 95% chloroform. Once the elutent reached 1cm from the top, the
plate was removed and left to air dry. When completely dry it was exposed 
directly to photographic film at RT.
3.9.4 Preparation of cell extracts for thymidine kinase (TK)
a s s a y s
Cells were scraped into the medium, then pelleted by centrifugation
at 5,000 rpm for 15min in a benchtop microfuge. The pellet was vortexed and 
0.1ml TK lysis buffer was added. The samples were vortexed, then left on ice 
for 5-10min. After a second vortex, they were centrifuged for 2min at 13,000 
rpm in a benchtop microfuge. The resulting supernatant contained the 
extract to be assayed for TK activity.
3.9.4.1 Determination of TK activity
Each TK reaction mix contained 50mM sodium phosphate buffer
(pH6.0); lOmM MgCl2 ; 5mM ATP; O.lmM dTTP; 100pCi/ml [^H]-thymidine. 5pl of 
cell extract was added to 45pl of the above reaction mix, and the samples 
vortexed. Incubation was carried out at 30°C for lh. 10p.l lOOmM EDTA; ImM 
thymidine was added and the samples heated for 5min at 100°C, and cooled on 
ice for 5min. They were then centrifuged for 5 min at 13,000 rpm in a 
benchtop microfuge and 50jil of the supernatant was spotted onto a DE8I disc.
The discs were immersed in 500ml 4mM ammonium formate; 10(iM thymidine
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at 37°C for lOmin. The first wash was poured off and another 500ml added. 
This procedure was repeated a third time, followed by two 5min ethanol 
washes. The discs were placed out to air dry, and the amount of ^H -th y m id in e  
incorporated was determined in a scintillation counter (See 3.11.3).
3.9.5 Protein concentration estimations
The protein concentrations of sample was determ ined using a 
Bradford assay (Bradford, 1976). 1ml of Bradford reagent was added to a 
sample of the cell extract and left at RT for 15min. The absorbance was 
determined at 595nm and the protein concentration estim ated from a 
calibration curve derived from known concentrations of BSA.
3.10 Manipulation of oligonucleotides
3.10.1 Purification of oligonucleotides
Deprotection of oligonucleotides was achieved by incubation at 55°C 
for 5h. After dispensing into four aliquots, they were frozen on dry ice then
dried under vacuum for 1.5h. Each pellet was resuspended in 50pl of 90%
formamide (deionised); IX TBE, heated at 95°C for 2min before being applied 
to a 15% acrylamide gel. The desired band was detected by placing a TLC plate 
underneath the gel and illuminating it with short wave UV light. The 
oligonucleotide appeared as a distinct grey band on a green background. The
uppermost band contained the full length oligonucleotide, and was excised 
from the gel and incubated at 45°C overnight in 2ml gel elution buffer (GEB). 
The content of each tube was filtered through glass fibre into a fresh vial 
and ethanol precipitated as previously described. Oligonucleotide pellets were 
stored dry at -70°C and resuspended in DW when required.
3.10.2 Annealing complementary o ligonucleotides
5 p g  of each oligonucleotide was brought up to 50pl in a solution 
containing 0.3M sodium acetate; 2mM EDTA; 40mM Tris-HCl pH7.5. Samples 
were incubated at 5 0 °C for lh, 37 °C for lh  and RT for lh . Annealed 
oligonucleotides were precipitated in 2.5 volumes of ethanol at -20° C for 2h 
and pelleted by centrifugation at 13,000 rpm in a benchtop microfuge for
20min. After a 70% ethanol wash, the pellet was dried under vacuum and
resuspended in the required volume of DW.
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3.11 3 ^  p.labelling of DNA probes in vitro
3.11.1 Hexanucleotide primer extension
lp g  of DNA was dissolved in a total volume of 23.5pl of sterile DW and 
denatured by heating at 100°C for lOmin. The sample was cooled on ice for 
lOmin, before a brief centrifugation to recover water lost by condensation.
To this, IOjj.1 oligo reaction mix; 20pM each non-radioactive dATP, dGTP, dTTP; 
2.0|xl 0.1% BSA; 5.0pl (50|iCi) a-[^^P]-dCTP and 5 units Klenow enzyme were 
added. Reactions were incubated at RT overnight (Feinberg & Vogelstein, 
1983).
3.11.2 End-filling labelling of oligonucleotide probes
A typical 50pl reaction contained 15-20mM oligonucleotide; IX T4 pol 
buffer; ImM DTT; O.lmM each non-radioactive dATP, dGTP; 2.5pl (25p.Ci) each 
of oc-[3 2p]_(iCTp> dTTP; 1/10 volume 0.1% BSA and 5-10 units T4 DNA 
polymerase. The samples were incubated at 37°C for lh. Upon completion of 
the reaction, 15pl of TBE loading buffer was added and the entire sample 
loaded directly onto a 8% native polyacrylamide gel. Electrophoresis was 
carried out at 150V until the BPB band reached approximately 2 inches from 
the bottom. The highly radioactive bands were identified by autoradiography 
of the wet gel, excised and eluted at 45°C overnight in 0.5ml GEB. The 
supernatant was purified by passing it through a 10ml Sephadex G50 column. 
The peak, usually four four drop fractions, was collected ,and lp g  
poly(dI).poly(dC) was added to each, along with sodium acetate to 0.3M and 2.5 
vols ethanol. After at least 2h at -20°C, the oligonucleotides were pelleted by 
centrifugation, washed in ethanol, then dissolved in 50pl DW. lp l of this was 
removed and its Cerenkov c.p.m. was determined.
3.11.3  D eterm ination  of percentage in co rp o ra tio n  of  
radiolabel into probe
0.5pl of the above labelling mix was diluted into lOjil DW. 3pl duplicate 
samples were spotted onto Whatman No.l filter paper discs. The filters were 
dried briefly under a heat lamp, and one kept aside to determine the total 
c.p.m. in the sample. In order to remove the unincorporated radiolabelled 
nucleotides, the other filter was placed in 10% (w/v) TCA for 5min, then 
transferred to a fresh 10% (w/v) TCA wash for a further 5min. Two 5min 5% 
(w/v) TCA washes were then carried out followed by two 5min ethanol
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washes. The discs were dried then placed in a scintillation vial containing
5ml Ecoscint A. The level of radioactivity was measured in a scintillation 
counter and compared to that of the unwashed sample.
3.12 Southern transfer and hybridisation
3.12.1 Southern blot-alkaline transfer method
The trimmed agarose gel was soaked in 50ml of alkaline transfer 
solution for 30min with occasional agitation. Two pieces of Whatman No.l
filter paper and one piece of Genescreen Plus membrane were cut to the same 
size as the gel. Two filter paper wicks were soaked in alkaline transfer
solution, and placed over a glass plate on a rack with the ends touching the 
bottom of the dish. It was important to ensure that there were no air bubbles 
as this would interfere with the DNA transfer. The gel containing denatured 
DNA was placed on top of the wicks, the Genescreen Plus membrane and two 
pieces of filter paper were placed on top of the gel. A 2 inch thick pile of 
paper towels were added and weighted down. The remaining alkaline transfer 
solution was poured into the dish and left for 16-18h to allow capillary
transfer to occur. The membrane was immersed in 200ml of neutralising 
solution for 15min and air dried. The DNA was irreversibly bound to the 
membrane by exposing it to short wave UV light for 6min (Chomczynski & 
Qasba, 1984).
3.12.2 DNA hybridisation with DNA probes
The Genescreen P lu s  membrane was prehybridised in 100ml of
prehybridisation mix for 3h at 72° C in a shaking water bath. The 
prehybridisation mix was poured off and 20ml hybridisation mix containing
the radiolabelled probe was added using a syringe and needle. The bag was 
resealed and the blot returned to the shaking 72° C water bath overnight. The 
next morning two 45min washes in prehybridisation mix were carried out at
72°C . The blot was finally rinsed quickly in DW at RT then left to air dry, 
before autoradiography.
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3.13 RNA blot transfer and hybridisation
3.13.1 RNA dot blots
RNA samples were diluted to 3, 1 and 0.3|ig in a total volume of 50pl. 9 
X 12cm pieces of nitrocellulose and Whatman No.l filter paper were cut and 
soaked in DW and 20 X SSC, before being placed on a hybrid manifold with the 
filter paper beneath the nitrocellulose. The apparatus was then reassembled 
and the plates screwed in position. 50pl dilutions of each sample was loaded 
into the appropriate well under suction. The water pressure was increased to 
full pressure for 5min. Once the apparatus was dismantled, the nitrocellulose 
filter was placed on a tissue and left to air dry overnight at RT. Filters were 
baked in a vacuum oven for 2h at 65° C prior to hybridization (White & 
Bancroft, 1982).
3.13.2 Northern transfer from form aldehyde/agarose gels
The formaldehyde/agarose gel was prepared for northern transfer 
by washing twice in DW for 5min then equilibrating in 10X SSC for 45min. 
The blot was set up as described for the Southern blot, but using a 
nitrocellulose filter and transferring in 20X SSC. The filter was prehybridised 
at 42°C for 2-4h in 50% formaldehyde (deionised); 5X SSPE; 5X Denhardt's 
solution; 0.5% SDS and 100|ig/ml denatured and sonicated calf thymus (CT) 
DNA. Hybridisation was carried out using fresh prehybridisation buffer 
containing denatured and neutralised radiolabelled probe, overnight at 4 2 °C . 
The filter was washed for 20min in 2X SSC; 0.1% SDS at 65°C, for lOmin in 0.2X 
SSC; 0.1% SDS and for lOmin in 0.2X SSC.
3.13.3 RNA hybridisation with DNA probes
Nitrocellulose filters were prehybridised for 3h at 4 2 °C in 15ml of 
50% formamide (deionised); 5X SSPE; 5X Denhardt's solution and lOOpg/ml 
sonicated denatured calf thymus DNA. Hybridisation was carried out at 42°C in 
8.8ml 50% formamide (deionised); 5X SSPE; IX Denhardt's solution; lOOpg/ml CT 
DNA and a radiolabelled DNA probe. After incubation for 16h the 
hybridisation solution was removed and two 30min washes in 2X SSC, 0.1% SDS 
at RT; two 30min washes in 0.1X SSC, 0.1% SDS at RT and two 15min washes in 
0.1X SSC, 0.1% SDS at 60°C were carried out.
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3.14 Preparation of HMBA stock solution
A stock solution of lOOmM HMBA was prepared in PBS by incubation 
at 37°C for lh, and filter sterilised before use.
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/«1814 particle counts were obtained by electron microscope analysis 
and the corresponding particle to pfu ratio was determined. The 
isolates of /«1814 used in this thesis all had the same particle to pfu 
ra tio .
4. RESULTS
4.1 Objective
A number of structurally and functionally related chemicals have 
been identified which reverse the phenotype of the Vmw65 insertion mutant, 
in 1814 (Ace et al., 1989) in tissue culture cells, such that replication rather 
than latency is the normal outcome of infection (McFarlane et al., 1992). The 
work presented in this thesis documents the characterization of the effect of 
HMBA on /n l814  replication, the investigation into how HMBA functions at 
the molecular level and the elucidation of the signals involved in this 
process. HMBA and DMSO are both potent inducers of terminal differentiation 
of MELCs (Friend et al., 1971; Reuben et al., 1976) and have been shown to 
increase the speed and efficiency of reactivation of both HSV-1 and HSV-2 
from the latent state in a number of animal models (Whitby et al., 1987; 
Bernstein & Kappes, 1988; Leib et a l ,  1989). Determination of the molecular 
basis for the activity of HMBA on /nl814 infection may reveal the primary 
events by which the compound affects the poorly understood process of 
reactivation. In addition, stimulation of HSV-1 IE RNA accumulation is, to our 
knowledge, the first example in which genes in their normal genomic 
environment are activated by HMBA, and therefore studies on the mechanism 
of the effect on IE gene expression should be relevant to understanding the 
primary changes in gene expression that trigger erythroleukaemic cell 
d iffe re n tia tio n .
4.2 The effects of HMBA on in 1814 replication
4.2.1 Effect of HMBA on in 1814 titre
-k
Titration of in 1814, and the rescued 'revertant' 1814R, was carried out 
on HFL cells, with various concentrations of HMBA included in the culture 
medium after a lh  adsorption and penetration period. Tenfold dilutions of 
virus suspension (200p.l) were added to cell monolayers on 30mm diameter 
dishes. After incubation for lh, to allow adsorption and penetration of virus,
2ml of EHu5 was added. HMBA was routinely added after the lh  period. A large
increase in /n l8 1 4  titre was observed with increasing concentrations of 
HMBA, reaching a value of 500-fold at the optimal concentration, 5mM HMBA
(Figure 4.1a). Titration of /nl814 in the presence of 5mM HMBA reduced the
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Figure 4.1 Effect of HMBA on the titre of i n i  8 1 4  
and 1814R
Mutant m l 814 (■) and wt revertant 1814R (♦) were titrated on 
HFL (a), BHK (b) or HeLa (c) cells. Monolayers were fixed and 
stained 2 days post-infection.
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particle to pfu ratio from 30,000 to 60, a value close to that routinely observed 
for wild type HSV-1 preparations. In contrast, the titre of 1814R was virtually 
unaffected by the presence of HMBA. At 5mM HMBA, HFL cells were slightly 
elongated but otherwise morphologically normal, whereas evidence of cell 
degeneration was observed at 7mM HMBA.
To determine whether the effect of HMBA was specific to HFL cells, 
in 1814 and 1814R were titrated on BHK and HeLa cells in the presence and 
absence of HMBA (Figure 4.1b,c). Again inl814 reached a titre of 5 x 10^ 
pfu/ml or greater, raising the possibility that HMBA is either affecting or 
working via a ubiquitous phenomenon or protein.
The effect of HMBA on overall protein synthesis after infection of 
HFL cells was investigated at a relatively low m.o.i. as the detrimental effect 
of the Vmw65 mutation on viral replication is not observed at high m.o.i. (Ace 
et al., 1989). HFL monolayers were infected, in the absence of cycloheximide, 
with 10 particles of i«1814 or 1814R per cell, in the presence or absence of 
5mM HMBA, and radiolabelled after 8h with [35s]-methionine (Figure 4.2). 
The presence of HMBA did not significantly alter the polypeptide profile of 
mock- (lanes 1 and 2), or 1814R-infected (lanes 3 and 4) cells, but changed 
the pattern of i/zl814-infected cells (lanes 5 and 6) to resemble that of 1814R- 
infected cells rather than mock-infected cells.
The presence of 3-5mM HMBA, the optimum concentration for 
induction of MELC differentiation (Reuben et al., 1980), therefore increases 
dramatically the titre of in 1814, enabling the mutant to initiate infection 
almost as efficiently as wild type HSV-1.
4.2.2 Effects of DMSO, hypoxanthine and 5-azacytidine on 
in 1814 titre
The effects on the titre of in 1814 of two other agents known to induce 
erythroid differentiation was investigated (Table 4.1). DMSO, like HMBA, is a 
polar-planar compound whereas hypoxanthine is not strongly charged. Both 
compounds significantly increased in 1814 titre at concentrations previously 
shown to be optimal for differentiation (Gusella et al., 1976; Reuben et al., 
1980), but they were not as effective as HMBA. This result is consistent with 
the observation by Palfrey et al. (1977) that HMBA is a more potent inducer of 
MELC differentiation, acting in a concentration range 50 times lower than 
that of DMSO.
The increased efficiency and speed of reactivation of latent DNA in 
the presence of HMBA or DMSO in a number of different model systems
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Figure 4.2 Effect of HMBA on HSV-1 protein
s y n t h e s i s
HFL monolayers were mock-infected (lanes 1 and 2), 
infected with 10 particles of 1814R (lanes 3 and 4) or in 1814 (lanes 
5 and 6) per cell, in the absence (lanes 1, 3 and 5) or presence 
(lanes 2, 4 and 6) of 5mM HMBA. At 8h post-infection, monolayers 
were radiolabelled with [^^S]methionine, in the absence of HMBA. 
The positions of virus-specified proteins Vmwl55, glycoprotein B 
and Vmw65 are shown.
Cells were labelled for 90 min in the presence of lm g/m l 
actinomycin D.
The apparent increased molecular weight of Vmw65 specified by
in 1814, due to the insertion of 4aa, has been previously documented 
by Ace et al., 1989.
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Table 4.1 Effect of DMSO and Hypoxanthine on the titre 
of in 1 8 14
V i r u s T r e a t m e n t Titre (pfu/ml)
ini  8 14 NONE <5 X 105
ini  8 1 4 5.0mM HMBA 1.2 X 109
ini  814 lOOmM DMSO 1.4 X 108
in i 8 1 4 150mM DMSO 2.7 X 108
in i 8 1 4 200mM DMSO 4.4 X 108
in i 8 1 4 2.5mM Hypoxanthine 3.5 X 108
in i 8 1 4 3.75mM Hypoxanthine 3.9 X 108
in i 8 1 4 5.0mM Hypoxanthine 5.3 X 108
1814R NONE 1.3 X 109
1814R 5.0mM HMBA 1.2 X 109
1814R 200mM DMSO 1.2 X 109
1814R 5.0mM Hypoxanthine 1.2 X 109
HFL cells were infected with either in 1814 or 1814R and
agents added to the culture medium after the lh  adsorption 
and penetration period. Monolayers were fixed and stained two 
days post-infection and the resulting titres determined.
(Whitby et al., 1987; Bernstein & Kappes, 1988; Leib et al., 1989) has been 
attributed to demethylation, for two reasons. Firstly, addition of 5-azacytidine 
or L-ethionine also improved reactivation of latent HSV (Whitby et al., 1987; 
Stephanopoulos et al., 1988), and secondly, during induction of MELCs, a 
transient decrease in 5-methycytosine levels occurs (Razin et al., 1988). 
Therefore to determine whether demethylation is the underlying mechanism 
whereby HMBA exerts its effect on in 1814, titrations of in 1814 and 1814R 
were carried out in the presence of the hypomethylating agent 5-azacytidine 
(Table 4.2). To determine whether 5-azacytidine could directly antagonize the 
HMBA effect on in 1814 titre, cells were exposed to both 5mM HMBA and 8pM 5- 
azacytidine after the lh  adsorption and penetration period until 48h, when 
the cells were fixed and stained and the resulting titres determined. In 
addition, HFL cells were pretreated with 8|iM 5-azacytidine for 24h and the 
agent was either retained after adsorption or withdrawn immediately prior to 
infection. Addition of 8pM 5-azacytidine decreased the titre of in i  8 1 4 , 
especially when present prior to and after the addition of virus, whereas 
little  effect was noted on the titre of 1814R (Table 4.2). Therefore, 
hypomethylation of DNA by exposure of cells to HMBA is not responsible for 
the effect on the replication of the HSV-1 Vmw65 insertion mutant i n i 814.
4.2.3 HMBA exerts its effect transiently, early during  
in f e c t io n
For the experiments shown in Figure 4.1, HMBA was present from lh 
after the addition of virus until monolayers were stained, usually two days 
later. The time of exposure required for maximum effect was subsequently 
investigated. It was first ascertained that pre-exposure of cells to 5mM HMBA
for lh  to 5h immediately prior to infection gave no stimulation of plaque
numbers, provided the monolayers were washed thoroughly before the 
addition of virus (results not shown), demonstrating that HMBA does not act 
by inducing stable cellular alterations.
The time of exposure after infection was therefore varied (Figure 
4.3). Mutant in 1814 was titrated on HFL cells, and EHu5 containing 5mM HMBA 
was added after adsorption and penetration. At various times, the medium was 
removed, monolayers were washed twice with EHu5 and overlaid with EHu5. 
Cells were fixed and stained 2 days later and the resulting titres determined. It 
was found that only lh of treatment with HMBA gave a large increase in titre,
and that retaining the agent until 5h post-infection was as effective as
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Table 4.2 Efffect of 5-azacytidine on the titre of 
z'nl814 and 1814R
5 - a z a c y t id in e  (itM) T i t r e  ( p f u / m l )
Pre- Post- in 1 8 1 4  1 8 1 4 R
in f e c t io n 3 in fect ion^
o 0 3.5 X 106 2.8 X 108
8 0 2.2 X 106 2.8 X 10&
0 8 7.5 x  105 3.0 X 10$
8 8 <5 X 104 1 . 7 X 1 0 8
a 5-azacytidine present for 24h immediately prior to infection, 
b 5-azacytidine present after adsorption and penetration.
Figure 4.3 Time of exposure to HMBA required for 
maximum increase in titre
M utant in  1814 was titrated on HFL cells, and EHu5 
containing 5mM HMBA was added after adsorption and 
penetration. At various times, the medium was rem oved, 
monolayers were washed twice with EHu5 and overlaid with EHu5. 
Monolayers were fixed and stained 2 days post-infection.
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maintaining it throughout the 48h titration period. HMBA therefore exerts its 
effect early during infection, and is only required transiently.
The time of addition of HMBA after infection was the next variable 
investigated (Figure 4.4). HMBA was added to the culture medium at various
times after adsorption and penetration of /«1814. A steady decline in the 
response was observed and by 6h after infection the addition of HMBA was 
without effect. Cells infected with in 1814 thus rapidly became refractory to 
activation of the viral genome by HMBA. The loss of responsiveness of in 1814 
to HMBA is reminiscent of the progressive insensitivity to complementation 
by Vmw65 observed previously by Harris and Preston (1991). In the absence 
of sufficient IE protein production the in 1814 genome is converted to a latent 
state in which it is refractory to the action of all trans-activator proteins
except VmwllO (Harris & Preston, 1991).
4.2.4 Addition of HMBA stimulates IE RNA production
The finding that HMBA raises the titre of in 1814, which is known to 
synthesize reduced levels of IE RNAs (Ace et a l,  1989), and that it acts early in 
infection, suggests that the agent acts by increasing the amounts of IE RNAs,
and hence IE proteins. HFL cells were infected with 100 particles of in 1814 or
1814R per cell and incubated for 5h in the presence of 2 5 |ig /m l  
cycloheximide, with or without the addition of 5mM HMBA. Cytoplasmic RNA 
was isolated and analysed by dot blot hybridization, using radiolabelled IE 
gene-specific probes (Figure 4.5) representing IE-1, IE-2, IE-3 and IE-4. As
found after infection of BHK cells (Ace et al., 1989), in 1814-infected HFL cells
accumulated lower levels of IE RNAs than 1814R-infected cells (Figure 4.5). 
Incubation with 5mM HMBA resulted in an increase of approximately 
4wOfold in IE RNA accumulation, bringing the levels close to those found in 
untreated, 1814R-infected cells. The greatest increase was seen for VmwllO 
and Vmw63 RNA levels, with a smaller increase in Vmw68 and Vmwl75 RNAs. 
These increases are consistent with the observed phenotype of in 1814, which 
shows a fourfold reduction in the levels of accumulation of VmwllO and 
Vmw63, a twofold reduction in Vmw68 RNA but little effect on the level of 
V m w l75 (Ace et al., 1989). The level of cellular actin RNA was not 
significantly affected by HMBA. The effect of HMBA on the titre of i«1814 can
thus be explained by an increase in IE RNA accumulation. HMBA can
therefore exert its effect in the absence of protein synthesis, suggesting that
its target may be a pre-existing cellular or virus structural component(s).
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Figure 4.4 Time of effectiveness of HMBA
Mutant i«1814 was titrated on HFL monolayers and HMBA 
was added to a final concentration of 5mM at the times after 
adsorption and penetration indicated. Monolayers were fixed and 
stained 2 days post-infection. In the absence of exposure to HMBA, 
the titre of ml814 on HFL cells is 5 x 106.
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Figure 4.5 Effect of HMBA on IE RNA accumulation
HFL cells were infected with 100 particles of in 1814 (14) or 
1814R (R) per cell, or mock-infected (M), in the presence of 
25p.g/ml cycloheximide. After adsorption and penetration, culture 
medium containing cycloheximide and, where appropriate, 5mM 
HMBA was added. After a further 4h, RNA was extracted and 3, 1 or 
0 .3 p g  was applied to nitrocellulose membranes. Membranes were 
probed with radiolabelled DNA fragments specific for IE genes 1 
(encodes VmwllO), 2 (encodes Vmw63), 3 (encodes Vmwl75) or 4 
(encodes Vmw68), or mouse y-actin (A).
The absorbance at 260nm was measured to determ ine the 
concentration of the RNA.
This experiment has been repeated, and the results obtained here 
confirmed. This effect has also been demonstrated in BHK cells and 
the levels of the IE RNAs, in the presence and absence of HMBA, has 
been determined by densitrometric analysis and normalized to actin 
(McFarlane et al., 1992).
Hybridisation signals in figure 4.5 were quantified by densitometric 
measurement of spot intensities. The percent area under the curves after 
gaussian integration analysis are the values noted.
-HMBA 
3.0 1.0 0.3
+HMBA 
3.0 1.0 0.3fin RNA Mean Fold Increase Mean Increase
1 8 1 4 R
IE1 21.6 19.0 6.4 28.7 18.2 6.2 1.3 0.96 0.97 1.1
IE2 22.7 21.5 11.7 17.9 19.2 7.5 0.97 0.89 0.64 0.77
IE3 18.0 19.7 9.4 26.9 17.7 8.4 1.5 0.9 0.9 1.1
IE4 24.0 14.5 5.6 28.8 18.4 8.7 1.2 1.3 1.6 1.37
A ctin  28.7 17.8 5.5 26.7 14.8 6.5 0.9 0.8 1.2 0.97
-HMBA +HMBA
3.0 1.0 0.3 3.0 1.0 0.3ug RNA Mean Fold Increase Meanlncrease
in 1 8 1 4
IE1 24.4 11.3 3.3 35.5 19.9 7.6 1.45 1.76 2.3 1.8
IE2 20.9 12.2 5.0 30.3 23.6 7.8 1.45 1.9 1.56 1.6
IE3 27.6 14.0 5.2 32.5 14.1 6.5 1.18 1.0 1.25 1.14
IE4 19.9 12.0 4.2 31.2 21.0 11.7 1.57 1.75 2.8 2.04
A ctin  32.3 19.7 5.5 26.9 11.5 5.1 0.83 0.58 0.93 0.78
-HMBA +HMBA
3.0 1.0 0.3 3.0 1.0 0.3ug RNA Mean Fold Increase Meanlncrease
M o c k
A ctin  24.2 22.4 9.2 27.1 13.2 3.9 1.12 0.59 0.42 0.71
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4.2.5 HMBA does not affect transport of viral genomes to
the nucleus
To investigate whether HMBA increased transport of f/zl814 DNA to 
the nucleus, HFL monolayers were infected with 100 particles of in 1814 per 
cell in the presence of 25pg/ml cycloheximide, and cultured with or without 
5mM HMBA. Nuclear DNA was extracted after 3h, cleaved with Bam  HI, blotted 
and probed with a mixture of radiolabelled pTKl and pMC17 (Figure 4.6). The 
intensity of hybridization to the three expected bands (5.0 and 3.0kbp from 
pMC17; 3.5kbp from pTKl) was unaffected by the presence of HMBA in the 
culture medium, demonstrating that HMBA does not increase the transport of
in 1814 DNA to the nucleus.
4.3 Specificity of action of HMBA
4.3.1 Effect of HMBA on promoters in plasmid based assays
To explore the responsiveness of a range of promoters and toI
potentially identify sequences that confer inducibility, CAT reporter gene
constructs linked to various viral promoters were introduced into HFL cells 
by lipofection, in the presence and absence of HMBA. lp g  plasmid DNA was 
introduced into HFL cells, and the lipofection treatment carried out for 5h, at 
which time reactions were terminated with the addition of 2ml fresh EFio- 
Cell extracts were prepared after 24h and CAT assays were carried out using 
equivalent amounts of protein (30pg) in each reaction for lh  at 30°C (Figure 
4.7). All the plasmids tested showed increased CAT activity in the presence of 
5mM HMBA. The results demonstrate an increase in CAT activity from IE, E 
and L HSY promoters, from the HCMV enhancer, and from the SV40 promoter 
and enhancer. The results reveal an apparent lack of promoter specificity in 
the mode of action of HMBA, as all the constructs tested in this transient 
system responded to HMBA treatment. Campbell et al. (1990) previously 
demonstrated that the HSV TK and SV40 early promoters were inducibile by 
HMBA in erythroleukaemic cells. However, constructs containing the mouse 
mammary tumour virus long terminal repeat (LTR), and the Moloney murine 
sarcoma virus LTR both failed to give significant increases in expression 
upon induction (Campbell et al., 1990). Due to the inability to demonstrate any 
correlation between upstream promoter sequences and the activation of CAT 
activity by HMBA, Campbell et al. (1990) suggested that HMBA-mediated
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Figure 4.6 HMBA does not affect transport of
in 1814 DNA to the cell nucleus
HFL cells were infected with 100 particles of z«1814 per cell 
in the presence of 25pg/ml cycloheximide. After adsorption and 
penetration , medium containing cyclohexim ide and, where 
appropriate, 5mM HMBA was added. After a further 2h, nuclear 
DNA was extracted, cleaved with BamUl  and analysed by Southern 
hybridization. DNA was extracted from infected cells after 
incubation without (lane 1) or with (lane 3) HMBA or from mock- 
infected cells without HMBA (lane 2). (a) Ethidium bromide-stained 
gel; (b) autoradiograph.
This experiment has been repeated, and the results obtained here
con firm ed .
Hybridisation signals representing the 3.5 and 3.0kb bands in figure 4.6b 
were quantitated by densitometric measurement of spot intensities. The
areas under the curves after gaussian integration analysis are 6298 in th< 
presence of HMBA and 6262 in the absence of HMBA.
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Figure 4.7 Effect of HMBA on different promoters 
in transfection assays
O .lpg  of pLWP15 containing the IE-4 promoter minus the 
TAATGARAT motif (IE-4-), pLWUS containing the IE-4 promoter 
including the TAATGARAT motif (IE-4+), pIElCAT containing the 
VmwllO promoter (IE-1), pIE3CAT containing the IE-3 promoter 
(IE-3), pTKCAT containing the TK promoter (TK), pgDCAT 
containing the gD promoter (gD), pRR55 containing the HCMV IE 
promoter (HCMVIE) and pSVECAT containing the SV40 promoter 
(SV40) were introduced into HFL cells by a 5h lipofection 
treatment, in the presence (+) or absence (-) of 5mM HMBA in the 
culture medium. Cell extracts were prepared at 24h and CAT assays 
carried out at 30°C for lh, then subjected to TLC. Plasmid constructs 
are described in detail in section 2.4.
This experiment has been repeated, and the results obtained here ! 
con firm ed . !
The radioactivity in the substrate and the acetylated product spots was 
determined by scintillation counting to calculate the percent conversion to 
product.
cpm -HMBA 
substrate nroduct
re­
conversion
cpm + HMBA % fold increase 
substrate nroduct conversion CAT activity + HMBA
PROMOTER
IE4- 83857 655 0.78% 58635 2359 3.87% 4.96
IE4+ 71559 620 0.86% 82503 1038 1.24% 1.44
EE1 100607 1190 1.17% 81507 4607 5.35% 4.57
IE3 78219 1355 1.7% 82939 7809 8.61% 5.06
TK 83302 238 0.28% 68610 940 1.35% 4.82
gD 61762 285 0.46% 56148 637 1.12% 2.43
HCMVIE 39742 20606 34.15% 2352 79640 97.13% 2.84*
SV40 71782 348 0.48% 72139 1420 1.9% 3.96
* The value for HCMV IE is likely to have been underestimated, as the assay was not in
the linear part of the reaction.
Figure 4.7
HMBA
induction of CAT activity may act at step intimately involved in transcription 
initiation (Section 4.5).
4.3.2 Effect of HMBA on a range of HSV-1 mutants
The question of specificity was subsequently addressed using a range 
of different HSV-1 mutant viruses, and testing whether HMBA could 
complement their defects in plaque assays. In contrast with the previous 
plasmid based assay (Section 4.3.1), the use of mutant viruses allows direct 
investigation into the effect of HMBA on different promoters in the
environment of the viral genome.
Previous work demonstrated that plaque formation by in 1814 was 
increased by up to 10-fold when VmwllO was provided in trans by plasmid 
transfection (Ace et al., 1989), suggesting that the decreased level of VmwllO 
contributed to the phenotype of m l 814. This conclusion is supported by the 
fact that <2/1403, an HSV-1 mutant in which the VmwllO gene is deleted, shows 
a m.o.i-dependent growth defect in tissue culture cells similar to that of
m l814 (Stow & Stow, 1986, 1989; Everett, 1989). To investigate whether the 
addition of HMBA could compensate for the absence of VmwllO, its effect on 
dl 1403 was examined, by titration in the presence of 0, 1, 3 and 5mM HMBA 
(Table 4.3). Despite a sevenfold increase in titre being observed, the effects 
were not comparable to that obtained with m l814. Another mutant, m l 825, in 
which the VmwllO promoter is replaced by the Moloney Murine Leukemia 
virus enhancer and promoter, an element that is not utilized efficiently in 
HFL cells (C.M. Preston, unpublished results), was examined. This virus 
effectively behaves like d/1403 in HFL cells, and again, HMBA resulted in a 
limited (fourfold) increases in the titre of m l825 (Table 4.3). These results 
demonstrate that HMBA does not substantially compensate for the absence of 
VmwllO. The small increase in the titre of d/1403 and m l825 in the presence
of HMBA was shown, by dot blot analysis of cytoplasmic RNA extracted with 
and without HMBA treatment, to be attributable to HMBA increasing the 
expression of other IE genes and hence partially overcoming the need for 
VmwllO transactivation (C.M. Preston & J.I. Daksis, unpublished results).
Mutant m l 820 has the VmwllO promoter replaced by the Moloney 
murine leukemia virus enhancer in the m l814  genome. The presence of 
HMBA in the culture medium did not dramatically increase the titre of m l 820 
(Table 4.3). Neither m l825 nor m l820 produced any detectable VmwllO RNA 
under IE conditions and exposure to HMBA did not switch on the expression of 
this gene. Dot blot analysis of cytoplasmic RNA reveals however, that there
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Table 4.3 Effect of HMBA on the titre of d/1403 and 
i n i  8 2  5 .
Titre ( p f u / m l )
HMBA rf /1403 iwl  8 2 5
(m M )
0 5.0 X 106 3.2 X 107
1 3.4 X 107 3.6 X 107
3 3.4 X 107 8.7 X 107
5 2.6 X 107 1.3 X 108
HFL cells were infected with either dl  1403 or in 1825 and 
various concentrations of HMBA were added to the culture 
m edium  after the lh  adsorption and penetration period. 
Monolayers were fixed and stained two days post-infection and 
the resulting titres determined.
was an increase in the other IE RNA levels in the presence of 5mM HMBA 
(C.M. Preston & J.I. Daksis, unpublished results). HMBA can therefore act to 
increase the level of expression of the VmwllO gene from its endogenous 
promoter but cannot detectably switch on its expression when under the 
control of the Moloney murine leukemia virus enhancer.
elements was investigate ' in 1827, which has the VmwllO
promoter replaced by the / , , sr in the in 1814 background, and
in 1833, which has the SV40 promoter/enhancer driving p -g a la c to s id a s e  
inserted into the TK gene, also in the in 1814 background. Analysis of IE RNA 
accumulation in the presence of 5mM HMBA (Figure 4.8) demonstrated that 
the HCMV enhancer is responsive to activation by HMBA in this 
environment. In addition, despite the level of expression being extremely 
low, an increase in p-galactosidase RNA was also detected by dot blot analysis 
of cytoplasmic RNA in the presence of HMBA (Figure 4.8). Therefore, both the 
HCMV enhancer and the SV40 promoter/enhancer are responsive to HMBA 
when in the viral genome.
Mutant in 1411 contains an insertion in the gene encoding Vmwl75, 
such that no functional Vmwl75 is produced, and consequently can only be 
grown on a complementing cell line. Exposure to HMBA did not allow m 1411 
to form plaques on HFL or BHK cells (results not shown), therefore HMBA 
does not act as or induce an active cellular homologue of Vmwl75. Another 
mutant HSV-140, in which the HS.V-1 Vmwl75 gene is replaced by the VZV 
homologue 140,000 protein, buF fails to form plaques on BHK cells, ( / i c c a V ^ ^  
in 1411, can only be propagated on a complementing cell line expressing 
Vmwl75 (Disney & Everett, 1990). .
effect on the ability of HSV-140 to form plaques on HFL or BHK cells (results 
not shown), thus confirming the conclusions from the titration experiments 
with in 1411, that HMBA does not act as or induce a homologue of Vmwl75.
The responsiveness to HMBA of different promoter
Exposure to HMBA had no
9 7
Figure 4.8 Effect of HMBA on IE RNA accumulation 
during i«1827 and in 1833 infection
HFL cells were infected with 100 particles of in 1814 (14), 
1814R (R), i/il827 (27), in 1833 (33) per cell, or mock-infected (M), 
in the presence of 25pg/ml cycloheximide. After adsorption and 
penetration, culture medium containing cyclohexim ide and, 
where appropriate, 5mM HMBA was added. After a further 4h, RNA 
was extracted and 3, 1 or 0.3pg was applied to nitrocellulose 
membranes. Membranes were probed with radiolabelled DNA 
fragments specific for IE genes 1 (encodes VmwllO), 2 (encodes 
Vmw63), 3 (encodes Vmwl75) or 4 (encodes Vmw68), or mouse y- 
actin (ACTIN). The m l833 RNA was also probed with a radiolabelled 
fragment specific for p-galactosidase.
This experiment has been repeated, and the results obtained here j 
con firm ed .
I
The absorbance at 260nm was measured to determ ine the ;
concentration of the RNA. I
Hybridisation signals in figure 4.8 were quantified by densitometric 
measurement of spot intensities. The percent area under the curves after 
gaussian integration analysis are the values noted.
-HMBA 
3.0 1.0 0.3
+HMBA 
3.0 1.0 0.3^ 12 RNA Mean Fold Increase Meanlncrease
1 8 1 4 R
IE1 20.1 15.7 8.6 22.4 22.6 10.6 1.11 1.44 1.2 1.25
IE2 28.7 17.4 2.7 30.6 18.0 2.5 1.07 1.03 0.93 1.01
IE3 17.3 21.0 7.9 28.7 18.2 6.9 1.66 0.87 0.87 1.13
IE4 28.7 14.0 3.1 33.0 16.1 5.2 1.15 1.15 1.68 1.33
-HMBA +HMBA
3.0 1.0 0.3 3.0 1.0 0.3|ig RNA Mean Fold Increase Meanlncrease
in  1 8 1 4
IE1 23.7 10.4 2.0 34.3 21.3 8.4 1.45 2.05 4.2 2.57
IE2 21.3 10.3 2.9 34.5 24.2 6.8 1.62 2.35 2.34 2.1
IE3 27.2 12.0 2.2 35.2 16.4 7.0 1.29 1.37 3.18 1.95
IE4 22.3 12.5 3.8 33.2 20.1 8.2 1.49 1.61 2.16 1.75
-HMBA +HMBA
3.0 1.0 0.3 3.0 1.0 0.3pp RNA Mean Fold Increase Meanlncrease
i#i 1827*
IE1 19.7 6.9 1.5 45.3 19.8 6.8 2.3 2.87 4.5 3.2
IE2 23.7 15.9 5.0 27.3 19.1 9.1 1.15 1.2 1.82 1.39
IE3 23.6 12.0 4.0 40.4 15.3 4.6 1.71 1.28 1.15 1.38
IE4 17.3 21.2 6.9 21.8 24.8 8.1 1.26 1.43 1.17 1.29
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IE 3
IE-4
-HMBA
3.0 1.0 0.3
+HMBA
3.0 1.0 0.3u p RNA Mean Fold Increase Meanlncrease
in  18  3 3
IE1 17.5 5.1 0.8 53.9 16.1 6.6 3.08 3.16 8.25 4.83
IE2 17.8 5.4 2.3 48.3 21.5 4.7 2.71 3.98 2.04 2.91
IE3 17.0 4.4 26.0 6.1 1 1.39 1.46
IE4 21.4 8.3 1.1 42.7 20.1 6.5 1.99 2.4 5.9 3.43
Bgal 18.7 10.2 7.7 31.5 20.2 11.8 1.68 1.98 1.53 1.73
-HMBA +HMBACOOooCO 3.0 1.0 0.3pp RNA Mean Fold Increase Meanlncrease
A C T IN
1814R 26.1 15.8 6.0 31.9 13.7 6.5 1.22 0.87 1.08 1.06
m l 814 25.9 24.0 7.2 29.2 9.7 3.9 1.13 0.61 0.54 0.76
m l 827 26.9 9.5 15.3 5.9 0.57 0.62 0.6
m l833 39.8 18.2 10.9 22.0 8.0 1.0 0.55 0.44 0.1 0.36
* The value for r'/z 1827 may be biased due to the obvious underestim ation o f the titre, 
causing an unexpectedly high accumulation of IE2, 3 and 4 mRNAs compared to 
i/|1814 .
4.4 Effect of HMBA on protein/DNA complex formation
4.4.1 HMBA does not promote IEC formation
As HMBA complements the effects of the Vmw65 mutation in m l 814, 
it was considered possible that HMBA may act as or induce a cellular 
homologue of Vmw65, and a number of possible mechanisms by which this 
may occur can be envisaged. For example, HMBA may activate a specific
cellular promoter and switch on the synthesis of a cellular homologue of 
Vmw65. However, the results from the dot blot analysis (Figure 4.5)
dem onstrate that the HMBA effect can occur in the presence of 
cycloheximide. In addition, the pretreatment of HFL cells with HMBA prior to 
infection with /«1814 had no effect on the titre, suggesting that HMBA may 
transiently modify a protein already present. It is possible that HMBA 
activates a pre-existing cellular homologue of Vmw65, perhaps through a
post-translational m odification such as phosphorylation. A lternatively , 
HMBA may act as as physical 'linker' molecule facilitating an interaction 
between the mutant Vmw65 and Oct-1. Finally, HMBA itself may, because of its 
negative charge, form a complex with Oct-1 at the TAATGARAT and activate 
transcription. A number of gel retardation assays were perform ed to
investigate these possibilities.
Nuclear extracts were prepared from untreated HeLa cells and from 
HeLa cells exposed to HMBA for 3h. Gel retardation assays were carried out to 
compare complex formation between untreated and HMBA-treated nuclear
extracts with oligonucleotides containing the Ig octamer (0 1 /0 2 ), and
modified versions of the Ig octamer containing GCGGTAATGAGAT (JD1/JD2) 
and ATGCTAATGAGATAT (027/028), in the presence or absence of virion 
extract containing partially purified Vmw65 (Figure 4.9). The inclusion of 
HMBA-treated nuclear extract did not induce IEC formation in the absence of
Vmw65 (lanes 3, 4, 7, 8 , 11, 12), and did not affect the ability of the extract to
form the IEC in conjunction with wild type virion extract (lanes 1, 2, 5, 6 , 9, 
10).
No novel complexes were detected using HMBA-treated nuclear 
extracts in conjunction with 01/02 and JD1/JD2 (Figure 4.9). However, in the 
absence of virion extract, a shifted complex of slightly greater mobility than 
the IEC was detected with the 027/028 oligonucleotide using both untreated 
and HMBA-treated extracts (Figure 4.9, lanes 11, 12).
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Figure 4.9 Analysis  of  protein/DNA complex
formation at TAATGARAT and octamer-containing
DNA fragments
Comparison of complex formation using 5pg nuclear extract 
prepared from mock (M) or HMBA-treated (H) HeLa cells, in the 
presence (+) or absence (-) of wild type virion extract on
oligonucleotides 01/02 (lanes 1-4), JD1/JD2 (lanes 5-8) and 027/028 
(lanes 9-12). The sequences of the oligonucleotides used in this
assay are listed in section 2.5.
The immediate early complex, containing Vmw65 and Oct-1, is denoted 
by IEC.
O represents the complex between DNA and Oct-1. The unbound
labelled oligonucleotide is denoted by P. The origin of the additional 
complexes is unknown, but may be due to proteolysis.
Before virion extracts were analyzed in gel retardation assays, 
protein level comparisons were made by SDS-PAGE and coomassie
brilliant blue staining.
Figure 4.9
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i f  The composition of the complex denoted X (Figure 4 ($  is unknown. 
However, it was noted that an increase in complex X occurred with 
the addition of nonradioactive 027/028 oligonucleotide, containing a 
strong Oct-1 binding site (Figure 4W, lanes 2-5), when compared to 
lane 1 .
£
Gel retardation assays were carried out to determine whether the IEC 
could be detected in conjunction with m l814 virion extract on 
oligonucleotides JD1/JD2 and 027/028 using untreated and HMBA- 
treated HeLa cell nuclear extracts.
To determine whether the shifted band obtained with the 0)27/028 
oligonucleotide is Oct-1 specific, competition assays were performed using 
unlabelled oligonucleotides containing a strong Oct-1  binding site ((0 1 /0 2 ), 
CCAAT box (CC1/CC2) and Ad MLP (L1/L2). Binding assays were performed 
using 5p.g untreated HeLa nuclear extract in conjunction with 0, 6 , 20„ (60 and 
1 0 0-fold excess of unlabelled 0 1 /0 2  oligonucleotide, 6 , 2 0  and 1 0 0 -fold excess 
of unlabelled L1/L2 and 6 , 20 and 100-fold excess of unlabelled CC1//OC2 for 
15min at 25° C. Radiolabelled 027/028 probe was subsequently added amd the 
reactions incubated for a further 30min (Figure 4.10). The addlitiion of 
increasing concentrations of unlabelled 0 1 /0 2 , containing a sequence which 
constitutes a strong Oct-1 binding site, namely the Ig octamer, competed for 
the formation of the upper complex (Figure 4.10, lanes 1-6). In contrast, 
addition of 6 , 20 and 100-fold excess of oligonucleotides representing the Ad 
MLP (Figure 4.10, lanes 7, 8 , 9) and the CCAAT box (Figure 4.10, lanes 10, 11, 
12) did not interfere with the formation of the upper complex. The shifted 
complex detected with the 027/028 oligonucleotide is therefore Oct-1 specific, 
as it was specifically competed using an unlabelled Oct-1 binding site . The 
027/028 oligonucleotide also contains a second conserved elem ent, the 
heptamer sequence (CTCATGA) which is recognized by both Oct-1 and Oct-2 
(V errijzer et al.y 199-2). Therefore, the 027/028 oligonucleotide has the 
potential to bind two Oct-1 molecules, one at a strong binding site and another 
at this weaker heptamer site. This hypothesis has recently been confirmed 
using DNasel footprinting analysis (C.M. Preston, unpublished results).
As pretreatment of HFL cells does not have any effect on the
subsequent titre of z«1814, it is possible that HMBA-induced changes could
not be detected in gel retardation assays using HMBA-treated extracts.
Therefore, i/il814- and 1814R-infected HeLa cell nuclear extracts were
prepared in the presence and absence of HMBA. HeLa cells were infected at
100 particles per cell of z«1814 or 1814R, in the presence of 5 0 jx g /m l
cycloheximide, with or without 5mM HMBA, and nuclear extracts were
prepared after 4h. Figure 4.11 demonstrates that IEC formation was only
observed using 1814R-infected extracts (lanes 4 and 5), not with i « 1 8 1 4  -
infected extracts, even with HMBA treatment (lanes 2 and 3). These results
are in agreement with those of Ace et al. (1989) who demonstrated that the
use of Zttl814 virion extract and z«1814-infected cell nuclear extracts did not
A
overcome the inability to form the IEC. Figure 4.12 illustrates that HMBA- 
treated HeLa cell nuclear extract does not complement the Vmw65 mutation in 
m l814 as it does not promote IEC formation (Figure 4.12, lanes 2 and 4).
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Figure 4.10 C om petition  analysis of com plex
form ation with 027/028 oligonucleotide
Gel retardation assays performed using 5|ig untreated HeLa 
nuclear ex tract, in conjunction with radiolabelld 027/028 
oligonucleotide and 0 (lane 1), 6 (lane 2), 20 (lane 3), 60 (lane 4) 
and 100-fold (lane 5) excess of non-radioactive 027/028, 
containing a strong Oct-1 binding site, 6 (lane 6 ), 20 (lane 7) and 
60-fold (lane 8 ) excess L1/L2 containing the Ad MLP and 6 (lane 9),
20 (lane 10) and 60-fold (lane 11) excess CC1/CC2, containing the 
CCAAT box. The additional shifted complex is denoted by the arrow.
The sequences of the oligonucleotides used in this assay are listed 
in section 2.5.
The immediate early complex, containing Vmw65 and Oct-1, is denoted by 
IEC.
O r e p r e s e n ' s  the complex between DNA and Oct-1. The unbound labelled 
oligonucleotide is denoted by P. The origin of the additional complexes is 
unknown, but may be due to proteolysis. The composition of complex X is 
unknown.
Before virio-i extracts were analyzed in gel retardation assays, protein level 
compariso: e made by SDS-PAGE and coomassie brilliant blue staining.
Figure 4.10
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Figure 4.11 Analysis of complex formation with
untreated and HMBA-treated infected cell extracts
Comparison of complex formation using 5pg mock-treated 
(M, lanes 1, 3, 4) or HMBA-treated (H, lanes 3 and 5) in 1814- (14, 
lanes 2 and 3) or 1814R-infected (R, lanes 4 and 5) HeLa cell 
nuclear extracts with the JD1/JD2 oligonucleotide containing the 
TAATGARAT element. The sequences of the oligonucleotides used in 
this assay are listed in section 2.5.
The immediate early complex, containing Vmw65 and Oct-1, is denoted 
by IEC.
0  represents the complex between DNA and Oct-1. The unbound 
labelled oligonucleotide is denoted by P. The origin of the additional 
complexes is unknown, but may be due to proteolysis.
Before virion extracts were analyzed in gel retardation assays, 
protein level comparisons were made by SDS-PAGE and coomassie 
brilliant blue staining.
Figure  4.11
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Figure 4.12 Analysis of  complex formation with
u n t r e a t e d  and H M B A -tr e a te d  e x t r a c t s  in
conjunction with in 1814 virion extract
Comparison of complex formation using 5pg mock (M) or 
HMBA-treated (H) HeLa cell nuclear extract, in the presence of 
in 1814 virion extract, on oligonucleotides JD1/JD2 (lanes 1 and 2) 
and 027/028 (lanes 3 and 4). The sequences of the oligonucleotides 
used in this assay are listed in section 2.5.
O represents the complex between DNA and Oct-1. The unbound 
labelled oligonucleotide is denoted by P. The origin of the additional 
complexes is unknown, but may be due to proteolysis.
Before virion extracts were analyzed in gel retardation assays, 
protein level comparisons were made by SDS-PAGE and coomassie 
brilliant blue staining.
Figure  4.12
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To determine whether the HMBA molecule itself forms a physical link 
between the mutant Vmw65 and Oct-1, gel retardation assays were performed 
with or without the inclusion of 5mM HMBA in the binding reactions, using 
mock, in 1814- and 1814R-infected HeLa cell nuclear extracts. The nuclear 
extracts tested were either untreated or exposed to HMBA prior to the 
preparation of the extract (Figure 4.13). The inclusion of 5mM HMBA in the 
binding assays did not promote IEC formation at the TAATGARAT element in 
the presence of the mutant Vmw65 (Figure 4.13, lanes 9 and 10), thus it can be 
concluded that HMBA does not appear to act as a linker molecule aiding the 
binding of the mutant Vmw65 to Oct-1 to form the IEC.
The results from the gel retardation assays demonstrate that HMBA 
neither acts as, activates nor induces a cellular homologue of Vmw65. HMBA 
must therefore function through an alternative mechanism, that does not 
require IEC formation, where it can facilitate complementation of the
phenotype of i n i 814.
4.4.2 Effect of HMBA treatment on complex formation at 
other promoter elements
As HMBA-treated HeLa cell nuclear extracts did not promote IEC 
formation in the absence of Vmw65, gel retardation assays were performed to 
determine whether the use of HMBA-treated HeLa cell nuclear extract 
promoted the binding of transcription factors at the Ad MLP or CCAAT box.
Binding assays were performed using 5pg HeLa cell nuclear extract, 
in 1814- and 1814R-infected nuclear extracts, produced in the presence or
absence of HMBA exposure. Figure 4.14 (lanes 1-5) reveals that HMBA- 
treatment of in 1814- or 1814R-infected nuclear extracts did not increase
complex formation at the CCAAT box, but appeared to interfere with compiex 
formation. In addition figure 4.14 (lanes 13 and 14) demonstrates that HMBA- 
treated HeLa cell nuclear extract showed decreased complex formation at the
CCAAT box compared to the untreated HeLa cell extract.
Similarly, analysis o f complex formation at the Ad MLP using 5pg 
in 1814- or 1814R-infected extracts, generated in the presence or absence of 
HMBA-treatment, revealed that HMBA-treatment does not promote complex 
formation at the Ad MLP (Figure 4.14, lanes 6-10). In fact, complex formation 
at the Ad MLP using HMBA-treated HeLa cell nuclear extract appeared to be 
slightly reduced in comparison with the untreated HeLa cell nuclear extract 
(Figure 4.14, lanes 11 and 12).
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Figure 4.13 Analysis of complex formation in the
presence and absence of 5mM HMBA
Gel retardation assays were performed to compare complex 
formation at the TAATGARAT motif using mock- (M, lanes 1, 2, 7 
and 8), in 1814- (14, lanes 3, 4, 9, 10) and 1814R-infected (R, lanes 5,
6 , 11, 12) HeLa cell nuclear extracts, prepared with (H, lanes 2, 4, 6 ,
8 , 10, 12) or without (lanes 1, 3, 5, 7, 9, 11) HMBA treatment. 
Binding assays were carried out in the presence (lanes 1-6) or 
absence (lanes 7-12) of 5mM HMBA in the reaction mix. The 
sequences of the oligonucleotides used in this assay are listed in 
section 2.5.
I
The immediate early complex, containing Vmw65 and Oct-1, is denoted j 
by IEC. |
O represents the complex between DNA and Oct-1. The unbound 
labelled oligonucleotide is denoted by P. The origin of the additional 
complexes is unknown, but may be due to proteolysis.
Before virion extracts were analyzed in gel retardation assays, 
protein level comparisons were made by SDS-PAGE and coomassie 
brilliant blue staining. !
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Figure 4.14 Analysis of complex formation at the
CCAAT box and Ad MLP
Gel retardation assays were performed to analyse complex 
formation at the CCAAT box (lanes 1-5) and AD MLP (lanes 6-10) 
using 5pg mock (M), /«1814- (14, lanes 2, 3, 7, 8) and 1814R- 
infected (R, lanes 4, 5, 9, 10) HeLa cell nuclear extracts, prepared 
with (H, lanes 3, 5, 8 , 10) or without (M, lanes 1, 2, 4, 6 , 7, 9) HMBA 
treatment. The complexes formed using mock-infected (M, lanes 11 
and 13) and HMBA-treated mock (H, lanes 12 and lif) extracts were 
also compared (lanes 11-14). The sequences of the oligonucleotides 
used in this assay are listed in section 2.5.
C represents the major complex formed on the CCAAT box 
oligonucleotide. M represents the major complex formed on the Ad 
MLP oligonucleotide. P represents the unbound oligonucleotide. The 
precise composition of the other complexes is unknown.
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Therefore, HMBA-treatment of m l 814-, 1814R- and mock-infected
HeLa cell nuclear extracts, does not promote complex formation at either the 
CCAAT box or Ad MLP compared to the level of complex formation seen using 
untreated extracts. In fact, HMBA-treatment of HeLa cells prior . to the
preparation of nuclear extracts appears to be associated with the depletion of 
factors required for complex formation at these motifs.
As HMBA-treatment does not increase complex formation at the
TAATGARAT motif, the CCAAT box or Ad MLP, it was feasible to consider 
whether there are any affects on the formation of the protein-DNA 
complexes at the TATA box. An oligonucleotide representing the HSV-1 strain 
17 VmwllO TATA box was constructed and gel retardation assays were 
performed in conjunction with 5pg mock-, m l 814- and 1814R-infected HeLa 
cell nuclear extracts, in the presence or absence of HMBA treatment (Figure 
4.15). A number of different, as yet, unidentified complexes were detected 
using an oligonucleotide containing the VmwllO TATA box. Although the
results from the gel retardation assays suggest that HMBA-treatment does not 
increase complex formation at the TATA box, variations in the intensity of 
certain complexes was observed. The intensities of complexes a , b and c were 
greater using uninfected HeLa cell nuclear extract than with either m l 814- 
or 1814R-infected HeLa cell nuclear extracts. This variation in complex 
formation between mock and infected HeLa cell nuclear extracts may reflect 
the sequestering of factors required for transcription initiation by the 
infecting viruses. In contrast, the intensity of complex e is greater using 
both m l 814- and 1814R-infected HeLa nuclear extracts than with uninfected 
HeLa cell extract, while the formation of complex /  appears to be unaltered by 
viral infection. A novel complex d, not detected using mock-infected HeLa 
cell nuclear extracts, is obtained using both m l814- and 1814R-infected HeLa 
cell extracts. HMBA treatment of m l814- and 1814R-infected HeLa cell 
nuclear extracts appears to slightly reduce the formation of complexes b, c, d, 
e and / .  However, the significance of these observations, with respect to the 
effect of HMBA on the replication of ml814, have not yet been determined.
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Figure 4.15 Analysis of complex formation at
VmwllO TATA box
Gel retardation assays were performed to analyse complex 
formation with an oligonucleotide containing the VmwllO TATA 
box (Section 2.5) and 5pg mock- (M, lanes 1 and 2), m l814- (14, 
lanes 3 and 4) and 1814R-infected (R, lanes 5 and 6 ) HeLa cell 
nuclear extracts, prepared in the presence (H, lanes 2, 4, 6 ) or 
absence (M, lanes 1, 3, 5) of HMBA treatment. Complexes are 
denoted a to /.
P represents the unbound oligonucleotide.
F igure  4 .15
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4.5 Effect of HMBA during in vitro  transcription
An in vitro transcription initiation system was employed using 
Manley whole cell HeLa extracts (Manley et al., 1980), as a tool to investigate 
the exact mechanism whereby HMBA acts at the molecular level and reveal 
the signals involved in this process. The observation of Campbell et al. (1991), 
that sequences upstream of the TATA box may not be required for HMBA-
mediated induction of CAT activity in transient transfection assays and the 
inability to demonstrate any sequence specificity (Section 4.3.1), raises the
possibility that HMBA may act, in transient assays, at the level of 
transcription initiation. A feasible mechanism would involve the post-
translational modification of a factor intimately involved in transcription 
initiation. The objective was therefore to prepare both untreated and HMBA-
treated Manley whole cell HeLa extracts, and to determine the activity of each 
extract in an in vitro transcription reaction. If the HMBA-treated extracts 
showed a significant increase in the level of transcriptional activity when 
compared to the untreated extract, then the HMBA-treated extract would be 
fractionated. Subsequently, addition of the different fractions to the 
untreated extracts and determination of the resulting transcriptional activity 
would facilitate the isolation of the fraction, to reveal the component 
responsible for increased transcription. Diagrammatic representations of the 
plasmids used as templates for in vitro transcription reactions are depicted in 
appendix 1 .
4.5.1 E ffect of HM BA-treatment of cell extract on 
transcription by RNA polymerase II in vitro
In the first instance extract and DNA template concentrations were 
titrated to establish the optimum conditions for transcription reactions. 
Figure 4.16 illustrates the effect of different DNA template concentrations on 
the level of transcription. The plasm idcogstru^t, pML(C2 A T ) i9 , containing 
the Ad MLP (Sawadogo et al., 1985) /(was cleaved with Sm a I, and several 
concentrations of the resulting linear template were incubated with 150|xg of 
untreated whole cell extract at 30°C for 2h. As Manley whole cell extracts 
contain relatively high concentrations of nucleic acids, mostly 18s and 28s 
RNA (Manley et al., 1980), only 25% of the RNA produced was analysed to 
prevent overloading of the gel. The data presented in figure 4.16 (lane 3) 
demonstrates there is a critical DNA template concentration of O.l^ig for the
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F ig u r e  4 .16  T i tr a t io n  o f  t em p la te  DNA
c o n c e n t r a t i o n
Titration of pML(C2 A T ) i9 containing the Ad MLP template 
DNA (Section 2.4), cleaved with Smal ,  to determine the optimum 
concentration for in vitro transcription. Reactions were carried 
out with 150pg untreated Manley whole cell HeLa extract and 
0 .05pg  (lane 1), 0.07|ig (lane 2), O.lpg (lane 3) and 0.3|ig (lanes 4 
and 5) plasmid DNA. Lane 5 contains 1.0[ig/ml a-amanatin. In vitro 
transcription reactions were carried out a 30° for 2h. Only 1/4 of 
each reaction  mix was analysed on a denaturing 6% 
polyacrylamide/6M urea gel. The arrow denotes the 390 nucleotide 
transcript produced.
-text. Sedve/i 4 5 .1
Figure 4.16
The bands denoted by B (Figure 4.16, lanes 4 and 5) only occur when 
the 390 nucleotide RNA transcript is detected. The origin and 
significance of this observation is unknown.
plasm id pM L(C 2 A T ) i 9 which had been linearized by Sm a I using this 
particular extract, below which transcription is not detected. The inclusion of 
1.0p.g/m l a -am anatin  in the reaction inhibits RNA polym erase II 
transcription, confirming that the band obtained is indeed a product of RNA 
polymerase II transcription (Figure 4.16, lane 5). The RNA transcript 
produced, denoted by the arrow (Figure 4.16) was, as expected, 390 nucleotides 
long (Appendix 1). The/| bands at the bottom of the gel (marked by *) 6  /\crt 
kxvouM.
Each template used was titrated to determine the optimum 
concentration required for maximal activity in conjunction with a particular 
ex tract. ^
RNA dot blot analyses (Figure 4.5) revealed that exposure to HMBA 
during /n l814 infection resulted in the greatest increase in VmwllO RNA 
accumulation. Therefore in vitro transcription experiments were carried out 
to compare the activity of the VmwllO promoter using untreated and HMBA 
treated Manley whole cell HeLa extracts. The plasmid pA7436, containing the 
regulatory^seguen^es of the VmwllO gene in a pUC18 vector, was cleaved 
with N d e I/\and incubations were carried out for 2h at 31°C using 0.1p.g of this 
linear template with either untreated extract or extract which had been 
exposed to HMBA for 3h, in the presence or absence of 1.0p.g/ml a -am an a tin . 
To ensure that the additional smaller RNA products obtained (Figure 4.17, 
lanes 2-5) were not due to initiations occurring within the vector sequences, 
pUC18 was cleaved with Nde  I, and O.lpg of linearized template DNA was 
incubated with untreated extract as previously described. None of the RNA 
transcrip ts previously obtained after transcrip tion of the tem plate 
containing the VmwllO promoter, were detected using the vector pUC18 as a 
template (Figure 4.17, lane 1). Therefore, the additional RNA products 
generated during transcription of the pA7436 template linearized by Nde  I are 
not a consequence of transcription initiation occurring at pseudo TATA boxes 
within the vector sequences. Sawadogo and Roeder (1985) and Carcamo et al. 
(1989) proposed that a similar regular pattern of decreasing length 
transcripts, detected after in vitro transcription o f a guanosine-free
template, was due to reinitiation of transcription on the same template. When 
the transcription complex reaches the end of the linear template it does not
fall off, preventing the next complex from generating a full length
transcript. Thus a family of regularly decreasing-length transcripts is
produced. It is therefore likely that the additional transcripts obtained from 
the VmwllO promoter are a consequence of reinitiation of transcription on 
the same template.
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Figure 4.17 Analysis of  transcriptional activity of
the VmwllO promoter using untreated and HMBA-
treated extracts
In vitro transcription reactions were carried out using 
0 .3 |ig  pA736 template DNA containing the VmwllO promoter 
(Section 2.4) cleaved with Ndel ,  with untreated (M, lanes 1, 2, 4) or 
HMBA-treated (H, lanes 3 and 5) Manley whole cell HeLa extracts 
in the presence (a ,  lanes 4 and 5) or absence (lanes 1, 2, 3) of 
1.0p.g/ml a-amanatin. O.lpg N del  pUC18 (18, lane 1) was incubated 
with untreared Manley whole cell HeLa extract. Reactions were 
incubated at 30° for 2h. The arrow denotes the 230 nucleotide 
transcript produced.
Figure  4.17
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The difference in transcriptional activity between untreated and 
HMBA-treated Manley whole cell HeLa extracts was subsequently analysed 
from the HSV-1 Vmw68 promoter, in the presence (Figure 4.18, lanes 5 and 6)
and absence (Figure 4.18, lanes 7 and 8) of upstream sequences containing
the TAATGARAT motif, from the Ad MLP (Figure 4^18, lanes 1 and 2) and from 
the HCMV IE promoter (Figure 4.18, lanes 3 and 4). A Comparison of the amount 
of RNA products obtained from each of these promoters using untreated and 
HMBA-treated extracts, showed that HMBA-treatment of HeLa cells did not 
significantly increase the resulting transcriptional activity compared with 
the untreated extracts. There was neither a significant nor consistent 
difference in transcriptional activity between the untreated and HMBA- 
treated extracts to warrant fractionation of the HMBA-treated extract.
4.5.2 Does HMBA act directly on transcriptional activity?
As Vmw65 functions through its negatively charged activation
domain (Triezenberg et al., 1988, Cress & Triezenberg, 1991), it is feasible that 
the polar planar HMBA molecule is also active as a result of its overall 
negative charge. To investigate this possibility 0, 1, 3 and 5mM HMBA was 
added directly  to a transcription reaction containing O. lpg  S m a  I
pM L (C 2 A T ) i 9 , containing the Ad MLP, and 150|ig of untreated extract (Figure 
4.19). Analysis of the RNA produced revealed that the addition of HMBA had 
an inhibitory effect on transcription. Therefore, it is unlikely that HMBA 
functions simply as a consequence of its overall negative charge. Similar 
results were obtained using the HSV-1 VmwllO promoter (results not shown).
4.5.3 Effect of HMBA-treatment of cell extract on RNA
polym erase III transcription
In vitro transcription experiments were subsequently undertaken to
determine whether HMBA-treatment of HeLa whole cell extracts has any 
effect on the level of transcription directed from an RNA polymerase III
promoter. A circular template, containing the Ad VA prom oter was
transcribed using untreated and HMBA-treated extracts (Figure 4.20a). The 
inclusion of 1.0p.g/ml a-am anatin in the reaction mix did not inhibit
transcription (Figure 4.20a, lane 1), confirming that the RNA products
obtained were produced by RNA polymerase III. The use of HMBA-treated
extracts did not increase the level of VA RNA accumulation compared with
untreated extract. The addition of increasing concentrations of HMBA to the
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Figure 4.18 Analysis of transcriptional activity of
from  RNA polym erase  II prom oters  using
untreated and HMBA-treated extracts
In vitro transcription reactions were carried out using 
150|ig untreated (M, lanes 1, 3, 5, 7) or HMBA-treated (H, lanes 2, 4,
6, 8) Manley whole cell HeLa extracts with 0.3p.g of pML(C2 A T ) i 9 
containing the Ad MLP, cleaved with Sm a I (lanes 1 and 2), pHCMV 
containing the HCMV IE promoter, cleaved with Kasl  (lanes 3 and 
4), pLWFU17 containing the IE-4 promoter plus additional 
upstream sequences, cleaved with £c<?RI (lanes 5 and 6) or pLWP 
containing the IE-4 promoter, cleaved with EcoRI (lanes 7 and 8). 
Samples were incubated for 2h at 30°C. Plasmid constructs are 
described in detail in section 2.4.
Figure 4.18
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Figure 4.19 Effect of HMBA on transcriptional  
a c t i v i t y
0 (lane 1), 1 (lane 2), 3 (lane 3) and 5 (lane 4) mM HMBA was 
added d irectly  to trancription reactions containing 150p,g 
untreated Manley whole cell HeLa extract and 0.3|ig pML(C2 A T ) i9 
(Section 2.4) containing the Ad MLP, cleaved with S m a I. The 390 
nucleotide produced is denoted by the arrow.
Fi gure  4.19
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Figure 4.20 Analysis of RNA polymerase III
t r a n s c r i p t i o n
(a) Comparison of transcription activity of untreated (M, 
lanes 1 and Z)  and HMBA-treated (H, lane 3) Manley whole cell 
extract on the Ad VA RNA polymerase III transcribed promoter 
(Section 2.4). Lane | also contains l.Opg/ml a-am anatin.
(b) Comparison of transcriptional activity of untreated 
Manley whole cell extract on the Ad VA promoter, in conjunction 
with 0 (lane 1), 1 (lane 2), 3 (lane 3) and 5mM (lane 4) HMBA.
Fi gure  4.20
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transcription reaction also had an inhibitory effect on RNA polymerase III 
transcription from the Ad VA promoter (Figure 4.20b).
4.5.4 Effect of in vitro synthesized and purified Vmw65 
and Oct-1 on transcription in vitro
Purified Vmw65 and the Oct-POU domain of Oct-1 (both kindly
provided by Dr, B. Luisi), previously shown to form the IEC and bind to the 
octamer, respectively, when added to HeLa cell nuclear extract in gel 
retardation assays, were added to in v i t ro  transcription reaction mixes 
containing templates with either the VmwllO or Vmw63 promoters, to 
determ ine whether they were functionally active (Figure 4.21). No 
significant increases in the amount of RNA produced from either the 
VmwllO or Vmw68 promoters were detected in the presence of either Oct-1 or 
Vmw65 singly or together. It is possible that the excess of Oct-1 and/or 
Vmw65 results in the "squelching" of additional cellular factors required for 
the formation of IEC.
4.6 Effect of HMBA on viral promoters in the cellular
g e n o m e
4.6.1 Construction of TK+-transformed cell lines
A series of TK+ -transformed cell lines were constructed with the 
HSV-1 TK gene under the control of different classes of viral promoters. The 
question of specificity of the action of HMBA was addressed using these 
variants. The parental cell line, the human line 143TK", was produced by
transformation with murine sarcoma virus and made TK- by selection with 
60|ig/m l bromodeoxyuridine (Bachetti & Graham, 1977). The mutant m l 814 
was titrated on 143TK' cells in the presence of HMBA and shown to respond to 
HMBA in the same manner as HFL cells. The titre of m l 814 on 143TK" cells
rose from 3.5 x 10^ pfu/ml in the absence of HMBA to 1.6 x 10^ pfu/ml in the
presence of 5mM HMBA.
The following plasmid constructs were cleaved with B a m  HI and
separately transformed into the parental 143TK' cell line :- (i) pTKl, which
contains the coding and regulatory sequences of the HSV-1 TK gene; (ii) 
pTKN, which consists of the HSV-1 IE-3 promoter linked to the TK coding 
sequences; (iii) pTKTaqA, which contains the IE-4 promoter linked to the TK 
gene. The structures of these plasmid constructs used to generate the
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Figure 4.21 Effect of in vitro synthesized Vmw65 
and Oct-POU domain of Oct-1 on transcription i n 
v i tro
In vitro transcription reactions were performed using 8 
units of a commercial HeLa cell nuclear extract with either O.lmg 
pA736 containing the VmwllO promoter, cleaved with Ndel  (IE-1; 
lanes 1-4) or O.lmg pLWFU17 containing the IE-4 promoter (IE-4; 
lanes 5-8) in the presence of 15pg Vmw65 (V, lanes 2 and 6) or 
15pg Oct-POU domain of Oct-1 (O, lanes 3 and 7) or both (lanes 4 and 
8).
F igure
transformed cell lines are shown in appendix 2. This was achieved by 
cleaving pTK l, pTKN and pTKTaqA with BarnHl, then introducing 1.25pg of 
the resulting linear plasmid DNA in conjunction with 8.75p.g TK' BHK cell
carrier DNA, into 143TK' cells by calcium phosphate-mediated transfection, 
in the absence of a DMSO boost (Corsalo & Pearson, 1981). The calcium 
phosphate/DNA precipitate was added to the overlying medium, and the 
monolayers were incubated for 24h at 37°C. The non-selective medium was 
subsequently replaced with HAT selective medium, and changed every 24h 
during the first 4 days, then every second day. Under HAT selective 
conditions, only the TK+ transformed cells survived, generating the mixed 
cell culture lines 143TK1-1 to 143TK1-4, 143TKN-1 to 143TKN-4 and 143TKTaqA- 
1 to 143TaqA-4.
4.6.2 Effect of HMBA on TK activity
Using the transformed cell lines 143TK1, 143TKN and 143TKTaqA, it
was possible to determine whether the TK, IE-3 or IE-4 promoters, 
respectively, are responsive to HMBA when resident in the cellular genome. 
Cell extracts were made from mock-infected untreated cells, and from cells 
exposed to HMBA for 4h and 8h. Monolayers were infected with 107 partic les 
of UV-irradiated tsK at 38.5°C and cell extracts were prepared at 4h post­
infection. At the NPT, infection with UV-irradiated tsK provides Vmw65, 
which will induce expression from the TAATGARAT motif. Extracts were also 
made from 143TK1 cell lines infected at 37°C with 20 pfu/cell TK' HSV-1, at 6h 
post-infection. Infection with a TK' virus provides the IE proteins required 
to transactivate expression from an early promoter. Cell extracts were also 
prepared from the parental 143TK' cell line under the conditions specified 
for the transformed cells. The protein concentration of each cell extract was 
determined before carrying out TK assays (Table 4.4).
The results from the TK assays confirm that both the IE-3 promoter,
(in the 143TKN cell lines), and the IE-4 promoter, (in the 143TaqA cell lines), 
were responsive to transactivation by Vmw65. This responsiveness to Vmw65 
was demonstrated by an increase in TK activity after infection with UV- 
irradiated tsK at the NPT. As expected, expression from the early TK promoter, 
(in the 143TK1 cell lines), was not induced by infection with UV-irradiated 
tsK at the NPT. Infection of the 143TK1 cell lines with a TK' virus did however 
demonstrate that the early TK promoter is responsive to transactivation by IE 
proteins (Table 4.4). Extracts were also prepared from the parental 143TK' 
cell line (Table 4.4). As predicted, 143TK' extracts did not display any
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Table 4.4 Effect of HMBA on TK activity
TK a c tiv ity (c .p .m ./|ig  ex tract)
Cell line M 4h 8h U Yt s K TK-
143TK N 1 1 7 835 2 6 5 9 9 3 0 8 3 0 8 6 6 9 7
2 2 0 2 3 0 2 6 5 1 6 3 7 3 3 6 6 0 6 8 4
3 9811 19628 9877 7 8 8 8 4
4 1 6 3 6 6 1 9 3 6 2 2 3 3 2 5 6 6 6 6 7
143TK 1 1 3 1 1 7 2 2 1 3 8 5 3 1 5 2 7 13486 37575
2 1 5 8 0 2 1 5 859 1 4 8 7 4 12113 39492
3 18485 1 6 254 1 7 1 5 0 14784 33560
4 117 1 8 13418 1 6 0 6 5 9456 31713
1 4 3 T K - 1 5 0 7  1 2 6 7 1 4 1 3 4 6 6 5 0 2 0 0
T a q  A 2 6637 1 0 154 6607 2 7 0 1 9
3 15877 2 6 4 5 8 1 4 3 9 5 3 4 4 2 2
4 12413 1 7 2 6 0 1 2 8 7 0 2 3 7 9 7
1 4 3 T K - 441 4 6 8 4 7 9 4 7 3
H e L a 7 8 2 4 7 6 4 5 7 2 8 4 ND
Extracts were prepared from untreated (M) 143TKN, 143TK1, 
143TKTaqA, 143TK- and HeLa cells, after exposure to 5mM HMBA 
for 4h (4h) and 8h (8h) and 8h after infection with 107 particles 
ultraviolet light-inactivated t sK  at 38.5°C (UVrsK). 143TK1 cells 
were infected 20pfu/cell TK- HSV-1 at 37oC and extracts prepared 
at 6h post-infection. TK activity was determined by assay o f the 
cytoplasmic fraction from each sample at 30°C for lh.
The TK+ transformed cell lines are derived from mixed cell
cultures.
Table 4.5 Effect of HMBA on TK activity
TK activity(c.p.m./| ig extract)
Cell line MOCK 24h HMBA T P
p T K l - 2 a 33581 61390 3.05 (4) <0.05
20096 41216
21837 36257
34227 36012
14949 21643
p T K l - 3 a 32355 48376 0.015 (4) N.S.
64006 44657
44487 35242
37732 56313
38032 32565
p T K N -2 a 24323 38031 0.62 (4) N.S
34836 79466
38510 74163
45511 44418
83678 39294
p T K N -2 b 5118 11262 2.433 (4) S
3032 11777
3807 5164
5994 16616
5930 5223
p T K N -4 a 6923 39052 2.98 (3) 0.1-
11262 34005 0.05
18608 39579
26296 26668
p T K T a q A -3 a 32355 48376 2.65 (4) N.S.
64006 44657
44487 35242
37732 56313
38032 32565
p T K T a q A -4 a 1 2 1 8 5  2 3 0 8 6  0.69 (4) N.S.
13251 9 6 0 0
1 1 6 3 0 2 1 3 2 5
131 0 3 2 6 2 1 6
7 7 7 7 6 1 2 7 9 4
Extracts were prepared from untreated (MOCK) cells and cells 
exposed to 5mM HMBA for 24h (24h HMBA). TK activity was 
determined by assay of the cytoplasmic fraction from each 
sample at 30°C for either lh  (a) or 15 min (b). A T-test (T) was 
em ployed to determ ine whether there is a sign ificant 
difference between the untreated cells and those exposed to 
HMBA. The number of degrees of freedom are indicated in 
brackets. With four degrees of freedom, any value greater than 
2.78 was regarded as significant. The probability (P) of these 
TK activity values not being significantly different is noted 
(N.S.= not significant; S= significant).
The TK+ transformed cell lines are derived from mixed cell 
I cultures.
significant TK activity either alone, after exposure to HMBA or when infected 
with UV-irradiated tsK (Table 4.4).
Analysis of the results (Table 4.4) suggests that the 143TKN and 
143TaqA cell lines showed a slight increase in TK activity after exposure to 
HMBA, while the 143TK1 cell lines did not appear to respond at all. However, 
the TK activities obtained after HMBA treatment did not approach the
significantly higher levels obtained after induction by UV-irradiated rsK. TK 
assays were also performed using HeLa cell extracts treated with HMBA for 0, 
4 and 8h, in the absence of 50pM dTTP in the reaction mix, to determine 
whether the resident TK promoter in the cellular genome is responsive to
activation by HMBA (Table 4.4). Unlike HSV encoded TK, cellular TK is 
inhibited by 50p.M dTTP (Jamieson & Subak-Sharpe, 1974). The TK activities 
obtained demonstrate that the HeLa cell TK promoter is not activated by 
HMBA.
Given that an 8h exposure to HMBA may not be sufficient to increase 
TK activity significantly, the time of exposure to HMBA was increased to 24h. 
In addition, to ensure that any variations in TK activity are real and not a 
consequence of random variations between samples, five mock and five 
HMBA-treated extracts were prepared from each cell line (Table 4.5). Within 
each set of results, obtained under identical conditions, the TK activity varied
approximately twofold. Despite this variation, it is clear that exposure to 
HMBA for 24h did not dramatically increase the level of expression from the 
IE-3, IE-4 and TK promoters in the cellular genome. This conclusion is despite 
observations that these promoters are responsive to HMBA in plasmid-based 
CAT assays (Figure 4.7) and that the IE-3 and IE-4 RNA levels during m l 814 
infection are increased in the presence of HMBA (Figure 4.5). The variations 
in TK activities between different isolates may represent differences in the
number of copies of the TK gene integrated into the cellular genome and/or 
the effect of the position of the integrated gene on its level of expression. 
Despite the small sample size and variation in TK activity, it is possible to 
employ a "T-test" to determine whether the differences between the sets of 
HMBA-treated and untreated extracts are statistically different from each 
other. With four degrees of freedom, any value of T greater than 2.78 was 
regarded as significant. Although, no significant difference in TK activities 
was seen between mock and HMBA-treated extracts prepared from 143TK1, 
143TKN and 143TKTaqA cells (Table 4.5), it is certainly possible that a larger 
sample size would reveal small but significant differences between the 
samples. Northern blot analysis of RNA extracted from each of the 
transformed cell lines, after 4h exposure to HMBA and mock treatment, did
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not reveal any obvious increase in RNA produced in the presence of 5mM 
HMBA (Results not shown).
Once integrated into the cellular genome, the IE-3, IE-4 and TK 
promoters lose their ability to respond to induction by HMBA, although the 
IE-3 and IE-4 promoters are still responsive to transinduction by Vmw65 and 
the TK promoter can be activated by IE proteins. Therefore, although when 
in the cellular genome these promoters are no longer responsive to HMBA, 
they are still activated by the appropriate viral transactivators. Clearly 
exposure to HMBA does not result in a gross increase in expression of all 
cellular genes but has an effect on specific, but as yet unidentified, genes. 
The results obtained suggest that the effect of HMBA on a particular promoter 
sequence, varies depending on the structural environment of the promoter.
4.7 Effects of the metabolites of HMBA on in 1 8 1 4
A number of known metabolites of HMBA have been tested for their
ability to induce differentiation of both MELCs and HL60 cells independently 
and in combination with HMBA (Reuben et al., 1976, 1978, 1980; Meilhoc et al., 
1986; Snyder et al., 1988). The primary m etabolite, N -acetyl-1,6-
diaminohexane, is a more potent inducer of HL60 cell differentiation than the 
parental molecule HMBA. The metabolites AmHA and AcHA both failed to 
induce differentiation of either MELCs or HL60 cells, but did potentiate the 
induction of differentiation of HL60 cells by HMBA, when used in 
conjunction with HMBA. In contrast, DAH did not induce differentiation 
either alone or in combination with HMBA (Snyder et al., 1988). Experiments 
were carried out to determine whether any of the metabolites of HMBA 
increase the titre of i n i 814.
Unfortunately, as a consequence of its extreme toxicity, N-acetyl-1,6- 
diaminohexane was not available for analysis. Titrations of in 1814 were 
carried out on HFL cells in the presence of various concentrations of AmHA 
and AcHA, individually (Table 4.6a) and in combination with 1 (Table 4.6b)
and 3mM (Table 4.6c) HMBA. At 2 days post-infection, cells were fixed and
stained, and the resulting titres determined. From these results, it was 
concluded that exposure to metabolites AmHA, AcHA and DAH does not have 
the same dramatic effect on in 1814 titre as does exposure to HMBA. In 
addition, titration of in 1814 in the presence of HMBA and in conjunction with 
AmHA, AcHA or DAH does not enhance the HMBA-mediated effect on the titre 
of in 1814. As HMBA treatment is required immediately after infection for 3 to 
4h for maximum effect, it would depend on how rapidly HMBA is metabolized
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Table 4.6 Effects of metabolites of HMBA on the titre 
of in 1 8 14
(a)
Concentration Titre (pfu/ml)
(m M ) HMBA AmHA AcHA
0 5.0 X 106 1.0 X 107 1.0 X 107
0.5 1.0 X 108 5.0 X 10« 5.0 X 10®
1 2.0 X 108 1.5 x  107 5.0 X 106
3 2.7 X 108 5.0 X 10® 5.0 x 106
5 3.7 X 108 1.5 x  107 1.0 X 107
(b)
Concentration Titre (pfu/ml) + ImM 
(mM ) AmHA AcHA DAH
1 1.3 X 108 1.5 X 108 4.5 x  107
3 1.1 X 108 1.3 x  108 TOXIC
5 8.0 X 107 1.4 X 108 TOXIC
(c)
Concentration Titre (pfu/ml) + 3mM 
(m M ) Am HA AcHA DAH
1 1.1 X 108 3.8 X 108 7.0 X 107
3 2.4 X 108 2.2 X 108 TOXIC
5 2.9 X 108 2.5 X 108 TOXIC
DAH
5.0 X 106
TOXIC
TOXIC
TOXIC
TOXIC
HMBA
HMBA
Compounds were added after the lh  adsorption and 
penetration period. Monolayers were fixed and stained 2 days 
p ost-in fection .
in HFL cells as to whether it is feasible to consider if any of these metabolites 
actually exert an effect on the titre of m l814. The conversion of HMBA to its 
metabolites may explain why HMBA pre-treatment of cells, prior to / az 1814 
infection, has no effect on the subsequent titre.
4.8 Modulation of PKC activity
As the phorbol ester TPA is known to antagonise HMBA-mediated 
induction of MELC differentiation (Falleto et al., 1985), experiments were 
carried out to determine whether TPA also inhibits the HMBA-mediated 
increase in the titre of zn 1814. The mutant m l814 and revertant 1814R were 
titrated in the presence and absence of 5mM HMBA, and in the presence of 
various concentrations of TPA. Cells were exposed to compounds immediately 
after the lh  adsorption and penetration period until 48h, when the cells were 
fixed and stained and the resulting titres determined (Table 4.7). The titres 
obtained reveal that exposure to TPA did not inhibit the HMBA-mediated 
increase in the titre of in 1814. Initial exposure of cells to TPA results in a rise 
of PKM activity. However, with continued exposure to TPA there is an overall 
decrease in PKM activity. Although initial exposure of cells to HMBA also 
results in a rise in PKM activity, there is no dramatic decrease upon
prolonged exposure (Section 1.4.4.2). Therefore, to investigate whether the
PKM fragment of PKC is responsible for the HMBA-mediated increase in the 
titre of m l 814, HFL cells were pretreated with TPA for 24h and the agent was 
withdrawn immediately prior to infection with in 1814 or 1814R, in the 
presence or absence of HMBA (Table 4.8). Pretreatment of cells with TPA for 
24h prior to infection with m l 814, which virtually eliminates PKM activity, 
did not inhibit the HMBA-mediated increase in m l814 titre.
Leupeptin is an inhibitor of the enzyme calpain, responsible for
catalysing the conversion of membrane bound PKC to the soluble activated
PKM form (Melloni et al., 1982; Pontremoli et al., 1987), which also blocks 
HMBA-induced MELC differentiation (Melloni et al., 1987). To investigate 
whether leupeptin specifically inhibits the HMBA-mediated increase in 
m l814 titre, HFL cells were infected with m l814 or 1814R in the presence or 
absence of HMBA. Various concentrations of leupeptin were also added to the 
overlying medium (Table 4.9). The titres obtained reveal that inhibition of 
PKM activity, by treatment with leupeptin, does not antagonize the HMBA- 
mediated effect on in 1814 titre. Therefore the modulation of PKC does not 
appear to be responsible for the HMBA-mediated increase in m l814 titre.
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Table 4.7 Effect of TPA on the titre of in  1814 and
1 8 1 4 R
V i r u s T r e a t m e n t Titre (pfu/ml)
m l 8 14 _ - 1.0 X 106
m l 8 14 - 10-9 m  TPA 1.8 X 106
ini  8 14 5mM HMBA - 2.3 X 108
m l 8 14 5mM HMBA 10-9 M TPA 2.6 X 108
m l 8 14 5mM HMBA 10-9 M TPA 2.4 X 108
ini  8 1 4 5mM HMBA 3 X 10-9 m  TPA 2.3 X 108
m l 8 14 5mM HMBA 3 X 10-9 M TPA 1.7 X 108
m l 8 14 5mM HMBA 6 X 10-9 M TPA TOXIC
1814R 8.9 X 108
1814R - 10-9 M TPA 8.7 X 108
1814R 5mM HMBA - 9.1 X 108
1814R 5mM HMBA 10-9 M TPA 8.5 X 108
1814R 5mM HMBA 10-9 m  TPA 8.8 X 108
1814R 5mM HMBA 3 X 10-9 M TPA 8.6 X 108
1814R 5mM HMBA 3 X 10-9 m  TPA 9.4 X 108
Compounds added after the lh  adsorption and penetration 
period. M onolayers were fixed and stained 2 days post­
infection.
Table 4.8 Effect of pre-exposure to TPA on the titre of
in!814 and 1814R
V iru s T reatm en t
m l 8 1 4 _
ini  8 1 4 -
m l 8 1 4 -
m l 8 1 4 -
m l 8 1 4 -
m l 8 1 4 5mM HMBAb
m l 8 1 4 5mM HMBA
m l 8 1 4 5mM HMBA
m l 8 1 4 5mM HMBA
m l 8 1 4 5mM HMBA
1814R _
1814R -
1814R -
1814R -
1814R -
1814R 5mM HMBA
1814R 5mM HMBA
1814R 5mM HMBA
1814R 5mM HMBA
1814R 5mM HMBA
Titre (pfu/ml)
1.0 X 106
10-9 m  TPAa <5.0 X 105
10-9 m  TPA 2.0 X 106
3 X 10-9 M TPA 1.0 X 106 
3 X 10-9 M TPA 1.5 X 106
3.1 X 108 
10-9 m  TPA 3.8 X 108 
10-9 M TPA 3.4 X 108 
3 X 10-9 m  TPA 3.5 X 108 
3 X 10-9 M TPA 3.7 X 108
9.9 X 108 
lO-9 M TPA 1.1 X 109 
lO-9 M TPA 9.6 X 108 
3 X 10-9 M TPA 1.1 X 109 
3 X lO-9 M TPA 1.2 X 109
1.0 X 109 
10-9 M TPA 1.1 X 109 
lO-9 m  TPA 1.0 X 109 
3 X lO-9 M TPA 1.0 X 109 
3 X lO-9 M TPA 1.1 X 109
a TPA present for 24h immediately prior to infection. The medium 
containing the TPA was removed, monolayers were washed twice 
with EHu5 and overlaid with EHu5.
b HMBA present after adsorption and penetration
Monolayers were fixed and stained 2 days post-infection.
Table 4.9 Effect of leupeptin on the titre of in 1814 and 
1 8 1 6 4 R
Virus T r e a t m e n t
m l 8 14 _
ini  8 1 4 - 10-9
ini  8 14 5mM HMBA
in i 8 14 5mM HMBA 10-8
m l 8 14 5mM HMBA lO'8
ini  8 14 5mM HMBA 10-9
in i 8 14 5mM HMBA lO'9
1814R _
1814R - 10-9
1814R 5mM HMBA
1814R 5mM HMBA 10-8
1814R 5mM HMBA 10-8
1814R 5mM HMBA 10-9
1814R 5mM HMBA 10-9
Titre (pfu/ml)
- <5.0 X 106
M leupeptin <5.0 X 106
- 2.7 X 108
M leupeptin 5.6 X 108
M leupeptin 3.4 X 108
M leupeptin 1.7 X 108
M leupeptin 1.7 X 108
_ 8.1 X 108
M leupeptin 8.1 X 108
- 1.4 X 109
M leupeptin 1.1 X 109
M leupeptin 1.2 X 109
M leupeptin 1.2 X 109
M leupeptin 1.0 X 109
Compounds added after the lh  adsorption and penetration period. 
Monolayers were fixed and stained 2 days post-infection.
HMBA-mediated MELC differentiation is a complex multistep process 
(Chen et al., 1982) and although TPA inhibits commitment to HMBA-induced 
differentiation, it does not prevent the early HMBA-induced changes in c - 
m y c , c - m y b  and c-fos expression. These early changes also occur in the 
presence of cycloheximide and may therefore reflect alterations in the state 
of phosphorylation of proteins involved in the regulation of these genes. 
Exposure of HFL cells to TPA, both prior to and post infection, did not 
significantly antagonize the HMBA-mediated effect on the titre of in 1814. It is 
therefore feasible that these early alterations in gene expression in response 
to HMBA, prior to the involvement of PKC, mediate the effect on m l 814 titre. 
Consequently, the HMBA-mediated increase in in 1814 titre may provide a 
model system for investigating the very early or initial events involved in 
HMBA-induced differentiation of MELCs.
4.9 The effect of HMBA exposure at different stages of 
calc ium  phosphate-mediated transfection
V arious m odifications to the calcium  phosphate-m ed ia ted  
transfection procedure (Stow & Wilkie, 1986) were introduced, to determine 
whether HMBA could functionally replace or have an additive effect in 
conjunction with the DMSO boost. 0.5pg HSV-1 DNA was introduced into BHK 
cells using the modified protocols detailed in Table 4.10a. Since 1.5% (v/v)
[200mM] DMSO is equivalent to 5mM HMBA during MELC differentiation then, 
25% DMSO is equivalent to 83mM HMBA during calcium phosphate-mediated 
transfection. However, the equivalent concentration of HMBA (83mM) was 
unable to functionally substitute for the 25% DMSO boost in the transfection 
procedure. However, addition of 5mM HMBA to the overlying medium after 
the DMSO boost apparently increased the efficiency of transfection, at least
with respect to the number of plaques obtained.
The effect of exposure to HMBA on the plaquing of both wild type
HSV-1 and in 1814 DNA was subsequently investigated . D ifferen t 
concentrations of either wild type HSV-1 or in 1814 DNA were introduced into 
BHK cells by calcium phosphate-mediated transfection. After the DMSO boost, 
5mM HMBA was added to the overlying medium, and the cells were fixed and 
stained 2 days later (Table 4.10b). The addition of 5mM HMBA to the culture 
medium after the DMSO boost, increases the number of plaques obtained for 
both in 1814 and wild type HSV-1 DNA and can therefore also compensate for 
the absence of the potent transactivator Vmw65 during transfection 
procedures. The observation that HMBA can also increase the number of
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Table 4.10a Effect of exposure to HMBA during calcium 
phosphate-mediated transfection of viral DNA into BHK 
c e l l s
Modified protocol No. plaques
Normal protocol 119
Minus DMSO boost 0
’’HMBA" boost replacing DMSO boost 0
HMBA during calcium phosphate
precipitation, up to & after boost 3 1 2
HMBA added after DMSO boost 3 2 2
Monolayers were fixed and stained two days post-transfection.
Table 4.10b Effect of addition of HMBA after DMSO 
boost on plaque formation
No. plaques
W T z'ft 1 8 1 4
[ig DN A - + - +
0.3 40 133 56 137
0.1 26 66 14 69
0.03 1 17 1 35
0.01 0 4 0 1
0.003 0 0 0 0
HMBA
5mM HMBA was added to the culture medium after the 4min 
25% DMSO boost. Monolayers were fixed and stained 2 days 
post-transfection .
plaques obtained after transfection of viral DNA implies that HMBA is not
involved in mediating the viral uncoating process during infection.
4.10 Effect of HMBA on Ad Ela  deletion mutant, d /3 1 2
Adenovirus E la  gene product is a potent and promiscuous 
transactivator of gene expression (Berk, 1986; Flink & Shenk, 1990) required 
for the positive regulation of early adenovirus gene expression (Jones &
Shenk, 1979) and is composed of three regions, namely 1, 2 and 3 (Moran & 
Mathews, 1987). Using GAL4-Ela fusion proteins, Lillie and Green (1989) 
demonstrated that region 3 contains both a transcriptional activation domain 
and a promoter binding activity. E la , like Vmw65, is not a sequence-specific 
DNA binding protein (Ferguson et ah , 1985) and the E la  activating region can 
substitute for the acidic activating region of the yeast activator GAL4 
(Ptashne, 1988; Mitchell & Tjian, 1989; Lillie & Green, 1989). As a consequence 
of these apparent similarities between Vmw65 and E la, titration experiments 
were performed to determine whether HMBA can also complement the
replication of an Ad5 E la deletion mutant d/312 (Jones & Shenk, 1979).
Wild type Ad5 and d /312 were titrated on HeLa cells in the presence of 
5mM HMBA for 24h post infection. At day 10, cells were fixed and stained and 
the titres determined (Table 4.11a). Exposure to 5mM HMBA for 24h had no 
effect on the titre of wild type Ad5, but resulted in a small rise in the titre of 
d/312. However, as d/312 forms plaques inefficiently on HeLa cells due to the 
lack of functional E la, it is possible that not all the progeny viruses were 
detected. In addition, the time of exposure to HMBA may not be the optimum 
required as the replication cycle of adenoviruses is considerably longer than 
that of HSV-1. Therefore, d/312 was titrated on HeLa cells, in the presence or 
absence of 5mM HMBA for 48h. The progeny viruses were then harvested and 
titrated on 293 cells, which constitutively express E la  (Graham et al ,  1977), 
thus allowing all potential d/312 plaques to be detected (Table 4.11b). Despite
an approximate 10-fold increase in the titre of d/312, HMBA treatment did not 
fully compensate for the lack of E la  activity and did not act as, nor induce, a 
cellular homologue of Ela. However, these results clearly suggest that HMBA 
affects gene expression of a non-herpesvirus, thus indicating a more 
universal mode of action. In addition, titration of in 1814 on 293 cells, which 
express E la, did not enhance the resulting titre (results not shown).
Table 4.11a Effect of HMBA on the titre of Ad5 and 
d/312 on HeLa cells
No. plaques 
Ad5 WT d/3 1 2
p f u /c e l l  - + p f u /c e l l  - + HMBA
0 .0 0 0 1  4 2  4 9  0 .01  1 5
0 .0 0 0 2  4 7  4 7  0 .0 2  2 8
0 .0 0 0 4  cpe cpe 0 .05  4 19
0 .0 0 1  cpe cpe 0 .0 7 5  4 3 4
5mM HMBA added to culture medium after the lh  adsorption 
and penetration period and retained for 24h then replaced by 
an agar overlay. Monolayers were fixed and stained 10 days 
post-infection and the resulting titre determined.
Table 4.11b Effect of HMBA on the titre of d l 312 on 
293 cells
Titre d/312 (pfu/ml)  
-HMBA +HMBA
1.3 X 103 3.5 X 104
2.5 X 103 3.7 X 104
5.0 X 103 7.2 X 104
1.4 X 104 1.3 X 105
5mM HMBA added to culture medium after the lh  adsorption 
and penetration period and retained for 48h. Progeny viruses 
were harvested and titrated on 293 cells. Monolayers were 
fixed and stained 10 days post-infection and the resulting titre 
determ ined .
5. DISCUSSION
The experiments described in this thesis demonstrate that a dramatic 
reversal of the phenotype of the Vmw65 insertion mutant m l814 (Ace et al.,
1989) can be achieved by the addition of 5mM HMBA to the cell culture 
medium. At this concentration, although cell division appears to cease, the 
agent is not cytotoxic and may be used on a variety of cell types. Apart from 
the theoretical considerations, the effect of HMBA is of practical value, since 
a short exposure of the agent allows /«1814 to be propagated and titrated 
almost as efficiently as wild type HSV-1. Previously, complementation with
ultraviolet light-inactivated HSV, a more cumbersome process, was necessary
to assay i/zl814 particle production by titration (Ace et al., 1989; Steiner et al.,
1990).
5.1 Relationship between the "HMBA effect" on i # z l 8 1 4  
titre and HMBA-induced MELC differentiation
The fact that HMBA, DMSO and hypoxanthine are all inducers of MELC 
differentiation (Friend et al., 1971; Reuben et al., 1976), and that the optimum 
concentrations for complementation of m l814 and differentiation (Reuben et  
al., 1980) are equivalent, suggests that a common pathway underlies the two 
phenomena. In addition, both DMSO and hypoxanthine significantly increase 
the titre of i«1814, however, they are not as effective as HMBA. This is 
consistent with the fact that HMBA is a more potent inducer of MELC
differentiation than DMSO, acting in a concentration range 50 times lower 
(Palfrey et al., 1977). In addition, the effect on m l 814 requires only a short 
exposure to HMBA (1 to 5h, Figure 4.3) whereas a longer treatment, greater 
than 12h, in combination with a period of protein synthesis is necessary for
irreversible commitment to differentiation (Marks et al., 1987).
The effect of HMBA on the titre of ml814 is not specific to HFL cells, 
being reproducible in BHK and HeLa cells (Figure 4.1). This finding suggests 
that HMBA affects or functions through a ubiquitous phenomenon or 
protein. In addition, the HMBA effect is presumably on pre-existing cellular 
or viral components, since the agent is ineffective if added and withdrawn 
immediately prior to infection, but can act on IE RNA levels in the presence 
of cycloheximide (Figure 4.5). Modification of proteins, perhaps as a 
consequence of alterations in PKC levels (Melloni et al., 1987), is a plausible
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On the assumption that the alterations in proto-oncogene expression 
in MELCs are the same as the changes in HFL cells in response to 
HMBA.
mode of action, but it is equally possible that the compound, or metabolites 
derived from it, act directly on cellular or viral macromolecules.
The phorbol ester TPA, a known antagonist of HMBA-mediated MELC 
differentiation which induces a transient rise in PKM activity (Falleto. et al., 
1985), fails to inhibit the HMBA-mediated increase in in 1814 titre when added 
in conjunction with HMBA after the lh  adsorption and penetration period. 
Depletion of PKM activity, by prolonged exposure to TPA, also fails to prevent 
the HMBA-mediated increase in in 1814 titre. In addition, exposure to 
leupeptin, which inhibits the conversion of membrane bound inactive PKC to 
the soluble activated PKM form (Melloni et al., 1982; Pontremoli et al., 1987) 
also fails to antagonize the effect of HMBA on in 1814. Therefore, HMBA- 
mediated modulation of PKC activity does not appear to be responsible for the 
effect on in 1814 titre.
To reconcile the fact that TPA, a compound known to antagonize
inducer-mediated differentiation, does not block the HMBA-mediated effect 
on in 1814 titre, the following points must be taken into consideration. Firstly, 
despite TPA inhibiting the commitment of MELCs to differentiation, TPA does 
not prevent the early HMBA-induced changes in c - m y c ,  c -m y b  and c - f o s  
expression (Melloni et al., 1987). It is therefore feasible that alterations in the 
expression of these oncogenes may be involved in the HMBA-mediated 
increase in in 1814 titre. Secondly, it is known that HMBA-induced early 
changes in protooncogene expression also occur in the presence of 
cyclohexim ide and may therefore reflect alterations in the state of
phosphorylation of proteins involved in the regulation of these genes. These
same putative regulatory factor(s) may be responsible for the increased
accumulation of in 1814 IE RNA. Indeed, a number of studies imply that
transcription factors may exist in an inactive state prior to post-translational
modification (Imbra & Kann, 1986), thus providing a potential mechanism
whereby HMBA could function. To investigate further whether any cellular 
or viral proteins are specifically phosphorylated in response to HMBA, 
proteins could be labelled with [3 2P]-orthophosphate in the presence and
absence of HMBA.
The decrease in c-myc  mRNA occurs within lh  exposure to HMBA,
while the alterations in c -m yb  and c-fos  levels occur by 4h (Ramsay et al.,
1986; Richon et al., 1989). it is more likely that the decrease in
c -m yc  levels, or the activity of a factor(s) controlling this effect, is involved 
in the HMBA-mediated increase in in 1814 titre, considering only lh  exposure 
results in a large increase in titre. To investigate this possibility, future work
could involve the introduction of a plasmid expressing anti-sense c-myc  RNA
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into HFL cells prior to infection with in 1814 or 1814R, in the absence of 
HMBA. If the increase in in 1814 titre in the presence of HMBA occurs as a 
direct consequence of the reduced c-myc  RNA levels, then one would expect 
to detect a rise in titre similar to that observed with HMBA treatment. If 
however, the sequestering of c-myc  mRNA had no specific effect on the titre 
of m 1814, it would be more likely that a factor(s) regulating c - m y c  
expression is also involved in the modulation of /«1814 titre. Darling et al. 
(1989) demonstrated that DMSO treatment did not induce a rapid transient 
reduction in the steady state levels of c-myc  in HeLa cells. Therefore, as the 
HMBA effect on in 1814 titre is observed in HeLa cells, it is unlikely that the 
reduction in c-myc  mRNA is directly responsible.
Like TPA, another inhibitor of HMBA-induced differentiation, 
dexamethasone, also results in a block at the late stage and has no effect on 
the early pre-commitment events (Santoro et al., 1978). It may prove 
illuminating to determine whether, like TPA, dexamethasone also fails to 
inhibit the HMBA-mediated increase in the titre of m l 814,
As the effect of HMBA on m l814 is immediate and given that PKC 
inhibitors, which function further along the multistep pathway, do not 
antagonize the HMBA-mediated increase in m l814 titre, it seems likely that 
the early precommitment events of HMBA-induced differentiation are being 
detected in this system.
It has been proposed that vincristine-resistant MELC variants, which 
display accelerated HMBA-mediated differentiation, display constitutive 
expression of a factor(s) critical, and rate-limiting, for early events in 
commitment (Melloni et al., 1988; Richon et al., 1991). If MELCs prove to be 
permissive for HSV infection, assays may be carried out to determine 
whether in 1814 has a greater titre on the vincristine-resistant cell lines 
than on the normal MELCs. Identification and isolation of this putative 
factor(s) would facilitate the titration of /n l 814 in its presence to determine 
whether this activity alone was sufficient to emulate the effect observed with 
HMBA treatment. In addition, nuclear extracts could be prepared from normal 
uninduced MELCs and from vincristine-resistant variants, to allow the 
comparison of complex formation, by gel retardation analysis, on a number 
of promoter motifs, including the TAATGARAT and TATA box.
As HMBA, is a potent hypomethylating agent, it may affect gene 
expression by altering the degree of methylation of particular genes. 
Demethylation of cytosine residues within the dinucleotide sequence CpG has 
been associated with transcriptional inactivity (Bird, 1986). Treatment of 
cells with the demethylating agent, 5-azacytosine, often leads to the
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reactivation of genes that were both methylated and transcriptionally 
repressed (M ohandas et al., 1981; Venolia et al., 1982). However, 
demethylation of DNA by HMBA is unlikely to be involved in the activity on 
in 1814, for a number of reasons. Firstly, HSV DNA is not methylated (Low et
al., 1969), thus a direct effect on the template is improbable. Secondly, it is
difficult to envisage how demethylation of cell DNA without subsequent 
protein synthesis could affect HSV gene expression. Thirdly, loss of 5- 
methylcytosine in MELCs does not commence until 3h after the addition of 
HMBA and reaches a maximum level at 6h (Razin et al., 1988), yet 3h exposure 
is sufficient to give an almost complete increase in in 1814 titre. Finally, 5- 
azacytidine did not mimic the effect of HMBA but reduced the titre of m l814.
The primary metabolite, N -acetyl-l,6-diam inohexane, is a more 
potent inducer of HL60 differentiation than the parent compound HMBA 
(Snyder et al., 1988), but is unfortunately not commercially available. If this 
compound was available, then in 1814 may be titrated in the presence of
various concentrations of N-acetyl-l,6-diaminohexane to determine whether 
it has any effect on the titre. None of the other metabolites of HMBA tested, 
namely AmHA, AcHA and DAH, facilitated a dramatic increase in the titre of 
/«1814. In view of the observation that the HMBA-mediated increase in 
in 1814 titre is an immediate response, it is likely that the action of HMBA 
itself, or possibly N-acetyl-l,6-diaminohexane, depending on the rate of 
metabolism in HFL cells, is responsible for the dramatic increase in i / i l8 1 4
titre. Pre-exposure of HFL cells to HMBA prior to in 1814 infection had no 
effect on the subsequent titre. This may be explained by the rapid conversion 
of HMBA to an inactive metabolite(s).
If the effect of HMBA on the titre of in 1814 occurs by the same 
mechanism as induced MELC differentiation, then it may be used as a simple 
system for rapidly screening related compounds for their ability to induce 
differentiation. A series of extremely potent differentiation inducing agents, 
which are structurally related to HMBA, have recently been synthesized 
(Breslow et al., 1991). Differentiation-inducing assays have revealed that 
related inducers with flexible linear structures are active differentiators of 
MELCs, HL-60 and HT-29 cells, being one hundred times more potent than 
HMBA. In contrast, rigid compounds, containing benzene ring spacers, show 
greater activity towards MELCs, while being much less active towards HL-60 
cells. Furthermore, as the rigid compounds have different geometric 
requirements and are not additive with HMBA in their effect, Breslow et al. 
(1991) proposed that rigid compounds have a different site of action from 
flexible inducers. If these compounds were made available, titrations of
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i« l 814 in the presence of agents belonging to each mechanistic group should 
be undertaken. If functional distinctions could also be made between the 
rigid and flexible inducers with respect to their effect in the titre of m l 81 4 , 
then this assay may form the basis of a rapid screen facilitating the 
identification of novel inducers of differentiation. It is likely that variations 
in the potency of compounds could be detected as hypoxanthine, a less potent 
inducer of differentiation, is also less effective than HMBA at complementing 
m l814. Characterization of the effect of compounds falling into two different 
mechanistic groups on in 1814 titre, may provide greater insight into the 
mechanism of action of HMBA on the titre of m l 814, reactivation of latent 
HSV and differentiation.
As the uptake of virus DNA to the nucleus was not altered by HMBA, 
the most likely events affected are uncoating or IE transcription. Little is 
known in detail about the mechanism of uncoating, but an hypothesis that 
HMBA affects this process presupposes that m l814 is defective in uncoating. 
Previous studies have shown that in 1814 can be complemented completely by 
the supply of Vmw65 in trans and partially by the provision of VmwllO 
through plasmid transfections (Ace et al., 1989), observations that are 
difficult to reconcile with an uncoating defect. In addition, the demonstration 
that HMBA treatment increases the efficiency of plaque formation after the 
introduction of both in 1814 and wild type HSV-1 DNA by calcium phosphate- 
mediated transfection (Section 4.9) argues against HMBA being involved in 
the viral uncoating process. Futhermore, in view of the involvement of 
Vmw65 in the activation of IE transcription, it is most likely that the reduced 
accumulation of IE RNA observed after infection with in 1814 is due to 
impairment of transcription.
5.2 Does HMBA activate a cellular homologue of a viral 
t r a n s a c t i v a t o r ?
It is feasible that the viral transactivator Vmwl75 could be a target 
for post-transcriptional modifications by the action of HMBA as it is known to 
be phosphorylated at serine and threonine residues and poly(ADP- 
ribosyl)ated (Powell & Purifoy, 1976; Pereira et al., 1977; Cabral et al., 1980; 
Hay & Hay, 1980; Preston & Notarianni, 1983; Faber & Wilcox, 1986a; Blaho et  
al., 1992). Furthermore, Michael et al. (1988) demonstrated that different 
electrophoretic forms of Vmwl75 differ in their ability to bind specific DNA 
sequences. Therefore, if  a cellular factor functionally similar to Vmwl75 
existed, then it would be likely that its activity would be controlled in a
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similar manner. However, HMBA does not complement the growth of the 
mutant in 1411, which lacks a functional Vmwl75, in BHK or HFL cells, and 
therefore does not act as or induce an active cellular/\ homologue of this 
essential viral transactivator. Further evidence supporting this hypothesis 
may be obtained if TK assays were performed and total protein synthesis 
examined, using untreated and HMBA-treated in 1411-infected cell extracts.
An alternative hypothesis As the possibility that HMBA functions 
'fo/icKoAd/ equv.abA'r 
through a cellu lar^  homologue of the potent promiscuous transactivator
VmwllO (Everett, 1984; O'Hare & Hayward, 1985; Gelman & Silverstein, 1985,
Quinlan & Knipe, 1985) which could be responsible for the activation of IE
gene expression in the absence of Vmw65. There are a number of lines of
evidence which suggest the existence of such a protein. In vitro, latent
dZ 1403, lacking a functional VmwllO (Stow & Stow, 1986), can be reactivated
by superinfection with HCMV in a situation where no VmwllO is present
(Russell et al ., 1987). When Harris et al. (1989) later demonstrated that
VmwllO alone was sufficient to reactivate latent HSV-2 from latency in vitro,
this observation raised the possibility of the existence of a cellular
homologue substituting for the function of VmwllO. Futhermore, a variant
cell line, 2.5BHK, has been isolated which supports the replication of d/1403 to
a greater extent than the parental BHK cell line (Everett, 1989). However, this
is unlikely to be the mechanism whereby HMBA increases the titre of /w 1814
for a number of reasons. Firstly, the provision of VmwllO in trans during
in 1814 infection does not fully compensate for the lack of Vmw65, resulting
in only an approximate 10-fold increase in titre (Ace et al., 1989), compared
with the 250-fold increase in the presence of HMBA. However, the
effectivness of this experiment is limited by the efficiency of transfection.
In addition, titration of VmwllO deficient mutants d/1403 and in 1825 in the
presence of HMBA results in limited sevenfold and fourfold increases
respectively (Section 4.2.2), demonstrating that HMBA treatment does not
substantially compensate for the absence of VmwllO.
The simplest explanation for the effect of HMBA on the titre of in i 814 
is that HMBA compensates for the lack of functional Vmw65, either directly 
or via the modulation of one or more cellular factors. As for VmwllO, there is
also evidence supporting the existence of a putative cellular protein which is
functionally equivalent to Vmw65. It seems unlikely that an alternative
virion component exists which is functionally similar to Vmw65, in view of 
the fact that PRV fails to stimulate HSV IE gene expression in the presence of 
cyclohexim ide (Campbell et al., 1987) and because of the absence of a
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functional homologue to Vmw65 in the VZV genome (Davison & Scott, 1987; 
McKee et al., 1990).
Stimulation of transcription through the octamer motif, in the 
absence of Vmw65, occurs in the cell cycle dependent regulation of the H2b 
gene (La Bella et al., 1988). HSV IE gene expression has also been shown to 
vary during the cell cycle, as the mutant m l8 1 4  forms plaques less 
efficiently on HeLa cells synchronised at the G2 phase of the cell cycle than 
at G i/S, demonstrating an increased requirement for Vmw65 when cultures 
reached the G2 phase (Daksis and Preston, 1992). Interestingly, treatment of 
cells with DMSO and HMBA is known to prolong the Gi phase (Terada et al., 
1977; Friedman & Schildkraut, 1978), during which m l814 has been shown 
to plaque most efficiently. It is possible that the lengthened Gi phase may
lead to either the accumulation or increased activity of a cellular factor
involved in the HMBA-mediated effect on m l814 titre. As the Oct-1 motif is 
required for the efficient in vitro transcription using S-phase, but not Gi 
phase extracts (Fletcher et al., 1987) it is feasible that this effect represents 
the differential expression of Oct-1 or other cellular transcription factors,
during the cell cycle. Extracts prepared from cells synchronised at different 
stages of the cell cycle could therefore be used to determine whether the 
degree of the HMBA-mediated rise in m l814 titre varies during the cell cycle.
Despite the potential existence of a Vmw65/[homologue, the inability 
of HMBA treatment to induce IEC formation in the absence of functional 
Vmw65, leads to the conclusion that the compound neither acts as, nor
activates, a cellular homologue of Vmw65 (Section 4.3.1). In addition, the 
observation that the inclusion of 5mM HMBA in the binding assays neither
promotes IEC formation with in 1814-infected nuclear extract nor m l 814
virion extract, reveals that the HMBA molecule does not function as a linker 
bringing together Oct-1 and the mutant Vmw65. There must be an alternative 
mechanism whereby HMBA promotes IE gene expression during m l 814  
in fec tio n .
The adenovirus transactivator, E la, shares a number of functional 
similaraties with HSV-1 Vmw65. For example the activating regions of both 
Vmw65 and E la  can be substituted for the acidic activation domain of GAL4 
(Ptashne, 1988; Mitchell & Tjian, 1989; Lillie & Green, 1989). In addition Ela, 
like Vmw65, has an indirect mechanism of transactivation which is mediated 
through protein protein interactions with cellular components (Ferguson e t  
al., 1985; Nevins, 1989). Titration of an Ad E la  deletion mutant, d/312, in the 
presence of HMBA revealed that HMBA treatment does not fully compensate
for the lack of E la  activity. Therefore, HMBA does not result in the activation
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of an Ela-like activity within the cell. The tenfold increase in the titre of 
d l312 represents an HMBA-mediated alteration of gene expression of a non­
herpesvirus gene in its natural environment, implying a more universal 
mode of action.
As HMBA-treated HeLa nuclear extracts did not promote complex
form ation at the TAATGARAT elem ent, subsequent investigations 
concentrated on the binding of transcription factors at other promoter 
motifs, namely the Ad MLP, CCAAT box and VmwllO TATA box. Analysis of 
complex formation at the TATA box is relevant as an acidic activator, such as 
Vmw65, stimulates transcription by increasing the number of functional 
preinitiation complexes by recruiting TFIID to the promoter (Lin & Green,
1991). However, use of HMBA-treated nuclear extracts, instead of untreated 
extacts did not promote complex formation at the Ad MLP, CCAAT box or
VmwllO TATA box. As HMBA does not act by inducing stable cellular 
alterations, gel retardation assays were performed using extracts exposed to 
HMBA for 1, 15, 30, 45 and 60min to ensure that any potential alterations are 
not missed. Even with only short exposures, HMBA treatment did not increase 
complex formation at any of the motifs analysed. Instead, there appeared to 
be a slight reduction in complex formation using HMBA-treated extracts, 
which is most pronounced for CCAAT box binding. This may reflect the 
modification or inactivation of factors involved in complex binding by the 
action of HMBA.
5.3 Sequence specificity
The question of sequence specificity in HMBA's mode of action was 
addressed using a number of plasmids with the CAT gene under the control of 
various viral promoters (Section 4.2.1). However, all the promoters tested to 
date shows increased CAT activity in the presence of 5mM HMBA. Therefore, 
in this transient system, exposure to HMBA increases the level of CAT activity 
from IE, E and L HSV promoters, and from the HCMV and SV40 enhancers. 
Campbell et al. (1990) also demonstrated that the transcription of many
transfected genes is stimulated by HMBA, whereas both the Moloney murine 
sarcoma virus and mouse mammary tumour virus LTRs failed to show 
significant increases in CAT activity in the presence of HMBA. As a
consequence of this apparent lack of correlation between prom oter 
specificity and inducibility, Campbell et al. (1990) suggested that CAT activity 
may be regulated by the post-trans La. tional modification of one or more 
factors d irectly  involved in transcription in itia tion . However, this
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hypothesis does not explain why a particular gene that is responsive in both 
the viral genome and in plasmid-based assays, is no longer responsive to 
HMBA once integrated into the cellular genome. Run-on transcription assays 
need to be performed to determine whether HMBA increases the rate of 
transcription of IE RNAs, rather than their accumulation.
This question of specificity was subsequently addressed using a 
number of mutant viruses which, in contrast with the plasmid based CAT 
assays, allow the direct investigation of the effect of HMBA on different 
promoters in their native genomic environment.
The Moloney murine leukemia virus enhancer and promoter is not 
efficiently utilized in HFL cells (C.M. Preston, unpublished results). When 
this element is substituted for the VmwllO promoter in the viral genome it is 
not responsive to activation by HMBA. In contrast, titration of mutants /w l827 
and rw 1833, in the presence and absence of HMBA, reveals that the HCMV 
enhancer and SV40 promoter/enhancers respectively are responsive to 
activation when in the viral genome. Therefore, there appears to be a 
limited degree of specificity in the action of HMBA on genes in the viral 
genome. HMBA can act to increase the level of expression of the VmwllO 
gene controlled by the IE-1 promoter, but cannot switch on its expression 
when under the control of the non-responsive Moloney murine leukemia 
virus enhancer. It is possible, however, that under IE conditions i«1827 does 
express VmwllO mRNA at a level not detectable in dot blots which is 
increased to a still undetectable level in the presence of HMBA.
This inability to demonstrate increased activity using HMBA-treated €*Vc4j^ 
in an in vitro transcription initiation system may be explained by the fact 
that HMBA does not increase the titre of 1814 by inducing stable cellular 
alterations. Pretreatment of cells with HMBA prior to infection with in 1814  
has no effect on the resulting titre. In this system, no significant differences 
were detected in transcriptional activity using untreated and HMBA-treated 
extracts, from the VmwllO promoter, Vmw68 promoter in the presence and 
absence of upstream sequences, from the Ad MLP or the HCMV IE promoter. 
However, these results do not preclude the possibility that specific factors 
affecting the transcriptional activity of an extract are modified in response 
to HMBA treatment, but are not detected as a consequence of their unstable 
n a tu re .
The C-terminal domain (CTD) of the large subunit of RNA polymerase 
II, containing multiple repeats of the consensus sequence Tyr-Ser-Pro-Thr- 
Ser-Pro-Ser (Allison et al., 1985; Corden et al., 1985), is a potential cellular 
target for HMBA-directed post-translational modification. This essential
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structural feature is unique to RNA polymerase II and is modified by 
phosphorylation in a post-translational process (Breant et al., 1983). 
Imm unoprecipitations can be performed to compare the electrophoretic 
mobilities of RNA polymerase II isolated from untreated and HMBA-treated 
HeLa cells. Any variations in mobility in SDS-PAGE may be attributable to 
different degrees of phosphorylation at the hydroxyl-rich CTD. Although the 
in vitro transcription experiments (Section 4.5) did not reveal any 
significant difference in transcriptional activity between untreated and 
HMBA-treated extracts, it is possible that unstable modifications which 
increase the activity of the enzyme have not been detected, as the CTD is 
highly susceptible to proteolysis (Sentenac, 1985).
The polar planar molecule, HMBA, does not appear to function 
directly as a consequence of its overall negative charge with a mechanism
similar to that of an acidic activator, as the inclusion of HMBA in the 
transcription reactions does not increase the amount of RNA produced from 
RNA polmerase II type promoters. In addition, hypoxanthine, which is not 
strongly charged, also significantly increases the titre of m l 814. The effect 
of HMBA on transcription catalysed by RNA polymerase III was analysed
using the Ad VA promoter. Again, neither HMBA-treatment of extracts nor 
the inclusion of HMBA in the assays increased transcriptional activity. The 
effect of HMBA exposure on transcription from an RNA polymerase III 
promoter in a transfection assay has not yet been investigated. As all the RNA 
polymerase type II promoters analysed in transfection assays to date have 
shown increased activity in the presence of HMBA, then a degree of promoter 
specificity may be established if RNA polymerase III promoters fail to 
respond in transfection assays.
5.4 Im portance of chromatin structure
During the establishment of a latent infection, Harris and Preston 
(1991) demonstrated that the in 1814 genome rapidly becomes refractory to
activation by Vmw65. Once latency has been established, m l814 cannot be 
reactivated or complemented by Vmw65, suggesting that the IE promoters
become insensitive to transactivators, with the exception of VmwllO (Harris 
et al., 1989; Harris & Preston, 1991). It is thought that this lack of response 
may represent an overall silencing of the m l8 1 4  genome as a result of 
chromatin formation (Deshmane & Fraser, 1989) or the presence of a 
repressor molecule which prevents the expression of IE genes and hence 
prevents reactivation (Kemp, 1990). As a similar refractoryness is observed
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with time during in 1814 lytic infection in the presence of HMBA, it is 
possible that this too is an effect of the overall silencing of the genome. 
Within 5h of infection, the /«1814 genome is converted to a non-linear 
configuration (Harris & Preston, 1991), and it is feasible that this 
phenomenon also interferes with the ability of HMBA to complement in l8 1 4 . 
In other words, as the population of viral genomes gradually moves towards a 
non-linear configuration, this alteration in structure may preclude HMBAs 
action .
The importance of chromatin structure in the ability of a promoter to 
respond to activation by HMBA is highlighted by the observation that the IE- 
3 promoter is responsive to HMBA both in a plasmid based transfection assay 
and in the viral genome, but is unresponsive once integrated into the 
cellular genome. The transformed cell line, 143TKN, containing the TK gene
under the control of the HSV-1 IE-3 promoter, is not responsive to activation 
by HMBA, despite these regulatory sequences retaining responsiveness to the 
viral transactivator Vmw65. Similarly, expression from the IE-4 promoter was 
found to be activated by HMBA treatment during in 1814 infection with the 
accumulation of IE-4 RNA, yet TK assays reveal that the IE-4 promoter is not 
responsive to HMBA once integrated into the cellular genome. Despite this
non-responsiveness to HMBA, the IE-4 promoter in 143TKTaqA cells is in a
structural conformation which is accessible to viral transactivators as 
infection with UV-irradiated ts K, which provides Vmw65, significantly 
increased TK activity. Transfection assays, in the presence and absence of 
HMBA, also reveal that the early TK promoter is responsive to HMBA in this 
plasmid based assay. However, TK assays with 143TK1 cell extracts reveal that 
the TK promoter when in the cellular genome is not activated by exposure to 
HMBA, despite retaining the ability to be transactivated by VmwllO.
Therefore, there appears to be a feature of the cellular genome's 
environm ent which impedes activation by HMBA, w ithout otherwise
affecting the responsiveness of the IE-3, IE-4 and TK promoters to activation 
by the appropriate viral transactivator. Work needs to be carried out to 
determine the structural aspects of promoter DNA in plasmids and in the viral 
genome which facilitates activation by HMBA. The early stimulation of CAT 
activity in transient transfectants and increased IE RNA transcription during 
in 1814 infection, is not sufficient to increase expression from the same 
promoters once integrated into the cellular genome. There is a delay of 12- 
24h following exposure to inducer before the induction of mouse-globin 
genes occurs (Salditt-Georgieff et al., 1984; Sheffery et al., 1984). This delayed
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response may reflect a requirement for de novo protein synthesis of 
transcription factors, or be a consequence of chromosomal integration.
The incorporation of DNA into a chromatin structure has been shown 
to inhibit the access of transcription factors (Emerson & Felsenfeld, 1984; 
Workman & Roeder, 1987; Workman et al., 1988; Cheng & Kelly, 1989). In the 
stable TK+ transformed cell lines, 143TK1, 143TKN and 143TKtaqA, the 
introduced DNA is in chromatin structure which, although accessible to 
either Vmw65 or VmwllO, does not appear to be responsive to HMBA. The fact 
that the transformed cell lines are responsive to these viral transactivators 
but not HMBA, suggests that the effect of HMBA is on one or more factors 
which are not involved in transactivation by Vmw65 or VmwllO. It is 
possible that activation of these stably integrated genes may depend on 
increased access to the promoters of a factor, modified by the action of HMBA, 
as a result of cell-cycle events (Conkie et al., 1981), changes associated with 
DNA replication (Enver et al., 1988) or alterations in the state of DNA 
methylation (Razin et al., 1980). In contrast, both plasmid DNA, introduced by 
transient tranfection, and viral DNA, are initially naked, providing an 
environment in which the control regions are not associated with histones 
and are therefore freely accessible to transcription factors.
Becker et al. (1991) demonstrated that the simultaneous addition of 
TFIID and histones during chromatin assembly on the D ro s o p h i l la  hsp70 
promoter resulted in the formation of 'potentiated' chromatin, capable of 
responding to the subsequent addition of heat shock transcription factors. It 
is possible that HMBA may function in an analogous manner, activating 
transcription from IE genes when in plasmids or in the viral genome as a 
result of the open active chromatin structures.
Sodium butyrate is a known inducer of MELC differentiation (Leder & 
Leder, 1975) and is associated with the hyperacetylation of histones H3 and H4 
through the inhibition of histone deacetylation (Candido et al., 1978) and the 
accumulation of a non-histone chromatin protein IP25  (Keppel et al., 1977). 
However, as other inducers such as DMSO do not cause hyperacetylation of 
histones, it is unlikely that butyrate induced hyperacetylation of H3 and H4 
in MELCs has any direct relationship to the induction of differentiation by 
this agent. Sodium butyrate does not increase the titre of in 1814 in HFL or 
BHK cells (C.M. Preston, personal communication). The PKCe fraction isolated 
from MELCs has the capacity to phosphorylate histones. In contrast, the 
induction of IP25 by sodium butyrate treatment also occurs in response to a 
large number of chemical differentiation inducing agents (Candido et al., 
1978).
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Another link between induction of MELC differentiation and HSV 
gene expression was made when Kemp and Latchman (1989) demonstrated 
that treatment of neuronal C1300 cells with sodium butyrate reverses a
transcriptional block, and thereby facilitates the expression of HSV IE genes. 
In addition, Ash (1986) demonstrated that exposure of C l300 cells to sodium 
butyrate increases the permissivity of these cells for HSV infection. The
effect of sodium butyrate treatment of C l300 cells on HSV IE gene expression 
is therefore unlikely to involve the same mechanism that is responsible for 
the HMBA-mediated increase in fn 1814 IE gene expression.
Acetylation of histones can affect the chromatin structure of a gene,
being associated with increased sensitivity to DNasel and micrococcal 
nuclease, and hence with transcriptionally poised chromatin. The 143TK1, 
143TKN and 143TaqA transformed cell lines could be treated with sodium
butyrate and TK assays performed to determine whether the action of this 
compound results in increased TK activity, either alone or in conjunction 
with HMBA. Similarly, the transformed cells could be treated with 5- 
azacytidine, in the presence and absence of HMBA, to determine whether 
demethylation has any effect on the ability of HMBA to activate expression of 
these selected genes integrated into the cellular genome. Before these
experiments are carried out the 143TK1, 143TKN and 143TaqA transformed cell
lines should be cloned and characterised.
5.5 Role of HMBA during reactivation of latent virus
During latency in vivo, Vmw65 is not thought to be present, thus 
reactivation must occur through a pathway that does not initially require 
this protein. Infection with /n l814  provides a situation in which Vmw65 
activity is absent or severely reduced, suggesting the stimulation of IE RNA 
levels observed in tissue culture cells represents the mechanism by which 
HMBA and DMSO enhance reactivation from the ganglia (Whitby et al., 1987; 
Bernstein & Kappes, 1988; Leib et al., 1989).
It has been recently reported that HMBA enhances the replication of 
HSV in IMR-32 human neuroblastoma and HEp-2 cells after infection at low 
m.o.i. (Yura et al., 1991), and that HMBA improves 'spontaneous* reactivation 
of latent HSV-2 from infected IMR-32 cells (Kondo et al., 1990). From the
studies presented in this thesis, it is likely that these events are due to 
stimulation of IE gene expression by HMBA.
Determination of the molecular basis for the activity of HMBA on
in 1814 infection may reveal the primary events by which the compound
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affects the poorly understood process of reactivation. Alternatively, the 
response to HMBA may operate after the initial trigger for reactivation,
simply by accelerating virus growth in explanted ganglia. The fact that the 
stimulation of reactivation of an HSV-1 mutant deleted for VmwllO coding 
sequences is "all or nothing" (Leib et al., 1989) supports the former pathway, 
but it is possible that the results could be accounted for by the relatively 
small effect on replication of mutants that do not produce VmwllO (namely 
d/1403 and m l825).
Since the action of HMBA on in 1814 is not thought to be due to 
demethylation but an effect on IE gene expression, it follows that the 
enhancement of reactivation may be due to the same activity. I would 
therefore favour the view that HMBA and DMSO improve reactivation of
latent HSV through direct modulation of viral or cellular gene expression by 
a mechanism related to their effects on MELCs and distinct from the action of 
5-azacytidine, assuming that 5-azacytidine primarily acts by demethylation.
Sears et al. (1991) previously showed that the neuronal expression of
Vmw65 did not preclude the establishment of a latent infection. By 
investigating whether latency can be established in vitro in the presence of
HMBA, one can confirm that, as expected, increased IE gene expression 
precludes the establishment of an in 1814 latent infection. In addition, the in  
vitro  system developed by Russell and Preston (1986) could be employed to 
determine whether exposure to HMBA prevents HSV-2 establishing latency in
vitro  at the supraoptimal temperature, 42°C. As HMBA functions through a 
mechanism whereby IE gene expression is increased, it is reasonable to 
hypothesize that exposure to HMBA would tip the lytic-latent decision in 
favour of a lytic infection. The mutant rn 1820, in which the VmwllO 
promoter in /n l814  has been replaced by the murine Moloney leukaemia 
virus enhancer, expresses VmwllO poorly in HFL cells and does not respond 
fully to HMBA. Experiments could be carried out to determine what effect 
HMBA-treatment has on the ability of r/i 1820 to establish latency in vitro.
The cAMP responsive element (CRE) in the LAT promoter may be 
involved in modulation of LAT promoter expression and the control of viral 
reactivation (Leib et al., 1991) as compounds which increase the intracellular
levels of cAMP also promote the reactivation of latent virus from the ganglia 
(Saiz de la Meza et a l,  1989; Foster et al., 1989). Prostcjglandins are examples of 
experimental reactivation inducing stimuli which are associated with
increased cAMP concentrations (Kimberg et al., 1972; Matsuzawa &
Nurenberg, 1975; Rodbell, 1980; Lentzki, 1988; Hu & Gudas, 1990). It is feasible 
that exposure to HMBA alters LAT expression through this control element, as
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HMBA-induced MELC differentiation is also associated with a transient rise in 
the concentration of cAMP. Gel retardation assays may be performed in order 
to compare complex formation at the CRE in conjunction with untreated and 
HMBA-treated extract nuclear extracts. As the prostc^glandin syhthesis 
inhibitor, indomethacin, reversibly inhibits reactivation of latent HSV from 
ganglia (Blyth et a l,  1976; Harbour et a l ,  1983; Kurane et a l ,  1984), titration 
could be performed to determine whether this compound also antagonizes the 
HMBA-mediated rise in in 1814 titre. If so, then it is likely that the mechanism 
of HMBA-mediated reactivation of latent virus involves the modulation of 
intracellular levels of cAMP.
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